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INTRODUCTION 
 The universal usage of traditional knowledge and skills to address the variety 
of health needs exists across cultures.  Today a large   number of medicinal plants 
have found their way into the modern scientific pharmacopoeia.  Across cultures, 
traditional medicine centers on integrating the emotional .physical ,mental and 
spiritual aspects of being ,aiming to restore a state of systemic balance between the 
individual and nature .D.C  j ayasuriya and  Shanti jaya surya define the practices of 
traditional medicine as “covering consultative ,diagnostic and care procedures that 
make exclusive use of traditional methods” 
 From the side of  the world health organization as well as from national 
governments ,there is now a global push to recognize ,protect and regulate traditional 
medicine knowledge ,training and practice. 
  Legislation concerned with monitoring traditional medicinal products include 
the Indian Drug and Cosmetic Act 1940 ,Dangerous Drug Act 2000, India’s 2005 
Patent Act . 
 The WHO notes, however that “inappropriate use of traditional medicines or 
practices can have negative or dangerous effect “and that “further research is needed 
to as certain the efficacy and safety” of several of the practices and medicinal plants 
used by traditional medicine system. In some  Asian  &African  countries,upto 80% of 
the population relies on traditional medicine for their primary health care needs.when 
adopted outside its traditional culture,traditional medicine is often called alternative 
medicine.practices known as traditional medicine includes Ayurveda , siddha 
medicine, unani, traditional chinese medicine ,traditional  Korean medicine, 
acupuncture, Islamic medicine. 
 Among those traditional medicine , siddha medicine is more popularly in 
Tamilnadu .siddha medicine is based on philosophy. Siddha medicine is a subsidiary 
of saiva  which appeared before 12,000 years  
“klqp<l{<!mzjlf<Kf<!kiuqb!Riel<!
Dlqp<uK!Ohiz!Uzgf<!kqiquiI!
nuqP!leLoll<!likq!bxqUf<!
klqp<l{<!mzjlf<Kf<!kk<Ku!liOl’’ 
                                                                   -Thirumoolar thirumanthiram 
 Siddhars are those who lived and maintained their bodies as they desired best.  
They had investigated that the body ,though transient was the one and only instrument  
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for attaining success in the spiritual development and growth and so worked out to 
attain the eight super natural powers, as  anima , magima, lagima etc., essential for 
their goal,as mentioned in silappathigaram. 
 According to agathiyar rathina surukkam nadi,disease are classified into 4448 
types. Medicine is classified into two types .they are agamarunthu  & puramarunthu 
,each  classification has 32 classification. The structural aspect of the human body is 
“udal thathus” and functional unit is” uyir thathus”.  Since olden days, the treatment 
of vatha disease in  siddha system has been very much popular and effective varma 
points are the every residing in the body. The stimulation of varma points are useful in 
treating vatha diseases. 
 In yugi vaithiya chinthamani ,yugimunivar has explained 84 types of vatha 
diseases. Santhuvatham is one among them. According to this study ,”santhuvatham 
“is correlated with “polyarthritis”in modern medicine. The common symptoms are 
pain in the joints,alteration in the gait ,malaise ,excessive salivation. 
  Ref: yugi vaithiya chinthamani 
 Polyarthritis is the chronic inflammation of the  synovial membrane of several 
joints. It involve 5 or more joints simultaneously. It is may be experienced at any age 
and is not gender specific. 
  Ref: principle and practice of medicine- Davidson 
 The medicine santhuvatha chooranam (internal)  Ref: athmarakshamirtham,pg 
no 312 & vatha ennai (external)  Ref:agasthiyarvaithiya soothiram 650 ,pg no  
280,281, are indicated for vatha disease in siddha literature. They contain ingredients 
,which have anti-inflammatory property. Considering this they are chosen as trial 
medicines in this study. The effectiveness of varmam , pottanam in alleviating pain in 
snthuvatham is also evaluated along with trial medicines.  
 The author postulate  that the dissertation work might arise new attitude  in 
their field especially in the treatment of santhuvatham. 
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AIM AND OBJECTIVES 
  
AIM 
 Phase II clinical study on  “SANTHU VATHAM” (polyarthritis) and the drug 
of choice is “SANTHUVATHA CHOORANAM” (internal), “VATHA ENNAI” 
(external),”SNEGHA POTTANAM"and VARMAM. 
 
OBJECTIVE: 
Primary objective 
 To evaluate the Therapeutic efficacy of SANTHUVATHA CHOORANAM 
(INTERNAL) & VATHA ENNAI (EXTERNAL) in the treatment of 
SANTHUVATHAM. 
 
Secondary objective: 
1. To evaluate the effect of varmam,pottanam in the management of 
SanthuVatham.  
2. To evaluate the Siddha cofactor towards the efficacy of the trial drug  
SANTUVATHA CHOORANAM  AND VATHA ENNAI and to evaluate the 
pharmacological actions.  
3.  
 
STUDY DESIGN & CONDUCT OF STUDY:  
Study type  :  prospective open labelled phase II  clinical   
criteria based study . 
Study Place :  OPD & IPD of Government Siddha medical College 
& hospital,   Palayamkottai.  
Study Period :  24 Months  
Sample Size :  40 Patients (20 OPD & 20 IPD).In IPD-10 Patients with  
trial medicine and pottanam, 10 patients with trial medicine and 
Varmamam. 
 
PRIMARY STUDY END POINTS: 
 The primary endpoints to be measured in this study include  
 X-rays will be taken once in two weeks and assessed for improvement.  
 Urine and blood samples will be collected once in two weeks and 
analyzed. 
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 The prognosis of inflammation will be measured by a measuring 
tape,twice in a week.  
 Number of visit to the OPD will be noted.patient will be asked to come 
to OPD weekly thrice. (Monday, Wednesday &Friday) for 6 weeks. 
 
SECONDARY STUDY END POINTS: 
 The secondary endpoint to be measured is evaluated relief in symptoms in 
subjects under study 3 times at weeks. 
 
PRIMARY SAFETY END POINTS:  
  The primary safety endpoint will be measured and collection of any serious 
adverse event that occurs from initial study treatment through and including 30 days 
after cessation of study treatment. 
 
  
5 
 
REVIEW LITERATURE 
SIDDHA ASPECTS 
Definition of vatham 
 Vatham is one of the three humours namely vatham, pitham and kabam and it 
consists of vayu (air) and aahayam (sky).  The two other dhosas are set in motion by 
the vatha.  In a healthy man the existance of three humours are in the ratio of 1: ½ : ¼ 
respectively.  This ratio is altered when there is a disturbance to the vatha by 
environmental factors, diet, habits etc., and vatha may be increased or decreased.  
When the equilibrium state is disturbed, vatha is altered, the other two also altered and 
leads to vatha disease. 
Elements which become thodams in the body 
Aahaayam (space) Vayu (air) Vatha thodam 
Thee (fire) Pitha thodam 
Appu (water) Piruthvi (Earth) Kaba thodam 
 According, the siddhar yugi described many vatha diseases so many decades 
ago approximately 7th century.  He classified the diseases under three thosas such as 
vatha, pitha, and kaba.  According to this classification vatha noi are further classified 
into 80 types.  In that, yugi described many type of poly arthritis conditions.  Santhu 
vatham is one of them.  The symptoms of the Santhu vatham are body pain, mmalaise, 
giddiness, salivation, depression etc. 
 
SYNONYM 
 SANTHU VATHAM = SANTHU + VATHAM, SANTHU – joints, 
VATHAM – Derangement of the vatham constituent therefore, we can say that santhu 
vatham means the joints are affected by derangement of vatham. 
 In siddha system of medicine, a human being is composed of 96 basic 
principles, among them the first thirty is considered very vital and the rest are the 
manifestation on extension of the first 30 principles.  These thathuvas are universal to 
all human beings in normal condition.  This not only consist of the physical 
components of the human body but also the mental, intellectual components like 
passions, qualities, knowledge, functions of the sense and motor organs and also their 
coordination.  
 Pancha boothas are the foundations for three dosham vatham, piththam, kabam 
which are the pillars that support our body structure. 
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✓
 Vaayu constitute vatham 
✓
 Theyu constitute piththam 
✓
 Appu constitute kabam 
 Any alterations in the level of mukkuttrams affect the normal functions of the 
body.  This is obvious from the verses. 
  “lqgqEl<!GjxbqEl<!Ofib<osb<Bl<!F~OziI!
! ! utqLkzi!ou{<{qb!&e<X”!
!!!!!!!!!!!!!!.kqVg<Gxt<!)lVf<K*!
The food we eat has six tastes namely sweet, sour, salt, bitter, pungent, astringent. 
Each of them is a mixture of two basic elements. 
-eqh<H!! .! l{<!+!fQI!
Htqh<H!! .! l{<!+!kQ!
dh<H! ! .! fQi<+,!kQ!
jgh<H!! .! utq!+!Ngibl<!
Kui<h<H! .! l{<!+!Ngibl<!
giIh<H!! .! utq!+!kQ!
Relationship between Vatham and Suvai 
Aggravating tastes 
 “HtqKui<!uqR<Sr<gxq!bix<H,iqg<!Gl<uikl<!
! ytq!Bui<jgh<!Ohxqz<!hqk<Ks<!sQXl<!.!gqtqolipqOb!
! giIh<hqeqh<H!uqR<sqx<!ghl<uqR<S!R<sm<cvks<!!
Osvh<H{i<!Ofib[giOk”!
.! g{<[silqbl<!
 According to this poem the sour and astringent tastes  increase the vatha 
humour. 
Neutralising tastes 
 “uik!Olzqm<miz<!lKvl<!HtqBh<H!
! OskLxs<!osb<BR<!sqjxjbl<!.!Ykg<Ogt<!
! givf<!Kui<gsh<Hg<!gim<MR<!Sjuobz<zil<!
! sivh<!hiqgivR<!six<X”!
.! g{<[silqbl<!
 According to this poem sweet, salt and sour can neutralise the vitiated vatha 
humour. Fate of three humours 
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 “nxqf<kqMl<!uiklmr<G!lzk<kqeqz<!
! hqiqf<kqMl<!hqk<kl<!OhviR<szk<kqeqz<!
! lxqf<kqMjlbl<!usqg<Gl<!uqf<Kuqz<!!
djxf<kql<&e<Xg<!Gxuif<k!zlqOk”!
.! kqV&zi<!
 From the above quoting, it is clear that the three humours can be discharged 
through the following routes. 
 Vatha - Faeces 
 Pitha - Urine 
 Kaba - Semen(sukkilam) /suronitham  
Formation of vatham  
 “uf<k!gjz!&e<xqz<!uiBuil!hieEme<!
! kf<k!hqvi{e<!slieEl<!sf<kLxg<!
! %m<MxU!Ovsqk<kz<!%Xl<!uikl<!!
hqk<kl<fim<Mr<!ghOlbil<!fiM”!
.! g{<[silqbl<!
“-Vh<hie!fic!wPhOkiC!vi!
! bqvlie!Okgk<kqz<!Wzh<!.!ohVfic!
yg<gk!slk<okipqjz!B,g<gks!uiBg<gt<!
! kg<ghc!obe<Ox!siVl<!
siVf<!ksfic!ke<eqz<!&zl<!&e<X!
! OhVlqmh<!hqr<gjzBl<!hqe<eZme<!.!liXl<!
djvg<g!uqvx<!gix<oxim<M{i<k<KOl!fisq!
! ujvs<!SpqObijlbk<kqz<!uf<K”!
.! Ofib<fimz<!Ofib<Lkeimz<!
! According to this the human body is composed of 72,000 naadi narambukal.  
Among this 72,000, ten are prominent naadies (Dasa naadies).  Of these ten naadies, 
Idagalai, pingalai and suzhumunai are known as moolaathara naadies. 
 Among the ten vayus five are more important.  These are piranan, abanan, 
viyanan, udhanan and samanan.!
!!!!!!nhiee<!! +! -mgjz! =! uikl<!
! !hqvi{e<!! +! hqr<gjz! =! hqk<kl<!
! !sliee<! +! SPLje!! =! ghl<!
!
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  Abanan in conjunction with idagalai to produce vatha. 
  Piranan in conjunction with pingalai to produce pitha and samanan in 
conjunction with suzhumunai to produce kapha. 
 These three humours or thadhus i.e., vatha, pitha and kapha are the functional 
principles in the composition and substance of the body. 
Location of vatham 
Below the navel 
 “fiole<x!uikk<Kg<!gqVh<hqmOl!Ogtib<!
! !fihqg<Gg<!gQope<X!fuqzziGl<”!
.! B,gqLeq!
Location 
 Vatham lives in 
✓
 Abanan Stools 
✓
 Idakalai 
✓
 Undhiyin keezh moolam 
✓
 Kaamakodi 
✓
 Hip bone 
✓
 Skin 
✓
 Nerves 
✓
 Joints 
✓
 Hair follicles and 
✓
 Muscles  
Natural properties of Vatham  
Physiologically 
✓
 Giving briskness 
✓
 Inspiration and expiration 
✓
 Functioning the mind, thoughts and body  
✓
 Regulation of the fourteen physiological reflexes (vegangal) 
✓
 Uniform function of the seven  udal kattugal 
✓
 Protection and strengthening of the five sensory organs. 
SIGNS AND SYMPTOMS OF VATHA DISEASE:- 
✓
 Pricking pain 
✓
 Dull pain 
✓
 Aching pain 
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✓
 Tremors 
✓
 Palpitation 
✓
 Spasm 
✓
 Dryness or dehydration 
✓
 Dislocation of joints 
✓
 Weakness of the body 
✓
 Paralysis 
✓
 Constipation 
✓
 Oliguria 
✓
 Excessive thirst 
✓
 Astrigent taste predominantly in the mouth 
✓
 Excretions like stools, urine, lacrimiation, sweat, becomes black in colour. 
 
ATTRIBUTES OF VATHAM: 
uikk<kqe<!G{l<;< < << < << < < !
✓
 uxm<sq  -  Dryness 
✓
 Gtqv<s<sq -  Coolness 
✓
 n[k<Kul< -  Subtlety 
✓
 gcel< -  Roughness 
✓
 njsk<kz< -  Mobility 
 
INFLUENCE OF VATHAM IN MONTHS: 
“uikuIk<!ke!gizOlOki!oue<eqz<!
lVUgqe<x!Neq!gx<gm!likl<!
Nkjeh<!hsqObiM!giIk<kqjg!ke<eqz<!
NmVOl!lx<x!likr<gt<!ke<eqz<!
OhigOu!sqlqg<gqe<x!gizliGl<”!
.! B,gq!sqf<kil{q!
!
 According to this poem vatha may be influenced in the following months 
normally. They are Aadi, Avani, Purattasi, and Iypassi. 
 
AGONIST QUALITIES OF VATHAM: - 
Normal qualities of vatha are, 
✓
 Dry 
✓
 Cold 
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✓
 Subtle 
✓
 Rough 
✓
 Unstable 
✓
 Light 
ANTAGONST QUALITIES OF VATHAM: 
✓
 Unctuous ‘Hot 
✓
 Solid 
✓
 Soft 
✓
 Stable 
✓
 Heavy 
SIGNS OF HYPERVATHAM:- 
✓
 Constipation 
✓
 Abdominal disturbances 
✓
 Fatigue 
✓
 Depression of sense organs 
✓
 Giddiness 
✓
 Incoherent speech 
✓
 Rigors 
✓
 Insomnia 
✓
 Fond of eating hot food stuffs 
✓
 Emaciation with blackish discolouration 
✓
 Loss of vigour. 
SIGNS OF HYPOVATHAM: 
✓
 Vague pain all over the body 
✓
 Low-pitched voice. 
✓
 Difficulty to do any work. 
✓
 Reduction of intelligence 
✓
 Syncope 
✓
 Symptoms of hyperkapha. 
  
Classification of vadham 
 Vatha can be classified into ten types.  This has been said in Yugimuni 800 as 
follows. 
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 “Ljxbil<!hqvi{Oei!mhiee<!uqbiee<!
! !&Ig<gli!LkieoeiM!slie!eigl<!
! !kqxjl!bir<!%IloeiM!gqVgve<xie<!
! !Oku!kk<k!oeiM!!keR<!sbEliGl;”. 
.! B,gq!juk<kqb!sqf<kil{q!
!
1. Piranan 
2. Abanan 
3. Viyanan 
4. Udhanan 
5. Samanan 
6. Nagan 
7. Koorman 
8. Kirugaran 
9. Devadhaththan 
10. Dhanajeyan 
Each one is responsible for various actions within the body. 
1. Piranan:- (Heart Centre) 
 It refers to the chest and it regulates the respiratory system and helps the 
digestive system. 
2. Abanan:- (Muladhar Centre) 
 The type of vatha corresponds to the pelvic and it is the seat of kundalini 
energy and controls excretions such as sweating, evacuation of stools, ejaculation of 
sperms, micturition, menstruation and parturition(delivery of child). Abana vayu is 
one of the 14 physiological reflex actions (Vegas) of the body. When its expulsion 
ispartially or completelly obstructed it leads to diseases like vayu gunmam, kudal 
vatham, vali vatham. 
3. Udhanan:- (Throat centre) 
 This corresponds to the pharyngeal plexus in the throat region and controls 
breathing and speech. It is also responsible for the physiological reflex actions like 
vomiting, hiccough, cough etc. 
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4. Vyanan:- 
 It helps in the circulation of energy through the entire nervous system and 
helps in the movements of various parts of the body. It is responsible for the tactile 
sensation. 
5. Samanan: - (Navel centre) 
 This corresponds to the solar plexus etc. By balancing the other vayus, the six 
tastes, water and food any one of the vayus is affected, this samanan is also affected. 
6. Naagan :- 
  It is responsible for the intelligence of an individual. It helps learning different 
arts, singing of good songs etc. It is responsible for blinking, opening of eyes and 
eyebrow raising. 
7. Koorman :- 
  This is responsible for yawning, closing of mouth, yielding strength and also 
blinking. It helps closing and opening of the eyes and shedding of tears. It is 
responsible for the vision. 
8. Kirukaran :- 
  It is responsible for the salivation in the oral cavity and mucous secretion in 
the nasal cavities. It is responsible for good appetite. It helps in meditation. It 
produces cough and sneeze. 
9. Devadhathatan :- 
  It is responsible for the lazziness and also lassitude while waking up. It helps 
movements of the eyeball in various directions. It is responsible for quarrelling, 
arguing etc., and also for much anger. 
10. Dhananjeyan :- 
  It is responsible for the swelling all over the body. It produces sensation of 
roaring like the sea in the ears. It leaves the body by blowing up the cranium on the 
3rd day after death.  
Classification of vatha diseases 
  In classification we can find different view regarding the number. 
In  Yugi vaithya chinthamani, Yugi says 
 “we<eOu!uiklK!w{<hkiGl<” when ending a verse describing the names of 
the types of vatha, yugi again says the number as 80, 
 “kig<gie!uikf<kie<!w{<hkiGl<”/!
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  But in the concluding section of the yugi vaidhya chinthamani, the number of 
vatha diseases has been given as 84. 
  In Agasthiyar 2000, 
 “w{<hK!uiklqG!lqVujgh<!hMk<Kg<!gi{qz<!
! !f{<HX!njvg<G!OlOz!fix<hK!uikliGl<!
! !h{<Osvjvg<Gg<!gQOp!hk<Kfie<!giGole<X!
! !u{<MOsi<!GpzqeiOt"!uikk<kqe<!%X!kiOe”!
  i.e. 40 types of vatha disease are in the upper half and 40 in the lower half of 
the body and the total number is 80. 
CHARACTERISTIC FEATURES OF VATHAM: 
 “uikOl!gkqk<k!OhiK!uiBu!olPl<Hr<!gi{<CI!
!uikOl!gkqk<k!OhiK!uiBuf<kqMR<!se<eqOki^l<!
!uikOl!gkqk<k!OhiK!uz<zMe<olzqf<K!ogiz<Zl<!
.ngk<kqbIsqgqs<sivk<ekQhl<!
!! uikl<!lqGl<!OhiK!se<eqOkiml<!Ohie<x!hz!uqbikqgt<!uf<K!OsVl<!
dmz<!olzqBl</!
“uikuQX!ne<elqxr<giK!gMh<H{<mil<!u{<{L{<mil<!
!OliKgm<M!Ovigl<!SvL{<mil<!lqVlZli!Lxr<gioke<Xl<!
!YKSiqb!uik!leziG!fMg<g!L{<mil<!ohiVt<gtib<k<!
!kQkeOu!fvl<hqsqk<K!sf<Kgt<!OkiXl<!gMg<Gl<!kqeLl<!kiOe”!
.!Okve<!uigml<!
 Loss of appetite, pain and discoloration, fever and cough, insomnia, tremors, 
pain in all the joints of the body are the characteristics of vatha diseases. 
 
PITHAM: 
 Pitham is responsible for all the transformation. Pitham is located in urinay 
bladder, heart, head, umbilicus, abdomen, blood, sweat, skin and eye. Pitham is 
classified into 5 types. They are, 
 Anar Pitham - Responsible for digestion of food. 
 Ranjaga Pitham - Responsible for colour of blood. 
 Sathagam - Located in heart and is responsible for normal activities of the 
body. 
 Alosagam - Responsible for normal vision. 
 Prasagam - Responsible for the complexion of skin. 
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KABAM: 
 Kabam stabilizes, maintains and lubricates all movements. Kabam is found in 
samanan, semen, brain, head, tongue, nose, bones, bone marrow, fat, nerves, chest, 
blood, large intestine, eye, stomach and pancreas. Kabam is classified into 5 types, 
they are: 
 Avalambagam :  
  Lung is the center for avalambagam. It controls all other forms of 
kabam. 
 Kilethagam :  
  Stomach is the centre for kilethagam. It gives moisture and softness to 
the ingested food and helps for digestion. 
 Bothagam :  
  Tongue is the centre for bothagam and it is responsible for the sense of 
taste. 
 Dharpagam :  
  Head is the centre for Dharpagam. It gives cooling effect to eyes. 
 Santhigam : 
  It lies in the joints and is responsible for the locomotive action of 
movable bony joints. 
 
SANTHU VATHAM 
 Santhu vatham is one of the vaatha diseases which is described in “Yugi 
vaithya chinthamani”. 
 
Definition 
 The term santhuvatham denotes all kinds of joint disease caused by the 
derangement of one of the uyirthathus “Vatham”. 
 In the same literature it is mentioned such type of joint disease as megasoolai 
under the chapter of “Soolai noikal”. 
 
SYNONYMS: 
Santhuvali )sf<Kutq* 
Moottuvali  )&m<Muzq) 
Megasoolai )Olg$jz* 
Mudakkuvaayu )Lmg<G!uiB* 
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Aama vatham )Nluikl<*!
Keelvayu  )gQz<uiB*!
- Siddha maruthuvam 
Santheega sleshmarogam )sf<kqgsqOz]<l!Ovigl<*!  
Santhu vatham )sf<K!uikl<*!
Soolaikattu )$jz!gm<M*!
Vathasoolai )uik$jz*!
Vayu rogam )uiB!Ovigl<* 
- Vaidya sara sangiraham 
In vaidya sarasangiraham 
 Agasthiyar vaidhya kaviyam 
 Agasthiyar Gunavahada thirattu 
 Thirumoolar karukkidai vaidhyam 600, 
Santhu vatham was explained in the name of soolai, because of excruciating pain 
caused by such diseases. 
 Since it causes pain in the santhu or moottu, it is called as moottuvali  or 
sandhuvali. 
 Restriction of movements and in some cases even immobility of the joints can 
occur, so it may be named as mudakku vaayu or mudakku vaatham. 
  Thus the terms of this disease are named according to the cause, derangement 
of the uyirthathu, kurigunam, site of lesion, complication etc. 
 
In TV Sambasivampillai medical dictionary Santhuvatham is described as 
! “sf<Kuikl<!.!ohiKuig!npx<sqbqeiz<!!
! dml<hqz<!Lpr<giz<!Lkzqb!ohiVk<Kgjt!
kig<gq!uQg<gl<!g{<M?!uzqBme<!gQz<gjt!
! Sx<xqBt<t!su<Ug<G!gi[l<!YI!uik!Ofib<”/!
  A form generally employed to inflammatory disease acute or chronic of the 
whole or greater part of the fibrous structures that constitute the formation of a joint-
arthritis. 
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According to Yugi vaidya chinthamani!
! “sf<Kgt<!lqg!kqlqIk<K!dml<olz<zil<!
! !lqg!ofif<K!lbg<gl<!uib<!fQVxz<?jggiz<!
! !H,lqbqz<!kiqg<goui{<{iK!uzqjb!d{<mig<Gl<!
! !uikOfib<”/!
! “Rheumatism is characterised by inflammation with the thickening of the 
fibrous tissues, body pain, giddiness, salivation and unbearable pain in the limbs 
rendering the patient unable to stand firmly”. 
 
According to Siddha maruthuvam (text book) 
! osb<jgkie<!sf<KgT!lqgk<kqlqi<f<K!
osmolr<G!ofif<KOl!lqgupx<xq 
jfjgbib<!fTk<KOl!lbqi<g<%s<sqm<M!
fi{qOb!Le<Ohiz!fjmogimiK!
jljgkie<!lbg<goliM!uib<fQXl<!
uv{<cMOl!fiUkie!cg<gcg<G!
jggiz<kie<!xv{qkeqx<!xiqg<ogi{iK!
sR<szqg<!GR<sf<Kuil<!uikr<OgOt”/!
!
  Santhuvatham is a disease characterised by difficulty in walking and inability 
to do the works with hands and legs as usual due to stiffness of joints and pain of the 
body.  Extra articular symptoms associated with this disease are excessive salivation, 
dryness of tongue, lassitude and lethargy. 
  It is a disorder of joints (santhu) where bone, muscles, tendons, ligaments and 
associated structures binds together, for the purpose of locomotion of the body, 
caused by deranged humour vaatha. 
Many literature references reveals above mentioned conditions associated with 
pathological conditions of vatha derangement/!!
  “uikOl!uiBuiGl<!uikOl!gizqx<OsVl<!
!uikOl!ge<eqobiM!lVuqcz<!uzqUL{<mil<”!
.! hvvis!Osgvl<!
! !
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uikOl!gkqk<kOhiK!uiBu!olPh<H!lQVl<!
osiz<zOu!uiklK!lQxqx<xieiz<!
OsiIujmf<K!uiBuqeiz<!Okgolr<Gl<!
olz<zOu!jggiz<gt!skqB{<mil<!
olb<Lmr<Gl<!fqlqvoui{<{ik<!kqlqV{<miGl<!
olz<zOu!Bmz<!ohiVLe<!ubqXjtg<Gl<!
uqVl<hqb!e<eR<!osz<ziK!uqf<Kfm<ml<!
ogiz<zOu!fih<Hg<Gl<!gib<s<sZ{<mil<!
%xqeiI!lijzbLeq!%xqeiOv”!
.! ngk<kqbi<!sqgqs<si!vk<kqe!kQhl<!
  Manifestations of vaatha vitiations are pain in extremities and joints, 
abdominal distension, swelling, immobilization of joints and stiffness, perverted taste, 
anorexia, fever etc., 
!
According to Agasthiyar Rathina surukkam 
! The character of vatha vitiations are joint pain, fever, nausea, body aches, 
constipation and  excessive sweating. 
!
According to Theraiyar vagadam 
  Indicates vatha vitiation causes cough, loss of sleep, swelling of 
interphalangeal, tarsal, metatarsal joints and bony prominence, stiffness of the body 
and excessive salivation.In santhuvatham disease mostly affected types of pitham are 
sadhakam, ranjakam and prasaga pitham. 
 
In Gunavagadam Noyin saram stated, 
 “kqVk<klil<!uikk<OkiOm!kQr<ogiM!hqk<kl<!Osiqz<!
! !ohiVk<Kgt<!OkiXl<!ofif<K!OhigOubqcg<Gl<!$jz”!
When pitha dhosha associated with vatha causes joint pain.  Other dhosha is 
kapha, kapha mainly regulates the fluid balance and structural component in all the 
tissues and organs of the body. 
When vathakapha gets deranged, 
 “utqjlBf<!ke<eqjz!ogm<M!
! !uzqBme<!uQg<gs<!SvLl<!gib<f<K!
! !&m<Mgt<!OkiXl<!LMg<gqOb!ofif<K!
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! !&m<Mgt<!ke<eqz<!fQVl<!Svf<K!
! !kir<ogi{i!uzqBme<!ofif<kqMll<Ol” 
Its manifestation are pain, swelling and fever associated with unbearable pain 
of the joints and increased secretion of synovial fluid. 
Aetiology of Santhuvatham 
 In yugi we cannot find any specific aetiology for santhuvatham, but causes for 
all types of vatha disease in general have been described. 
 “we<eOu!uikl<ki!oe{<hkiGl<!
! -gk<kqOz!leqki<gTg<!ogb<BliX!
! hqe<eOu!ohie<kjeOb!OsivR<osb<K!
! ohiqObiIgt<!hqvil{jvk<!K~]{qk<Kl<!
! ue<eOu!us<osik<kqx<!OsivR<!osb<K!
! liki!hqki!GVjul!xf<k!OhIg<Gl<!
! ge<eOu!Oukk<jkfqf<jk!osb<kiz<!
! gibk<kqx<!gzf<kqMOl!uikf<kiOe”!
!.! B,gq!juk<kqb!sqf<kil{q!
Since vatha is responsible for nervous function, injudicious actions like, theft, 
unreligiousness, unlowyality, will affect the mind and soul will cause disturbance of 
uyirthathu – vatham. 
According to Agasthiyar kanma kandam 300 
! “F~oze<!uikl<!uf<k!ujgkiOeK!
! ! K{<jlbib<g<!ge<lk<kqe<!ujgjbg<!OgT!
! gizqOz!Okie<xqbK!gMh<hOk!
! ! jggizqz<!Lmg<gqbK!uQg<glK!
! OgizqOz!hMgqe<x!uqVm<slie!
! ! Gpf<jk!lvf<kje!oum<mOlz<!Okiz<sQuz<!
! fizqOz!sQuosf<K!giz<!Lxqk<kz<!
! ! fz<z!ogil<H!kjp!lxqk<kz<!fzqk<kz<!giO{”!
.! ngk<kqbi<!ge<l!gi{<ml<!411!himz<.67!
 In siddha system many disease are due to kanmam which means the deeds or 
bad committed by an individual in his previous and the present birth.  The genetic 
disposition of certain disease are probably the result of kanmam.  Kanmam may also 
precipitate vatha disease. 
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Clinical features of santhuvatham 
! “uikhqk<kg<!gQz<uiBuqe<!uVr<Gxq!six<xg<!Ogtib<!
! WkliI!lf<k!Olh<hl<!-jvs<sZl<!ubqx<xqz<!fi[l<!
! YkVr<!Gk<kz<!uQg<gl<!Yb<kzqe<!wiqs<sZ{<mil<!
! gikXLxg<g!lqe<jl!gib<sZr<!gi[r<!g{<mib<”/!
.! shihkq!jgObM!
!
 Indigestion (Mantham) Eructation  - Yeppam 
 Borborymus of the abdomen 
 Pricking pain 
 Burning sensation 
 Swelling of the affected joints, fever, insomnia and lazziness. 
 Classification of Santhuvatha disease There are 80 types of vatha diseases are 
explained in Yugimuni vaidhya chindhamani among them, 11 types of vatha diseases 
are associated with poly arthritis. 
They are 
• Santhuvatham 
• Vatha suronitham 
• Kalanjaga vatham 
• Uthira vatha suronitham 
• Narithalai vatham 
• Malaitha kambha vatham 
• Vatha upakatham 
• Kumba vatham 
• Thandaga vatham 
• Sagana vatham 
In Agasthiar vaidhya kaviyam 5 types  
• Vatha soolai 
• Vatha azhal soolai 
• Marbil soolai 
• Azhal soolai 
• Amavatha soolai 
 In Jeeva Rackchamirtham 7 varieties are explained as vatha, pitha, kapha, 
mukkuttra soolai, Ama soolai, sankara soolai and Gunma soolai. 
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 There are additional 2 types in Anubava vaidya Devaragasiam 
 They are Mega soolai and Muri soolai . 
In thirumoolar karukkidai vaidyam -600  5 types 
o Vatha soolai 
o Pitha soolai 
o Kapha soolai 
o Vatha pitha soolai 
o Seezhmega vayu soolai  
 In Agasthiyar Gunavakadam 
o Vatha soolai 
o Vatha azhal soolai 
o Azhal soolai 
o Iya azhal soolai 
o Seezhmega soolai 
Thus many literaures mentioned joint disorders under the name of soolai. 
Complications of Santhuvatham 
 As the disease progresses, joint diseases leads to deformity and 
immobilization of the limbs.  In Siddha system such conditions are named as 
mudakku vatham, 
 “hk<kqb!uikf<Kbk<K!hiGOl!hbqk<kqbk<kiz<!
! wk<kqb!fvl<hqLk<K!OlzKR<!SV{<M!ogit<Tl<!
! Gk<kqOb!Kjtk<kix<!Ohiz<!Gjmf<K!gizjmf<K!gi[!
! lx<xqK!Lmg<G!uikli!oleg<!gVkziOl”/!
.! B,gqLequi<!ohVF~z<!juk<kqbgiuqbl<!.2111!
   It denotes, in mudakku vadha condition body will bend forward and rounding 
the shoulder probably due to vertebral column deformity (Hang dog position). 
Piniyari muraimai 
 Diagnostic methods adopted in siddha system of medicine are formed as 
“Piniyari muraimai”.  It is based on the following principles. 
1. Poriyal arithal 
2. Pulanal arithal 
3. Vinathal 
 Pori and pulan are the five organs of perceptions and their senses respectively.  
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 Nose-smell, Tongue – taste, Eyes –vision, Ears & Skin – Auditory & touch.  
Porigal of  patient and doctor are used by the physician as instruments. 
 Vinathal is a method of enquiring about the details of patient’s complaints 
from his own words or from their attendant. 
 The above mentioned principles can be compared to that of interrogation and 
inspection, palpation, percussion, auscultation. The important method adopted to 
diagnose the disease is by means of “Envagai thervugal”. 
 “fich<hiqsl<!fifqxl<!olipquqpq!
! lzl<&k<kqvlqju!lVk<kuviBkl<”!
.! Ofib<fimz<!Ofib<!Lkeimz<!higl< I 
  It is considered to be physician instruments and this can be understand by 
following poem, 
 “okiMg<gZx<xX!nm<muqkh<!hiQm<js!ke<je!
! Kzg<gLXl<!h{<ckOv!oktq!ukigh<!
! hGg<gib!ficjb!fQ!hqck<Kh<!hiV!
! hgi<gqe<x!uiIk<jk!hiI!fijuh<!hiV!
! uGg<giqb!Okgole<xk<!okim<Mh<!hiV!
! utlie!siQvk<kqe<!fqxk<jkh<!hiV!
sgqg<giqb!lzk<jkh<!hiI!szk<jkh<!hiV!
siIf<k!uqpqkjeh<!hiIk<K!oktquib<!giO{”!
.! ngk<kqbi<!juk<kqb!uz<zikq!711/!
Envagai Thervugal includes 
 Naadi, sparisam, naa, niram, mozhi, vizhi, malam, moothiram. 
Naadi (pulse) 
 “nxqf<K!hiI!uikOl!keqk<k!kieiz<!
! ne<el<!Ohiz<!fmg<Glh<hi!fic!hiV!
! siqf<kqmOu!giz<!Lmg<Gl<OhiK!gim<Ml<”!
.! ngk<kqbi<!vk<kqe!SVg<gl<!
 Vitiated vatha causes difficulty in walking or impaired function of lower 
extremities.  The examination of naadi has been recognised as one of the principle 
means of diagnosis and prognosis of disease from times immemorial. 
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Sparisam (skin) 
 Skin examination can be made out by touch and reveals about warmness, 
chillness, dry, weeping, skin rough, smooth, soft, hard, tenderness or presence of 
ulcers, swelling, wrinkles, hair, pigmentation etc., Naa (Tongue) 
 The colour, character and condition of the tongue changes according to the 
changes in mukkutrum. 
 
Niram (colour): 
 As vaatha is the root cause the colour of the patient’s skin, tooth etc., should 
be dark or black in colour. 
 
Mozhi (Speech): 
 Speech in vatha patients may vary according to the deranged dhosas and grade 
of the disease. 
 
Vizhi (Eye): 
 Burning of the eyes, lacrimation, irritation, colour changes are also noticed 
under this group.  In Santhuvatham patients no changes in the eyes. 
 
Malam (stools): 
 In Santhuvatham patients stools should look in dark colour with constipation. 
 
Moothiram (urine) : 
 “djxf<k!fQVr<!gV!gVk<K!
! Ljxbib<!OvigL!L{<miOl”!
.ngk<kqbi<!fic!
! “nvoue!fQ{<cce0Ok!uikl<”!
 When the oil drop spreads like a snake it indicates vathaneer.  
 
UYIR THATHUKKAL IN SANTHUVATHAM  :- 
Vatham 
1.Pranan : Inspiration and expiration responsible for sneezing coughing and  
  belching. Not affected 
2Abanan : Act with downward movement  .Affected (constipation). 
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3.Viyanan  : Helps in various movements of body, responsible for sensation.  
   Affected (Restricted movement of affected joints radiating pain also  
 present with tingling sensation). 
4.Udhanan : Regulates the higher functions of brain. Responsible for physiological  
reactions like hiccough and vomiting.Not affected 
5.Samanan : Regulates all other vayus .Affected(Due to vyanan affected). 
6.Nagan  : Responsible for intelligence helps in opening and closing of eyes .  
 Affected in aged pateints. ( Acuity of vision is deminished.) 
7.Koorman :Responsible for lacrimation . Helps in visualization of all things of   
 world. 
8.Devathathan: Responsible for lazziness. Rotation of eyeballs, 
  Affected (Sleeplessness). 
9.Thanajeyan : Responsible for tinnitus oedema.  
 
Pitham 
1.Anar pitham  : Digests all the ingested particles.Affected(loss of appetite). 
2.Ranjagapitham : Increases the blood and gives colour to the blood 
  Affected(decreased Hb level.) 
3.Saathaga pitham : Makes the work to complete what mind thinks to do.  
  Affected (Restricted movements  & pain present) 
4.Prasaga pitham  : Gives colours to skin. Not affected 
5.Aalosaga pitham  : Responsible for clear vision.Affected in old age peoples. 
 
Kabam 
1.Avalambagam  : Controls other 4 types of kabam.Affected 
2.Klethagam  : Moistens the food.Not affected 
3.Pothagam    : Helps to know the taste.Not affected 
4.Tharpagam  : Gives cooling effect to the eyes.Not affected 
5.Santhigam   : Gives lubrication to joints.Affected (Pain and restricted  
  movements present)  
 
UDAL VANMAI:- 
It means strength and vitality of the body and classified into three types. 
o Eyarkai vanmai - Inherited immunity 
24 
 
o Kala vanmai - age, season and time 
o Cheyarkai vanmai - improvement of 3 vitality obtained by diet, 
daytoday habits and physical exercises. 
 
SEVEN PHYSICAL CONSTITUENTS OF BODY 
1. Saaram : Strengthens the body and mind.Affected 
2. Senneer : Preserves brightness, boldness, power& knowledge.Affected 
3. Oon       :Gives structure and shape to the body.Early stage  - Not  
 affected.   Later stage  - Affected 
4. Kozhuppu : Responsible for movement lubricants the joint. Affected 
5. Enbu    : Responsible for joint movement. Affected 
6. Moolai  : Present inside the bones and gives strength to the bones.Not  
  affected 
7. Sukkilam or suronitham: Responsible for next generation of human beings.
 Not affected 
 
Thinai (land and place) 
 The geographical distribution of the land is classified into five regions. 
1. Kurinji  - Mountain and its surroundings 
2. Mullai  - Forest and its surroundings 
3. Marutham - Field and its surroundings 
4. Neithal - Sea and its surroundings 
5. Paalai  - Desert and its surroundings 
 Accordingly, vaatha diseases are common in  neithal nilam.  Palai nilam-
common places for all  types of diseases.  Marutha nilam is good for all types of 
treatment and health. 
 
Kalam 
 According to siddha system the year is divided into six seasons with reference 
to the position  of earth and sun. 
S.No. Paruvakalangal Kuttram 
1. Kaarkalam           –      August, September  
!!!!)Nu{q?!Hvm<misq* Vatham ↑ ↑Pitham  ↑ 
2. Koothirkalam     -       October, November 
!!!!!!!!!!!!!!!!!!!!!!)Jh<hsq?!giIk<kqjg*Vatham (-)Pitham  ↑ ↑ 
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3. Munpanikalam     -     December, January 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!)liIgpq?!jk* Pitham  ↑ 
3. Munpanikalam     -     December, January 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!)liIgpq?!jk* Pitham  ↑ 
 
4. Pinpanikalam        -    February, March 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!)lisq?!hr<Geq* Kabam  ↑ 
5. Ilavenilkalam       -     April, May 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!)sqk<kqjv?!jugisq*! Kabam ↑ 
6. Muduvenilkalam  -    June, July 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!)Neq?!Nc* Vatham  ↑ 
Kabam (-)Kaarkalam 
“outqs<!Spz<!km<hk<jk!uqR<Lm<!$m<jm!
ntqk<Kiqg<G!Ofi<osBliz<!big<jgg<!.!gtq!osiq!
ue<eqb0Gl<!gi{k<kiz<!uikikq!Lk<Okiml<!
fe<eqjzbqz<!fqz<zi!fuqz<”!
.lVk<Ku!keqh<himz<!
These above mentioned poem stated that the kaar and muthuvenil kalam are seasons 
for vatha diseases.  
SANTHUVAATHAM AFFECTED IN 96 THATHUVAM: 
 
1.  Bootham    :      Mun, Appu, Vayu andAagayam.  
     Symptoms   :      Deranged vatham 4 boothams. 
 
2. Pori             :     Mei (Aagaya bootham ). 
 
3. Pulan               :     Ooru  
    Symptoms        :    Pain and tenderness 
 
4. Kanmenthiriyam   :     Kaal and Kai  
    Symptoms        :     Pain, numbness,weakness, destroying,loosening, burning. 
 
5. Kanmavidayam   :    Kamanam,  Thaanam  
    Symptoms             :    Difficulty to normalmovements in limbs. 
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6. Naadi       : Edakalai Pinkalai Suzumunai .Three humours are 
         found by these naadies. 
 
7. Vayu       :    Piranan         - Deranged vatham 
     Samanan       - Vayu increased in joints 
             Devadathan   - Drowsiness,  tremor 
               Abanan          - Constipation 
   Udanan          -  Salivation, dryness of mouth 
   Kirukaran  - Salivation, mental agony 
 
8. Kosam  : Vali Udambu,Paru Udambu,Arivudambu,Inbaudambu Deranged  
  three humoursand seven udal thathu, drowsiness,  mentalagony,  
  weakness. 
 
9. Aatharam   
  Moolarthalam   - Weakness 
  Swathitanam    - Drowsiness 
  Manipooragam   - Destroying 
  Anagatham         - Burning sensation 
  Visutthi           - Tremor 
  Aakinai           - Dryness of mouth 
10. Gunam : Thamo Kunam    -Drowsiness,Mental agony character is one of  
  the main etiology. 
 
11. Vinai  : Thivinai is one of themain etiology for the santhuvatham. 
 
Uyir Thatukkal: 
 
1. Vatham  
Piranan         Deranged Vatham  
Abanan          Constipation 
  Viyanan           Pain and numbness in joints 
  Samanan       Pain all over joints 
27 
 
  Kirukaran      Salivation, mental agony 
  Devadathan    Drowsiness, mental agony 
 
 
2. Pitham   
Sathagam      : Difficulty to work due pain and 
numbness, mental agony, tremor 
weakness 
3. Kapham   
Santhigam    : Destroying, loosening, 
inflammation, burning sensation 
in joints, chillness of joints, 
weakness, pinching of joints. 
 
Affected Udal thaathukkal   
Symptoms 
Saaram  Salivation, Dryness of mouth 
Oon   Wasting, destroying, weakness 
Kozhuppu Destroying, Chillness, Inflammation, 
difficulty in movement of joints 
Enbu  Burning Sensation of joints, loosening, 
pain in all over the joints 
 
Ofib<!fqkiel<< << << < (DIFFERENTIAL DIAGNOSIS): 
gitiR<sguikl<< << << < (Kalanjaga Vatham): 
 Though the patient had numbness in both upper and lower limbs, twisting pain 
in joints destroying and inflammation, difficulty to walk, emaciation, cripple, rigidity 
due to morbid enlargement, wasting in body, pallorness, itching, ulcer, deranged 
iyyam, indigestion, drowsiness, it is not santhuvatham. 
uikSOvi{qkl<<<< (Vatha suronitham) 
 Though the patient had Wasting in whole body, swelling in joints, difficulty to 
walking, swelling in carpal joints, itching in all over the body, loss of appetite, coma, 
salivation, it is not sathuvatham. 
!
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dkqvuikSOvi{qkl<<<< (Uthiravatha Suronitham) 
 Though the patient had, swelling in ankle joint, knee joint and heel pain and 
inflammation in carpal and tarsal joints, drowsiness, exhausted, madness, deranged 
Azhal humour, loss of appetite, it is not santhuvatham. 
OlgS,jz!)Mega Soolai)  
Though the patient had pain in lower back and both limbs, constipation 
absolute suppression of urine, sweating in both limbs, shivering, redness in lips, 
wasting, burning sensation all over the body, fever, thirst, perplexity, mental delusion, 
it is not santhuvatham. 
uikS,jz (VathaSoolai) 
 Though the patient had, pain in both limbs, numbness, coma, pain in the body, 
chillness, pallorness in body and face,pain in the thigh, burning micturation, 
haematuria, pain increase in the body, it is not santhuvatham. 
 hqk<k$jz!<<< (Pitha soolai) 
 Though the patient had wasting and emaciation, pain in both limbs and joints, 
deranged humours, pallorness in all over the body, drowsiness and delusion, it is not 
santhuvatham 
 Santhuvadham is differentiated from other types of keel vaayu as follows: 
utqnpz<!gQz<uiB!< Q << Q << Q < (Vali Azhal Keel Vaayu)!
 It is characterized by excruciating pain and swelling involved in toes, knee 
joints, hip joints, elbow joints, shoulder joints and associated with systemic 
disturbances like dryness of mouth, pyrexia, headache, palpitation, constipationand 
sweating. In advanced cases it may affect the heart and produce “Thamaraga Vaayu”. 
JbgQz<uiB!Q <Q <Q < (Iyakeel vaayu) 
 It is characterized by severe pain in the joints associated with emaciation of 
the body, anorexia, insomnia, cough, hiccough, vomiting, anemia and dropsy. The 
common sites are spinal cord, hip joint and knee joint VALI IYAKEEL VAAYU: 
 It is characterized by pain in the joints associated with effusions of joint fluid 
and swelling, restricted joint movements, pyrexia, fainting, insomnia, especially in 
knee joint asymmetrically, lymphadenopathy, generalized malaise, atrophy of the 
affected limb etc., The affected joint looks like “Fox’s head”. 
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LINE OF TREATMENT 
 According to siddha system, the main aim of the treatment is to cure physical 
illness and mental illness.Treatment is not only for complete healing but also for the 
rejuvenation .Siddha system of medicine has a sophisticated treatment modality.  It 
not only cures the disease but it corrects the causative factors and insists to advise 
certain life style modification in order to prevent the disease again. 
 Thiruvalluvar says about physicians duty, study the disease, study the cause, 
seek subsiding ways and do what is proper and effective. 
 
‘Ofib<fic!Ofib<Lkeic!bKk{qg<Gl<!
uib<fic!uib<h<hs<!osbz<”!
!
‘dx<xietUl!<hq{qbtUr<!gizLl<!
 gx<xie<!gVkqs<!osbz<” <!
.!kqVg<Gxt<!
 So it is essential to know the disease, the aetiology, the nature of the patient, 
severity of the illness, the seasons and the time of occurrence must be observed 
clearly. 
Line of treatment is as follows: 
In Siddha system line of treatment consists of the following 
1.Neekam (Treatment) 
2. Niraivu (Restoration of wellbeing) 
3. Kappu (Prevention) 
NEEKAM: 
a) To bring the Three Thodams to equilibrium state. 
b) To treat the patient by Internal and external medicines. 
c) To stabilize seven Udal thadhukal and three Uyir thadhukal. 
 To bring the three Thodams to normal equilibrium state-by giving purgation. 
Purgation drug: 
 Purgation was given in early morning for balancing the deranged mukkutram 
on the first day of the treatment. Next day onwards the trial drugs 
.SANTHUVATHACHOORANAM (internally) and VATHA ENNAI (externally) 
were given. 
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NIRAIVU: 
 By promoting the awareness about the dietary, seasonal, emotional influence 
on the disease assurance from disease recovery was given. Life-style modification 
was also advised to them. 
KAAPU: 
 Knowing the cause there by removing it and thus preventing the disease is the 
main aim of Siddha system of medicine. Siddha system emphasizes the purification of 
thought and activities as mentioned in the siddha text “Theraiyar Pinianuga Vithi” 
which emphasizes virtueness to be followed even in the daily life activities. 
DIETARY ADVICE: 
 In Siddha system of medicine the importance of dietary habits have been 
emphasized for the management of diseases and its prevention in a effective manner. 
“gMG!fx<xqzk<!ok{<o{b<!%p<hi{<mr<gt<!
u_u!kiOb!ok{<o{b<!%p<hi{<mr<gt<!gmjz!
lcuq!zikout<Tt<tqogit<!Hjgbqjz!lKohe<! !
-mX!higOzi!mgk<kq!fQg<gqmzqs<!sihk<kqbl<”!
.!sqk<k!lVk<Kuir<g!SVg<gl< 
During the course of treatment, the patients were advised to follow certain diet 
regimen (Icha pathiyam) which is mentioned for vatha diseases. 
1. Kadugu - Brassica nigra (Mustard seed) 
2. Ell Nei - Gingelly oil 
3. Poosanikkai - Bennicasa hispida 
4. Kadalai - Arachis hypogea 
5. Thengai - Coccus nucifera 
6. Maangai - Mangifera indica 
7. Poondu - Allium sativum 
8. Pala - Artocarpus heterophyllus 
9. Kollu - Horse gram 
10. Pugaiyilai - Nicotiana tobaccum 
11. Pagal-- Momordica charantia 
12. Agathi - Sesbania grandiflora 
13. Sour taste 
14. Astringent taste 
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Substances used for neutralizing three humours are: 
“ye<xqb!uikhqk<k!ghlqju!Bbvi!u{<{l<!
fe<xX!gxq!gotz<zil<!fiTOl!sjlh<hvib<OkiI!
kqe<xqM!lqtG!lR<st<!sQvg!LbIf<k!gibl<!
oue<xq!ogit<!Sg<OgiOmzl<!ouf<kqbl<!dt<tq!OsIOk”!
.!h/G/sq!
To maintain three vital humours in equilibrium one should take food cooked with: 
Pepper  -  Piper nigram 
Turmeric  -  Curcuma longa 
Cumin seeds  -  Cuminum cyminum 
Asafoetida  -  Ferula asafoetida 
Dry ginger  -  Zingiber officinalel  
Cardamom -  Elettaria cardamomum 
Fenugreek  -  Trigonella foneum 
Garlic   -  Allium sativum 
Substances advised for vatha diseases are : 
“osr<gPfQI!Ogijmk<!Oke<!lqtG!fz<oz{<j{!
kr<G!ohVr<gibk<!kPkijp!.!wr<ogr<Gl<!
gm<M!sqX!Lk<K!ofb<!Ogikqz<!dTf<Kjugt<!
uim<M!l{qzg<jg!lkq”!
.!h/G/sq!
 Honey collected during summer 
 Pepper  -  Piper nigram 
 Gingelly oil  -  Sesamum indicum 
 Asafoetida  -  Ferula asafoetida 
 Castor oil  -  Riccinus communis 
 Black gram  -  Vigna mungo 
 Garlic   -  Allium sativum 
OsIg<gg<!%cb!d{Ugt<;< < << < << < <  (Diet to be included) 
gib<gt<< << << < (Vegetables): 
 gk<kiqh<hqR<S  - Unripe brinjal 
 LVr<jgh<!hqR<S        -  Unripe drumstick 
 nujvh<hqR<S! - Unripe broadbeans 
!gQjvgt<Q <Q <Q < (Greens): 
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 ohie<eir<g{<{q       - Alternanthera sessilis 
 &g<gqvm<jm  - Boerhaavia diffusa 
 KiKOujt!  - Solanum trilobatum 
 LVr<jgg<gQjv - Moringa oleifera 
 gxqOuh<hqjz            - Murraya koenigii 
 Lmg<gXk<kie< -     Cardiospermum halicacabum 
 nXgQjv  -       Amaranthus tristis 
 giqsijz!  -      Eclipta prostrate 
hpr<gt<< << << < (Fruits): 
 liKjt  -     Pomegranate 
 Nh<hqt<  - Apple 
 hh<hitq  - Papaya 
 NvR<S!  - Orange 
 OhiQs<js  - Dates 
 nk<kq   - Figs 
 fiuz<   - Syzygium cumini 
njsul<<<< (Non-Vegetarian diet): 
 out<tim<Mg<gxq! -      Meat 
 gijm   -      Quail 
 sqX!-xiz<!lQe< -       Prawn 
 
VARMAM 
 Varmam is the vital energy point. The praanan flowing all over the body is 
channelized and stored at many points,from where it is distributed to the target 
regions.when these points are stimulated, by concentration or by physical touch, 
energy  is  generated and the regions under the control of each point, gets 
strengthened. If  the stimulation goes beyond the limit,the energy point gets damaged. 
 Varmam points are present in the pathway of dasanaadi, dasavayu, saram and 
naanku kalai.so they are used to control energy channels, i.e. 
saram,dasanadi,dasavayu,kalai,amirtham etc. using  these points,we can control and 
regulate the functions of the body.   
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Reason  for varma impact: 
 Fall from trees,fall while running,striking stones,hitting by sticks of irregular 
shape leaping,receiving any hits of irregular sticks,sexual contact and intoxication. 
Fall of hands and legs due to disorderly manner, while retrieving the patient, pressure 
exerted at the place beyond the required measure ,holding the breath while lifting the 
heavy load,pulling &holding others while fighting. These are some of the reasons, 
when the varma imacts occurs. 
Sign &symptoms of varma impact: 
 Eye ball will go round and round. Black spot of the eye will disappear into the 
socket and give room for whiteness. Convulsions will arise with hiccup,the breath will 
be hold and passed out at low ebs. There  will be swelling of the lower abdomen .If 
the signs are there ,the impact is of ordinary type. 
 The following all the incurable type of impacts.when the patient becomes 
unconscious. It is a serious type and life will depart from the body. 
 Analyzing the curable and incurable nature of the impact,one should enter into 
treatment and following the guide  lines given by the guru. 
Classification of varma: 
 Total varmams are 108 in number. 
 Inside womb only 8 varmams are present after  3 yrs, varmam start developing 
upto 12 years.  All the varmam  points  get fully developed by the age of 23. Based on 
their energy level and effect,  Varmam points are classified into two. 
They are  
• Padu varmam -12 
• Thodu varmam-96 
• Thattu varmam-8 
• Ul varmam -6.( thattu varmam and ul varmam are included in thoduvarmam) 
 
Varmam points for santhuvatham 
Kai Kavli  -Situate in Thumb and index figure. 
Puyavarmam  -Tip of the shoulder joint. 
Muttusuzharchivarmam-Around the knee joint. 
ArumugaAdangal-Persent in the upper, middle, lower border of the knee joint.  
Nangana pootuvarman-Present in both sacroiliac joint 
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Mudichu varmam        -  It is located at the back in the cervical prominence at the c7,  
    T1 junction. 
Kakkattai kaalam        -   It is located in the supraclavicular fossa. 
Manibantha varmam   - It is located in the middle of the wrist joint. 
Kuttikaal varmam         -  Situated 7 finger breaths above posterior aspect of the heel. 
Viruthi kaalam            -  situated  between big toe and adjacent in its dorsal aspect 
Komberi kaalam: situated-  8 finger breaths above medial malleolus. 
Pottanam: 
  The raw drugs or either pounded or leaves of medicinal plants are fried ,tied 
in a cloth piece as bundle. This medicated bundle is dipped in a particular medicated 
oil and then applied over affected area.it  is effective in diseases due to the morbidity 
of kapha and vaatha dosham ,pain and swelling in the joints as well as 
paralysis.depending upon the requirement whole body below the neck or a part of the 
body may be treated by this  procedure. Thokkanam  followed by application of the 
heat with the warm packs of herbal powder for above 30 to 45 minutes is the method 
of pottanam.when the process is complete ,patient is given a bath in warm water . The  
above mentioned treatments can be done in a perfectly healthy person as well as to 
enhance his/her immunity ,vitality and longevity. This  type of external application is 
comes under both manida maruthuvam(rat ional method) and asura maruthuvam 
(surgical method) agni  or heat application. 
 
SNEGHA POTTANAM 
  Nochi kolunthu,aamanaku illai,sirramanaku vidai,paruthikottai,theankai 
thiruval,veapamkottai,thazhuthalai kolzhunthu,punnai vethai,magilam 
vethai,samuthira palam,koliyavarai vethai.all the ingredients are keep in pottanam,dip 
in the heated neem oil,apply to the affected area for 15-30 minutes. 
     It cures  the santhuvatham and some vatha diseases. 
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KAIKAVALI VARMAM MOOTU SULARCHI VARMAM 
SNEGA POTTANAM 
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MODERN ASPECT 
 Joint  
  A joint or  articulation is the connection made between  bones in the body 
which link the skeletal system into a functional whole. 
 
Disease of joints: 
        Joint diseases form one of the most important  groups of crippling diseases in the 
world . the  most  common cause of arthritis in india is due to the prevailing infections 
of various types ,whereas degenerative and metabolic joint diseases predominante in 
the developed countries. 
 
Anatomical and physiological factors: 
 Synovial joint are those ,where two bones are connected by a fibrous capsule 
with a well defined space between them lined by the synovial membrane . the bone 
ends are covered with a layer of hyaline articular cartilage and in some joint  .There  
are intra-articular cartilage acting as cushioning and shock absorbing structures.  
 The  capsule is fibrous and is attached firmly around each articulating bone 
near the epiphyseal plate and in folded on itself to be attached to the periphery of the 
articular cartilage. The synovial membrane get reflected similarly. 
 The  articular cartilage is a vascular. The nutrition to the superficial part is by 
seepage of the synovial fluid between the lamination of the chondroid and to the 
deeper part from  the vascular channels of the subchondral  cancellous  bone. 
 
Synovial fluid 
  It is a clear ,viscous, pale yellow fluid with a specific gravity of 1008 to 1015, 
which fills the synovial cavity. It is a dialysate  of the blood plasma with mucin and 
hyaluronic acid added to it as secretions from the synovial cells. The main functions 
of the synovial fluid are lubrication and nourishment of the articular cartilage. 
 Analysis of the synovial fluid is helpful  in diagnosing various types of 
arthritis by changes in its viscosity, cell content and biochemical features. 
 
Classification: 
  Joints are subject to various types of disease and disorders. Disease of joint 
can be classified as follow  
 
37 
 
I.Infective arthritis: 
      Bacterial,viral and parasitic: 
a) Acute infection 
Acute pyogenic arthritis 
Acute gonococcal arthritis 
Acute rheumatic arthritis 
Small pox arthritis 
b) Chronic infections 
Nonspecific : pyogenic arthritis 
Specific          :  tuberculous  arthritis 
                         Syphilitic arthritis 
                         Gonococcal arthritis 
Parasitic         : guinea worm arthritis 
 
2. RHEUMATOID ARTHROPATHY: 
a) RHEUMATOID ARTHRITIS 
 Rheumatoid Arthritis (Adult) 
Juvenile Rheumatoid Arthritis(JRA) 
b) SERO NEGATIVE SPONDYLO ARTHROPATHY: 
Ankylosing spondylitis 
 Reiter’s Disease 
 Psoriatic arthritis 
 Enteropathic Arthritis 
 3. DEGENERATIVE ARTHRITIS: 
 Osteoarthritis 
1. Primary Osteoarthritis 
2. Secondary Osteoarthritis 
4. NEUROPATHIC ARTHROPATHY: 
 Tables – charcot’s Arthropathy 
 Syringomyelia 
 Leprosy 
 Diabetes Mellitus 
5.METABOLIC ARTHRITIS: 
 Gout 
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 Alkaptonuric Arthritis 
6.ARTHRITIS IN SYSTEMIC DISORDER: 
 Allergic arthritis 
 Haemophilic Arthritis 
7. MISCELLANEOUS JOINT: 
 Villo – Nodular synovitis 
 Synovial Chondromatosis 
8. HYSTERICAL JOINT 
Arthritis 
    The word arthritis is  derived from the greek words “arthro’’ meaning joint and 
‘’itis’’ meaning inflammation. In dealing with a patient with arthritis  it is important 
to categorize the underlying cause of arthritis as the management differs according to 
the aetiology. 
PATHOLOGY: 
  Arthritis is the inflammation of all the component structures of the joint with 
involvement of the synovium, articular surfaces and capsule. 
The following stages can be identified: 
 Stage of synovitis 
 Stage of reversible arthritis   
 Stage of irreversible arthritis 
 Stage of ankylosis  
 The critical stage of the disease is the involvement and destruction of the 
articular cartilage, as any gross damage to the cartilage is irreversible leading to 
ankylosis and loss of function.   
Clinical approach to arthritis 
  History should be taken regarding the distribution of joint involvement,joint 
swelling,morning stiffness,extra articular features,if any ,family history of rheumatic 
disorders,past history of rheumatic symptoms, other disease and treatment 
history.arthritis can be classified as acute or chronic (6 to 8 weeks being the dividing 
line). It can be of adult onset or juvenile type. Depending  on the total number of 
joints involved, arthritis can be divided into monoarthritis(one joint) ,oligoarthritis(2 
to 4 joints),and polyarthritis (5 or more joints).polyarthritis can be  symmetrical or 
asymmetrical . 
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 Arthritis can be inflammatory or non-inflammatory. In inflammatory arthritis, 
morning stiffness is prolonged(more than 1 hour). In non-inflammatory arthritis, there  
is only ‘gelling’,lasting a few minutes after a period of joint immobility. In 
inflammatory arthritis ,improvement of joint symptoms occurs on joint usage , nights 
are worse than days, spontaneous flare  ups are common ,constitutional features 
(fever,malaise,loss of appetite and weight ) and elevated erythrocyte sedimentation 
rate (ESR)  and C- reactive protein (CRP)  are usual. These features are absent in non 
–inflammatory arthritis. 
 Examination should include  the following peripheral and axial jonts 
(swelling, warmth, tenderness hypermobility and deformity); entheseopathy (tendo-
achilles insertion ,plantar fascia);skin (subcutaneous nodules, rash); hair (loss of hair 
in scleroderma); nails (nail fold infarcts);eyes (episcleritis ,scleritis, conjunctivitis , 
iridocyclitis) ; oral mucosa and genitalia (ulcers) and systemic examination 
(hepatosplenomegaly, pericarditis, pleural effusion, pericardial effusion, 
lymphadenopathy).findings are best recorded around skeleton charts or homunculi for 
quick  and easy comparison between visits to the clinic. 
  Arthritis may present as acute monoarthritis ,aute polyarthritis, chronic 
monoarthritis and chronic polyarthritis. 
Acute monoarthritis 
 Differential diagnosis of  acute monoarthritis includes trauma, septic arthritis , 
crystal arthropathy (gout ,pseudogout),haemophilic arthropathy ,monoarticular onset 
of chronic inflammatory polyarthritis. In the hip joint, transient synovitis, 
perthes’disease and psoas abscess should be considered. In the knee prepatellar 
bursitis should be excluded. 
Chronic monoarthritis  
  Causes of chronic monoarthritis include osteoarthritis, tuberculosis 
,brucellosis,pigmented villonodular synovitis, synovial chondromatoss ,initial 
presentation of chronic polyarthritis ,monoarticular rheumatoid arthritis or juvenile 
chronic arthritis, malignancy and neuropathic joint,causes of neuropathic joint include 
tabes dorsalis ,syringomyelia,leprosy, diabetes mellitus ,myelomeningocele, 
congenital insensitivity to pain and iatrogenic(repeated steroid injections). 
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Acute polyarthritis 
 Acute polyarthritis  includes reactive arthritis (classical and non classical )and 
acute onset of chronic inflammatory polyarthritis. In classical reactive arthritis ,there 
is gastrointestinal or genitourinary infection initially. Arthritis follows infection a 
month later.lower limb joints are involved. Sacroiliac joint involvement and 
entheseopathy are common.patient is usually HLA B27 positive. If eyes are involved 
(conjunctivitis ),reiter’s syndrome, oral ulcers are not painful.scleritis ,cavitary 
nodules on chest X-ray ,sinusitis and haematuria should make the clinician suspect 
wegener’s granulomatosis(scleritis is not common in rheumatoid arthritis ). In non-
classical reactive  arthritis, there is no history of preceding infection. Other causes  of  
acute polyarthritis include acute rheumatic fever ,polyarthritis  following viral 
infections and polyarticular septic arthritis . 
 Chronic polyarthritis 
 Polyarticular asymmetrical arthritis is typically seen in  sero-negative 
spondyloarthropathies (ankylosing spondylitis,psoariatic arthritis). 
 Causes of polyarticular symmetrical arthritis include rheumatoid 
arthritis,connective tissue disorders (systemic lupus erythematous,systemic  sclerosis, 
polymyositis and dermatomyositis, CREST  syndrome ,vasculitis, anti- phospholipid 
syndrome, polymyalgia rheumatica/giant cell arteritis,etc.),osteoarthritis ,polyarticular 
gout, pseudogout,poncet’s disease (tubercular rheumatism) and arthritis associated 
with systemic diseases (bacterial endocarditis, HIV infection , endocrine and 
metabolic disease). 
 Features suggestive of systemic  vasculitis  are rash with purpura, peripheral 
neuropathy ,glomerulonephritis and evidence of regional ischaemia such as vasculitis 
are rash with purpura ,peripheral neuropathy ,glomerulonephritis and evidence of 
regional ischaemia such as vasculitic ulcers.SLE commonly presents as fever ,malar 
rash,alopecia,arthritis and oral ulcers. Anti-phospholipid syndrome presents with 
recurrent venous and /or arterial thrombosis ,recurrent fetal looss usually at around 10  
weeks og gestation ,thrombocytopenia and/or hemolytic anemia. APS can occur 
secondary to SLE also . In fact, it was first described in patients with SLE .The 
characteristic serum markers for APS are family of autoantibodies   reactive against 
different anionic  phospholipid required in the formation of prothrombin activator 
complex of the blood coagulation cascade. The antibodies include the anticardiolipin 
antibody ,lupus anticoagulant, etc.  
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  The initial symptom of systemic sclerosis (scleroderma) is usullay raynaud’s  
phenomenon with or without puffiness of fingers.this may be accompanied by fatigue 
,early morning stiffness and arthralgia. The tight skin typical of scleroderma may take 
years to develop . D- penicillamine is the mostly used drug in scleroderma. For severe 
Raynaud’s  phenomenon ,vasodilator drugs such as nifedipine or prazosin  are used. 
Seronegative inflammatory polyarthritis 
 Polyarthritis is a feature of a number of conditions  vaguely related  RA, 
psoariatic arthritis, jeuvenile chronic arithritis ,SLE  and other connective tissue 
diseases.  
Inflammatory polyarthritis 
  It usually involves the smaller joints as well and systemic features of 
inflammation are none marked. 
Polyarthritis of the  finger: 
  Polyarticular OA may be confused with other disorders which affect the 
finger joints.close observation slows several distinguishing features. Nodal OA affects 
predominantly the  distal joints,rheumatoid arthritis the proximal joints,psoariatic 
arthritis in a purely destructive arthropathy and there no interphalangeal 
nodes.tophaceous gout may cause knobby fingers ,but the knobs are tophi ,not 
osteophytes .xrays will show difference. 
Characteristics of inflammatory joint disorders: 
1.significant early morning stiffness >30 minutes. 
2.pain aggravation on resting the joints. 
3.symptomatic improvement on gentle use of joints. 
4.spontaneous flares (up –and –down course)are common. 
5. constitutional symptoms-fatigue , loss of appetite ,weight loss ,low grade  
fever,night sweats are very often present. 
6. Increased acute phase reactants eg.high ESR and CRF. 
In non –inflammatory disorders, from 1 to6 ,respectively they are <30 minutes,pain 
on moving the jointS.NO. improvement ,uncommon, absent, and normal. 
Pattern recognition in MSK disorders: 
  Pattern recognition in MSK disorders or rheumatological diseases is of 
immense importance to have a clean cut diagnosis.often features of two or more MSK 
disorders are present in a single patient to build up a diagnosis of ‘ overlap syndrome’.      
If the pattern of involvement is not recognized clinically, it is very difficult to clinch a 
42 
 
diagnosis of rheumatological diseases only by ordering of RF,ANA,autoantibodies or 
other immunological markers. 
 
1. Mode of onset :acute or insidious. 
2. Duration of joint pain :acute <weeks or chronic >6 weeks. 
3. Number of joints affected: monoarthritis,oligo or pauciarthritis ,polyarthritis. 
4. pattern of involvement :axial (spine,sacroiliac,anterior chest wall,shoulder and 
hip joint)or appendicular (peripheral joints).shoulder and hip joints are known 
as root joints. 
5. Distribution of joint involvement: symmetrical or asymmetrical ,small or large 
joint,lower limbs or upper limbs.involvement of any specific joint(eg., 1st  
metatarsophalangeal joint in gout,haemarthrosis of knee joint in haemophilia. 
DIP joints of hands in osteoarthritis). 
6. order of sequence of affection : intermittent (gout) or progressive(classical 
RA),migratory(rheumatic arthritis,SLE,serum sickness) or additive(RA). 
7. Extra articular manifestations: constitutional symptoms (eg.,fever),skin 
rash,subcutaneous nodule,oral ulcer,conjunctivitis or episcleritis,penile 
ulcer,nail changes (eg,.psoriasis), Raynaud’s  phenomenon (eg.,scleroderma). 
Small and large joint involvement in MSK diseases: 
1. Small joint arthropathy : RA.SLE,gout ,nodular osteoarthritis ,psoriasis, 
enteropathic arthritis, sarcoidosis. 
2.  Large joint arthropathy : RA, ankylosing spondylitis, rheumatic 
arthritis,generalized osteoarthritis,psoriatic and enteropathic arthritis. 
3. Both large and small joints arthropathy: RA ,SpA, osteoarthritis. 
4. Differentiate arthritis according to serology: 
5. Seropositive (RF positive)- sjogren’s syndrome, RA,SLE, polymyositis –
dermatomyositis,systemic sclerosis, vasculitis. The higher the titre of RF ,the 
more severe is the disease. 
 Seronegative (RF negative)- SpA(the whole group), gout, osteoarthritis, 
juvenile idiopathic arthritis (JIA: majority are RF negative ),RA (30%),rheumatic 
arthritis, still’s disease . 
 RF is also positive  in certain non-rheumatic diseases like fibrosing 
alveolitis,leprosy,tuberculosis,infectious mononucleosis,syphilis,kala-azar,chronic 
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hepatiis,infective endocarditis,cryglobulinaemia,malignancy,and in normal population 
(5% women aged above 60 years). 
Common imaging modalities done in musculoskeletal disorders: 
1. X-ray : to demonstrate fracture ,bony erosion ,osteophytes,ankylosis etc. 
2. Ultrasonography : to visualize soft tissue/periarticular structures/ 
tendon,baker’s cyst, rotator cuff tear ,thickened achilies tendon. 
3. Radionuclide scintigraphy :  99m Tc-biophosphate, 67- gallium and 111-
indium scans are occasionally used to localize infections. 
4. CT scan: for sacroliitis ,prolapsed intervertebral disc,trauma to the spine etc. 
5. MRI scan: to visualize vessel,nerve,fascia,muscle,cartilage,ligament,synovial 
effusion,bone marrow oedema, commonly used in spinal cord compression 
,prolapsed intervertebral disc,early avascular necrosis etc. 
6. Bone mineral density measurement: dual energy X-ray absorptiometry 
(DEXA) is the current method of choice to diagnosis osteopenia and 
osteoporosis (T-score and Z-score).  
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POLYARTHRITIS 
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MATERIALS AND METHODS 
 
 The Clinical study on Santhuvatham was carried out in the Post graduate 
Sirappu Maruthuvam department of Govt Siddha Medical College, Palayamkottai. In 
this study 40 patients (who satisfy the inclusion criteria and exclusion criteria) were 
treated as OP and IP patients. The clinical trial was duely approved by the 
Institutional Ethics Committee (IEC), Government Siddha Medical College, 
Palayamkottai. 
 
SAMPLE SIZE : 
 40 patients (20 OPD &20 IP- 10 Patients with trial medicines and Varmam, 10 
with pottanam along with trial medicines). 
 
INCLUSION CRITERIA: 
• Age   :  between 20- 60 years  
• Sex  : Both male and female 
• Joints pain : more than 5 joints 
o Swelling   
o Stiffness  
o Restricted movements in affected joint.  
o Willing for admission and study in IPD for 40 days or willing to attend 
OPD 
EXCLUSION CRITERIA: 
• Rheumatic Fever 
• Rheumatoid arthritis 
• Other systemic illness 
• Gout  
• Recent Fracture  
• Recent Dislocation of joints 
• Malignancy  
• Use of narcotic drugs  
• Pregnancy and Lactation  
• Tuberculosis 
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WITHDRAWAL CRITERIA: 
✓
 Intolerance to the drug and development of adverse reactions during drug trial. 
✓
 Poor patient’s compliance and defaulters. 
✓
 Patient turned unwilling to continue in the course of clinical trial.  
✓
 Occurrence of any serious illness.  
TESTS AND ASSESMENTS: 
• Clinical assessment  
• Routine investigations 
• Specific investigation 
• Radiological investigations  
• Siddha investigations 
CLINICAL ASSESSMENT: 
• Pain in more than five  joints 
• Tenderness, Numbness  
• Stiffness  
• Restriction of movements of  affected joints 
• Effect of treatment will be evaluated on the basis of changes in the signs and 
symptoms after the treatment. 
 
PAIN ASSESSMENT  
UNIVERSAL PAIN ASSESSMENT SCALE  
 
 
 
A.0 : No Pain  
B. 1-3  : Mild pain  
C.4-6 : Moderate pain 
D.7-10 : Severe pain  
Reference: Clinical Manual for Nursing Practice. (National Institute of Heatlth 
Warren Grant Magnuson Clinical center 
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GRADATION:  
Grade 1: Fit for all activities to do their work without support (Normal)  
Grade 2: Mild Pain and Mild restriction of Movements  
Grade 3: Moderate Pain and Moderate restriction of Movements  
Grade 4: Severe Pain and Severe restriction of Movement   
Investigations 
 The symptoms of santhuvatham were more or less correlated with polyarthritic 
conditions of (Rheumatological and collagen diseases) in modern medicine.  So 
investigations meant for such diseases were done for santhuvathamSome of these are 
routine blood tests, urine tests, stool examination and specific tests such as 
rheumatoid arthritis factor, radiographic evaluation etc.  Besides this blood sugar, 
blood urea, serum cholesterol were also investigatedThe diagnosis was made by 
following Siddha diagnostic methods. Nilam, Kalam, Poriyalaridhal, Pulanalarithal, 
Vinaadhal, Mukkutra Nilaigal , UdalThathukalNilai and EnvagaiThervugal, and the 
diagnosis of Santhuvatham were obtained which correlated with modern diagnosis of 
Polyarthritis by the XRay findings.  
INVESTIGATION: 
 The following investigations were done in all selected patients in the 
laboratory of Government Siddha Medical College, Palayamkottai. 
BLOOD: 
TC  (Cells/cumm)  
DC P     L   E    M   N 
ESR ½ hr   1hr 
Hb  g% 
Blood Sugar: 
 Fasting  
 Post prandial 
Renal function tests:  
 Blood urea 
           Blood uric acid 
 Serum creatinine 
Serology:  
 C-reactive protein  
 RA factor   
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 ASO titre 
Urine examination:  
 Albumin 
 Sugar 
           Deposits. 
RADIOLOGICAL INVESTIGATIONS: , 
 X-Ray of affected jonts(AP and Lateral view). 
TREATMENT   : 
! “uqOvsek<kiz<!uikf<!kiPl<”!
 Vellaiennai 15ml at morning with hot water was given on the first day of 
treatment. 
INTERNAL; 
 Drug:santhuvatha chooranam 
REFERENCE: 
 Athmarakshamirtham,pageno-312DOSE:      800-1000 mg        Three times 
per day 
ADJUVANT: 
 Hot water 
DURATION: 
 48 days. 
EXTERNALDRUG: 
 Vatha Ennai 
REFERENCE: 
 Agasthiyar vaithiya soothiram-650,page no-280,281 
POTTANAM 
DRUG: 
 snegha pottana 
REFERENCE: 
 Sarabendirara  vaithiya muraigal-vatha roga sigichai. 
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RESULTS AND OBSERVATION 
 For the clinical study 40 patients were selected and treated in PG-III Sirappu 
Maruthuvam Department, GSMC hospital, Palayamkottai.  Results were observed 
with respect to the following criteria. 
1. Gender distribution 
2. Age distribution 
3. Kalam 
4. Paruvakalam 
5. Gunam 
6. Thinai 
7. Socioeconomic factors 
8. Etiological factors 
9. Occupation 
10. Disturbance in vatha 
11. Disturbance in pitha 
12. Disturbance in kapha 
13. Udal thathukkal 
14. Envagai thervu 
15. Naadi 
16. Neikuri 
17. Distribution of illness 
18. Clinical manifestation 
19. Systemic manifestation 
20. Locomotor system 
21. Internal and external medicines 
22. a.Effect of Trial drug 
  b.Effect of  pottanam 
  c.Effect of varmam 
 23. Effect of Trial drug along with complementary therapies 
 24. Comparison between effective of trial drug and trial drug with complementary 
therapies 
 25 . Comparison between effective of trial  drug and trial drug with pottanum and 
trial drug with varmam. 
 26.         Effect of theraphy. 
 
 S.NO GENDER
1 MALE
2 FEMALE
 
 
Inference 
• Out of 20 out patients 30% were male 70% were female
• Out of 20 inpatients 30% were male and 70% were female.
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Table 1 
GENDER DISTRIBUTION 
 
OP IP 
NO 
OF 
CAS
ES 
PERCENT
AGE 
% 
NO 
OF 
CAS
ES 
PERCENT
AGE
 6 30 6 30 
 14 70 14 70 
 
 
 
 
 
S.NO. 
1 
2 
3 
 
Inference 
Among 20 out patients 
15% of cases were observed in the age group 31
40% of cases were observed in the age group 41
45% of cases were observed in the age group 51
 
Among 20 In patients 
5% of cases were observed in the age group 31
10% of cases were observed in the age group 41
85% of cases were observed in the age group 51
Table 3 
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Table 2 
AGE DISTRIBUTION 
 
OUT PATIENTS 
 
INPATIENTS
NO OF 
OPCA
SES 
PERCENT
AGE 
NO 
OF 
IPCA
SES 
31-40 3 15 1 
41-50 8 40 2 
51-60 9 45 17 
-40 years 
-50 years 
-60 years 
-40 years 
-50 years 
-60 years 
 
PERCENT
AGE 
5 
10 
85 
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Table  3 
KAALAM (LIFE SPAN) 
S.NO. KAALAM NO OF CASES PERCENTAGE 
1 VATHA KALAM(upto 33 years) 0 0 
2 PITHA KALAM(34-66 years) 40 100 
3 KABA KALAM (above 67 years) 0 0 
 
 
 
Inference 
Out of 40 patients100% of cases were in the Pithakaalam 
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Table  4 
PARUVAKAALAM 
S.NO.                              SEASON NO OF 
CASES 
PERCENTAGE 
% 
1 Kaarkaalam  - Aavani, Purattasi 
(15 Aug -  14 Oct ) 
7 17.5 
2 Koothirkaalam - Iyppasi, Karthigai 
(15 Oct -  14 Dec) 
6 15 
3 Mupanikaalam - Markazhi, thai 
(15 Dec – 14 Feb) 
14 35 
4 Pinpani kaalam – Masi, Panguni 
(15 Feb – 14 Apr) 
9 22.5 
5 Ilavenirkaalam - Chithirai, vaikasi 
(15 Apr – 14 June) 
0 0 
6 Muthuvenirkaalam-aani ,aadi (15 June-14 
Aug) 
4 10 
 
 
Inference 
 Among 40 cases,    
• 17.5% of patients were admitted in  kaarkalam                             
• 15% of patients were admitted in  koothirkaalam 
• 35% of patients were admitted in Munpanikalam 
• 22.5% of cases were admitted in pinpanikalam  
• 10% were admitted in  muthuvenirkaalam 
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PARUVAKAALAM
 S.NO
. 
GUNAM 
1 SATHUVA
2 RASO 
3 THAMO 
 
 
 
Inference 
• About 5% of the patients had Sathuva gunam
• 87.5% of the patients had Rasogunam
• 7.5% of the patients  had Thamogunam 
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Table 5 
GUNAM 
NO OF CASES PERCENTAGE %
 2 5 
35 87.5 
3 7.5 
 
 
 
 
 
S.NO. THINAI 
1 KURINJI
2 MULLAI
3 MARUTHAM
4 NEITHAL
5 PALAI 
 
 
 
Inference 
 About 82.5% of the patients were from marutham, 2.5% were from 
kurinji, 15% were from Neithal.
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Table  6 
THINAI 
NO OF CASES PERCENTAGE
 1 
 0 
 33 
 6 
0 
 
 
 
2.5 
0 
82.5 
15 
0 
 
 S.NO SOCIO ECONOMIC 
STATUS
1 POOR
2 MIDDLE CLASS
3 
 
 
Inference  
 The above study consists of 62.5% of cases from middle class, 32% of 
cases from poor and 5% of rich.
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Table  7 
SOCIO ECONOMIC STATUS 
 
NO OF CASES PERCENTAGE
 13 32.5 %
 25 62.5%
RICH 2 5 %
 
 
 
 
 
 
 
DISTRIBUTION BASED 
S.NO. PRECIPITATING 
FACTORS
1 Exposure to cold
2 
3 occupation
4 metabolic
 
Inference 
 It was noted while taking the history of the patients Santhuvatham was 
caused mainly 67% due to the senility.  The remaining were due to other factors like 
occupation and exposure to cold.
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Table 8 
ON ETIOLOGICAL FACTORS
 
NO OF CASES PERCENTA
GE %
 4 10%
Senility 27 67.5%
 9 22.5%
 0 0
 
 
 
 
 
 
 
 
 
S.N
O 
OCCUPATION
1 Farmer
2 Household
3 Clerk 
4 Saloon
5 Beedi rolling
6 Watchmen
7 Retired officer
 
Inference 
55%  has been household
17.5% has been farmer 
7.5% has been beedi rolling and watchman
5% has been clerk and retired officer
2.5% has been saloon 
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Table  9 
OCCUPATIONAL STATUS 
 NO OF CASES 
PERCENTAGE 
%
 7 17.5%
 22 55%
2 5 %
 1 2.5 %
 3 7.5 %
 3 7.5 %
 2 5 %
 
 
 
 
 
 
 
 
 
 
 
 
 
S.NO VATHAM
1 PRANAN
2 ABANAN
3 VYANAN
4 SAMANAN
5 UTHANAN
6 NAAGAN
7 KOORMAN
8 KIRUKARAN
 
9 DEVATHATHAN
 
10 DHANASEIYAN
 
Inference 
 100% has viyanan
samanan affected(due to vyanan affected)
has devathathan affected(sleeplessness)
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Table  10 
DISTURBANCES  IN VATHAM 
 NO OF CASES PERCENTAGE
 0 0
 10 25%
 40 100 %
 40 100  %
 0 0
 0 0
 0 0
 6 15 %
 34 85%
 0 0
(restricted movement of affected joints and radiating pain)
, 25% abanan affected(constipation)
,15 % kirukaran has affected(cold)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
, 
, 85% 
. 
  
S.NO PITHAM
1 Anarpitham
2 Ranjagam
3 Prasagam
4 Alosagam
5 Saathagam
 
 
  
Inference 
100%saathagam pitham has affected(pain and restricted movement).
45%   Anarpitham  pitham has 
20%  ranjagam pitham has affected(Hb level decreased).
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Table: 11 
DISTURBANCES IN PITHAM 
 NO OF CASES 
PERCENTA
GE%
 18 45%
 8 20%
 0 
 0 
 40 100 %
affected(loss of appetite). 
 
 
 
 
 
 
0 
0 
 
 
S.NO KABHAM
1 Avalambagam
2 Kilethagam
3 Pothagam
4 Tharpagam
5 Santhigam
 
 
 
 Inference 
  100% Santhigam has affected
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Table 12 
DISTURBANCES IN KABHAM 
 NO OF CASES PERCENTAGE%
 0 0 
 0 0 
 0 0 
 0 0 
 40 100 %
 (pain and restricted movement)
 
 
 
. 
CONDITIONS OF UDAL KATTUKAL
S.NO. UDAL KATTUKAL
1 Saaram 
2 Senner 
3 Oon 
4 Kozhuppu 
5 Enbu 
6 Moolai 
7 Sukkilam/Suronitham
 
 
Inference 
In 7 udal kattukal , 100% was enbu affected(restricted in joint movement),85% was 
saaram affected (loss of strength to body),50% was kozhuppu was affected(movement 
restriction),45% was moolai affected,20% senner 
was oon affected(later stage)
 
0%
20%
40%
60%
80%
100%
120%
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Table 13 
 
 NO OF CASES PERCENTAGE%
34 85% 
8 20% 
7 17.5% 
20 50% 
40 100% 
18 45% 
 0 0 
was affected(low energy),17.5% 
. 
 
UDAL KATTHUKAL 
UDAL KATTHUKAL 
 
 
CONDITION OF ENVAGAITHERVUGAL
 
S.No. Envagai thervugal
1. Naa
2. Niram
3. Mozhi
4. Vizhi
5. Sparisam
6. Malam
7. Moothiram
8. Naadi
 
 
Inference 
 100% seen in naadi (patient had thontha naadi)
 30%  seen in sparisam. 
 25% seen in malam( constipation).
 
NAADI
65%
ENVAGAITHERVUGAL
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Table  14 
 
 Number of cases 
 0 
 0 
 0 
 0 
 12 
 10 
 0 
 40 
 
 
 
NAA
0%
NIRAM
0%
MOZHI
0%
VIZHI
0%
SPARISAM
19%
MALAM
16%
MOOTHIRAM
Percentage% 
0 
0 
0 
0 
30% 
25% 
0 
100% 
 
0%
 S.No. Parameters
1. Vathapitham
2. Vatha kabam
3. Pitha vatham
4. Pitha kabam
 
  
 
 
Inference 
 As mentioned above thontha naadi was noted in all cases and among them 
50% were  pitha vatha  nadi,  22.5% were vathakabha nadi and remaining 27.5% were 
vathapitha nadi. 
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Table 15 
ILLUSTRATION OF NAADI 
 Number of cases Percentage
 11 
 9 
 20 
 0 
 
 
27.5 
22.5 
50 
0 
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Table 16 
NEIKURI 
 
S.N
O 
SPREADING PATTERNS NO OF CASES PERCENTAGE
% 
1 Snake 10 25 
2 Ring 4 10 
3 Pearl 6 15 
4 Combination of snake and pearl 20 50 
 
 
 
Inference 
In neikuri analysis,  50% of the cases presented with pithakabha  neer, 25% with 
vatha neer, 15% with kaba neer and the remaining 10% presented  pitha neer. 
 
  
  
0%
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40%
50%
60%
SNAKE RING PEARL COMBINATION 
OF SNAKE AND 
PEARL
NEIKURI
NEIKURI
 S.No. Duration of illness 
(Months)
1. 
2. 
3. 
4. 
5. 
6. 30 Above
 
 
Inference 
In duration of illness, 47.5% occur 
occur in 13-18 months,  15% occur in19
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Table 17 
DURATION OF ILLNESS 
 
Number of cases Percentage (%)
1- 6 19 47.5
7 – 12 10 25
13 – 18 1 2.5
19-24 6 15
25-30 0 0
 4 10
 upto 6 months, 25%  occur in 7-12 months, 2.5% 
-24 months, 10% occur in Above 30 months.
 
 
 
 
 
 
 
 
 
 
S.NO SYMPTOMS 
CASES%
1. Joint pain 
2. Swelling 
3. Morning 
stiffness 
4. Restricted to 
walk 
5. Difficulty to 
walk 
6. Neck pain 
7. Difficulty in 
chewing 
8. Fever 
9. Sleeplessness 
10. Loss of 
appetite 
11. Loss of 
weight 
12. Constipation 
13. Easy 
fatiguability 
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Table 18 
CLINICAL MANIFESTATIONS 
 
BEFORE TREATMENT AFTER  TREATMENT
NO OF 
 
PERCENTAGE% 
NO OF 
CASES 
 
PERCENTAGE%
40 100 4 
20 50 3 
30 75 4 
27 67.5 8 
33 82.5 9 
8 20 2 
0 0 0 
0 0 0 
23 57.5 4 
20 50 2 
5 12.5 2 
10 25 1 
34 85 8 
 
 
 
 
10 
7.5 
10 
20 
22.5 
5 
0 
0 
10 
5 
5 
2.5 
20 
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Inference 
 Before treatment 100% of cases had pain, 82.5% of cases has difficulty to 
walk, 75% of cases had morning stiffness, 67.5% if cases had restricted to walk, 
57.5% of cases had sleeplessness, 12.5% has loss of weight ,50% of cases had 
swelling and loss of appetite, 85% of cases had easy fatiguability and 25% has 
constipation. 
 After treatment 10% of cases had pain, morning stiffness,  sleeplessness. 20% 
of cases had easy fatiguability, restricted to walk, 22.5% of cases had difficulty to 
walk.  7.5%  cases had swelling, 5% of cases had loss of appetite,loss of weight and 
neck pain, 2.5% of cases had constipation. 
 
  
SYSTEMIC MANIFESTATIONS
 
S.NO SIGNS
1 Subcutaneous nodules
2 Muscle wasting
3 Opthalmic manifestations
4 Hepatomegaly
5 Spleenomegaly
6 Respiratory system
7 Cardiovascular system
8 Centralnervous system
 
Inference 
 20% cases show muscle wasting
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Table  19 
 
 NO OF CASES PERCENTAGE%
 0 
 4 
 0 
 0 
 0 
 0 
 0 
 0 
 
 
 
0 
20 
0 
0 
0 
0 
0 
0 
 
 S.NO 
INVOLVEMENT OF UPPER AND 
LOWER EXTREMITIES
1 Upper extremity
2 Lower extremity
3 Both upper and lower extremity
 
 
 
Inference 
 90% cases show lower extremity, 75% cases show upper extremity 
and 77.5% cases show both
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Table 20. 
A.LOCOMOTOR SYSTEM 
 
NO OF CASES 
 30 
 36 
 31 
 
 
PERCENTAGE % 
75 
90 
77.5 
 
20. B. INCIDENCE OF INDIVUDUAL JOINT INVOLVEMENT.
S.N
O 
JOINT INVOLEMENT
1. Wrist joint 
2. Elbow joint
3. Shoulder joint
4. Lumbosacral joint
5. Minor joints in upper &lower limb
6. Cervical spine
7. Hip joint 
8. Knee joint 
9. Ankle joint
  
Inference 
 100% cases show pain in knee joint 26% cases show pain in lumbo 
sacral joint, 11% cases show pain in hip joint an ankle joint, 23% cases show pain in 
shoulder , 8% cases show pain inwrist joints, 15% cases show pain in elbow joint, 
14% cases show pain in cervical spine.13% case show pain in minor joints in upper 
and lower limb. 
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 NO OF CASES 
8 
 12 
 23 
 26 
 13 
 14 
11 
36 
 12 
 
 
PERCENTAGE % 
20 
30 
57.5 
65 
32.5 
35 
27.5 
90 
30 
ASSESSMENT OF CURATIVE EFFECTS IN PATIENTS TREATED ONLY 
WITH TRIAL DRUGS (INTERNAL 
 
S.NO 
BEFORE TREATMENT
 
 
SYMPTOMS 
1. Mild 
  
  
  
2. Moderate 
  
  
  
3. Severe 
  
  
  
 
Inference 
 From the above study, it was inferred that severe pain that was noted in 
patients before treatment had a remarkable decline after treatment similarly moderate 
and mild pain were also observed to have 
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Table 21 
AND EXTERNAL MEDICINES)
 
AFTER TREATMENT
NO OF CASES SYMPTOMS 
5 No pain 
 Mild 
 Moderate 
 Severe 
6 No pain 
 Mild 
 Moderate 
 Severe 
9 No pain 
 Mild 
 Moderate 
 Severe 
decreased after treatment. 
 
 
 
NO OF CASES 
5 
0 
0 
0 
4 
0 
2 
0 
4 
2 
3 
0 
A.EFFECT OF TRIAL DRUG ALONE
S.NO EFFECT OF TRIAL DRUG
1. Good
2. Moderate
3. Mild
4. No
 
 
Inference 
 Administration of trial drug alone had a 65% with good response, 
moderate and 10% with mild response.
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Table 22 
 
 
 NO OF CASES 
 13 
 5 
 2 
 0 
 
 
PERCENTAGE 
65 
25 
10 
0 
 
25% with 
75 
 
B.ASSESSMENT OF CURATIVE EFFECTS IN SANTHU VATHAM 
PATIENTS TREATED WITH TRIAL DRUG ALONG WITH 
COMPLEMENTARY THERAPY (POTTANAM) 
S.NO 
BEFORE TREATMENT 
 
AFTER TREATMENT 
SYMPTOMS NO OF CASES SYMPTOMS NO OF CASES 
1. Mild 2 No pain 2 
   Mild 0 
   Moderate 0 
   Severe 0 
2. Moderate 4 No pain 3 
   Mild 1 
   Moderate 0 
   Severe 0 
3. Severe 4 No pain 2 
   Mild 1 
   Moderate 1 
   Severe 0 
 
 
 Inference 
 Administration of trial drug along with complementary therapy reduced severe 
pain almost all the cases also in mild and moderate cases were notably reduced. 
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AFTER TREATMENT
C.  ASSESSMENT OF CURATIVE EFFECTS IN SANTHU VATHAM 
PATIENTS TREATED WITH TRIAL DRUG ALONG WITH 
COMPLEMENTARY THERAPY (VARMAM)
 
S.NO 
BEFORE TREATMENT
SYMPTOMS
1. Mild 
  
  
  
2. Moderate 
  
  
  
3. Severe 
  
  
  
 
 
Inference 
 Administration of trial drug along with complementary therapy reduced severe 
pain in almost all the cases, mild and moderate cases were notably reduced.
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 AFTER TREATMENT
 NO OF CASES SYMPTOMS NO OF CASES
1 No pain 
 Mild 
 Moderate 
 Severe 
4 No pain 
 Mild 
 Moderate 
 Severe 
5 No pain 
 Mild 
 Moderate 
 Severe 
 
BEFORE TREATMENT
AFTER TREATMENT
 
 
1 
0 
0 
0 
3 
1 
0 
0 
3 
0 
2 
0 
 
 
EFFECT OF TRIAL DRUG ALONG WITH COMPLEMENTARY 
S.NO EFFECT OF CASES
1. Good
2. Moderate
3. Mild
4. No 
  
 
Inference 
 Administration of trial drug along wi
good effect , 15% moderate effect and  10
reported of having no effect.
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Table  23 
THERAPIES 
 NO OF CASES PERCENTAGE
 15 
 3 
 2 
0 
th complementary therapies had 75% 
% mild effect not even a single case have 
 
 
MODERATE
MILD
NO
15%
10%
0
% 
75 
15 
10 
0 
 
 COMPARISON BETWEEN EFFECTIVE OF TRIAL DRUG AND TRIAL 
DRUG WITH COMPLEMENTARY THERAPIES.
S.NO EFFECT OF THERAPY 
TRIAL DRUG ALONE
NO OF 
CASES
1. Good 13
2. Moderate 
3. Mild 
4. No 
 
 
  
 
INFERENCE 
    In comparative study , the  trial drug with  external therapy is more effective than 
trial drug alone. 
65%
75%
GOOD
COMPARISON BETWEEN TRIAL DRUG AND 
TRIAL DRUG WITH EXTERNAL THERAPY
TRIAL DRUG ALONE
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Table : 24 
 
 
 
TRIAL DRUG WITH EXTERNAL 
THERAPY
 
 
PERCENTAGE
% 
 
NO OF CASES 
 65 15 
5 25 3 
2 10 2 
0 0 0 
 
25%
10%
0
15%
10%
MODERATE MILD NO
TRIAL DRUG WITH EXTERNAL THERAPHY
 
PERCENTAGE% 
75 
15 
10 
0 
 
0%
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TABLE - 25 
COMPARISON BETWEEN EFFECTIVE OF TRIAL DRUG ,TRIAL DRUG                    
WITH POTTANUM, TRIA   DRUG WITH VARMAM 
 
 
S,NO 
EFFECT OF 
THERAPY 
TRIAL DRUG 
ALONE 
 
 
TRIAL DRUG 
WITH POTTANAM 
TRIAL DRUG 
WITH VARMAM 
No of 
cases 
Percentage%  No of 
cases  
Percentage%  No of 
cases  
Percentage& 
1 GOOD 13 65 8 80 7 70 
2 MODERATE 5 25 1 10 2 20 
3 MILD 2 10 1 10 1 10 
 
 
INFERENCE: 
     In this comparative study conclude that trial drug with pottanum is more 
effective than other two . 
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Table 26 
EFFECT OF THERAPY 
 
S.NO EFFECT OF THERAPY NO OF CASES PERCENTAGE 
1. Marked effect 28 70 
2. Moderate effect 8 20 
3. Mild effect 4 10 
4. No effect 0 0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inference 
 Thus from the analysis of the data collected during the course of treatment 
and at the end of treatment it is inferred that the overall effect of the therapy (internal, 
external and complementary) had marked effect of 70%, moderate effect of 20% and 
mild effect of 10% . 
81 
 
Out Patients of PG-III Sirappu Maruthuvam Department Given 
Santhuvatha Choornam- Internal 2. Vatha Ennai – External 
S.NO OP.NO NAME AGE/SEX OCCUPATION DATE OF ADMISSION 
DATE OF 
DISCHARGE 
TOTAL NO OF 
DAYS 
TREATED 
RESULTS 
1 63678 Thuraichi 42/F House wife 26/7/17 12/9/17 48 days Good 
2 65162 Rasathi 57/F House wife 31/7/17 16/9/17 48 days Moderate 
3 66875 isakkiammal 40/F Housewife 5/8/17 21/9/17 48 days Good 
4 68061 Swarnam 55/F House wife 9/8/17 26/9/17 49 days Good 
5 70076 Daniel 60/M Retired officer 16/8/17 5/10/17 51 days Good 
6 70477 krishnammal 42/F Housewife 17/8/17 5/10/17 50 days Good 
7 71054 Chandira 50/F Housewife 19/8/17 6/10/17 48 days Moderate 
8 71915 Isakkiammal 53/F Housewife 22/8/17 9/10/17 48 days Good 
9 2244 Isakkiammal 56/F Housewife 14/12/17              2/2/18 50 days Good 
10 892 Susila 45/F Housewife 20/12/17 17/2/18 49 days Good 
11 1001 Muthukumar 45/M Clerk 26/12/17 9/2/18 45 days Good 
12 1497 Gnanamani 55/F Housewife 27/12/18 13/2/18 48 days Moderate 
13 763 Antonyammal 60/F Housewife 3/1/18 19/2/18 48 days Mild 
14 10172 Abdulkathar 55/M Saloon 30/1/18 19/3/18 48 days Good 
15 14510 Shanthi 42/F Beedi rolling 12/2/18 4/4/18 52 days Good 
16 14722 Balamurugan 35/M Farmer 12/2/18 4/4/18 52 days Good 
17 17150 Selvaraj 60/M Watchmen 19/2/18 5/4/18 46 days Mild 
18 30518 Basker 44/M Clerk 2/4/18 19/5/18 48 days Moderate 
19 30873 Rose 38/F Housewife 3/4/18 20/5/18 48 days Good 
20 30872 Sarabhegam 50/F Housewife 3/4/18 20/5/18 48 days Moderate 
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List of  In Patients of PG-III Sirappu Maruthuvam Department Given 
1.Santhuvatha Choornam- Internal 2. Vatha Ennai – External with varma and pottanam therapy. 
S.NO IP.NO NAME AGE/SEX OCCUPATION DATE OF ADMISSION 
DATE OF 
DISCHARGE 
TOTAL NO 
OF DAYS 
TREATED 
RESULTS 
1 2283 Shanthi 38/F House wife 16/8/17 8/9/17 24 days GOOD 
2 2428 Arumugam 60/M Farmer 29/8/17 9/10/17 42 days GOOD 
3 2437 palaniyammal 60/F Housewife 30.8.17 9.10.17 41days GOOD 
4 3082 Pichammal 50/F Farmer 18/11/17 11/12/17 24 days MODERATE 
5 3252 Poolaiya 55/M Farmer 12/12/17 8/1/18 28 days GOOD 
6 3264 Malliga 43/F Farmer 13/12/17 6/1/18 25 days GOOD 
7 3262 Pappa 58/F Beedi rolling 13/12/17 3/1/18 22 days GOOD 
8 3373 Saraswathi 60/F Housewife 28/12/17 31/1/18 35 days GOOD 
9 77 Deivani 60/F Housewife 17/1/18 29/1/18 13 days MILD 
10 35 Ponnuthai 55/F Farmer 4/1/18 21/2/18 49 days GOOD 
11 90 Kandaswamy 60/M Retired officer 18/1/18 12/2/18 26 days GOOD 
12 166 Ramalakshmi 53/F Housewife 24/1/18 27/2/18 35 days GOOD 
13 199 Somu 60/M Farmer 26/1/18 14/3/18 48 days GOOD 
14 371 Kasiammal 60/F Housewife 12/2/18 25/3/18 42 days GOOD 
15 379 Vellathai 60/F Housewife 13/2/18 7/3/18 23 days GOOD 
16 745 Selvaraj 60M/ Watchmen 19/3/18 25/4/18 37 days GOOD 
17 892 Nagarajan 52M/ Watchmen 3/4/18 26/4/18 24 days GOOD 
18 984 Rasathi 60/F Housewife 11/4/18 30/4/18 20 days MODERATE 
19 925 Mariammal 52/F Beedi rolling 5/4/18 21/4/18 17 days MODERATE 
20 488 Saraswathi 60/F Housewife 22/2/18 9/3/18 16 days MILD 
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BLOOD INVESTIGATION OF IP PATIENTS 
S.NO IP.NO AGE/ SEX 
BLOOD 
SUGAR 
BLOOD 
UREA(MGS%) 
SERUM 
CHOLESTEROL(MGS%) RA FACTOR 
ASO 
TITRE 
C-
REACTIVE 
PROTEIN 
BT AT BT AT BT AT 
1 2283 38/F 102 95 33 33 193 190 -VE -VE 7.2 3.3 
2 2428 60/M 100 97 25 20 214 196 -VE -VE 15.7 4.1 
3 2437 60/F 145 130 23 2O 205 200 -VE -VE 9.5 2.7 
4 3082 50/F 81 96 41 36 205 194 -VE -VE 14.1 5.3 
5 3252 55/M 80 79 21 20 235 215 -VE -VE 17.2 8.3 
6 3264 43/F 100 98 26 20 178 182 -VE -VE 12.2 5.2 
7 3262 58/F 96 100 20 18 206 194 -VE -VE 11.8 3.3 
8 3373 60/F 108 94 34 29 142 168 -VE -VE 13.3 6.6 
9 77 60/F 102 98 21 18 160 174 -VE -VE 9.4 5.2 
10 35 55/F 96 116 26 24 164 178 -VE -VE 17.2 8.3 
11 90 60/M 75 89 40 32 168 176 -VE -VE 12.4 4.3 
12 166 53/F 118 109 20 14 174 179 -VE -VE 16.3 6.2 
13 199 60/M 118 106 25 20 192 199 -VE -VE 9.5 5.5 
14 371 60/F 102 98 32 29 171 184 -VE -VE 9.6 3.8 
15 379 60/F 145 130 23 2O 205 200 -VE -VE 9.5 2.7 
16 745 60M/ 102 97 26 20 125 140 -VE -VE 15.7 6.3 
17 892 52M/ 112 98 16 14 117 130 -VE -VE 12.7 4.2 
18 984 60/F 115 105 19 16 178 182 -VE -VE 19.4 7.5 
19 925 52/F 113 96 27 22 120 138 -VE -VE 9.5 2.7 
20 488 60/F 104 92 20 18 178 180 -VE -VE 11.4 7.5 
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BLOOD AND URINE INVESTIGATIONS OF IP PATIENTS 
s.no Ip.no 
Haemotological investigation Uri ne analysis 
WBC Total WBC differential count(%) Hb mg/dl ESR mm BT AT 
BT AT BT AT BT AT 
BT AT 
sug alb dep sug Alb Dep 
½ hr 1 hr 
½ 
hr 1hr P L E P L E 
1 2283 8300 8700 67 30 03 66 31 03 9.8 11 14 28 9 16 Nil Nil 1-3 pus 
cells Nil Nil NAD 
2 2428 6100 7200 50 49 1 52 47 1 14 14.1 4.5 9 3 6 Nil Nil NAD Nil Nil NAD 
3 2437 7100 7400 68 28 04 67 31 02 11.1 12.3 25 50 12 24 Nil Nil NAD Nil Nil Nil 
4 3082 7000 7,400 65 30 5 66 33 1 10.4 10.8 11 22 3.5 7 Nil Nil 
Few 
epithelial 
cells 
Nil Nil Nil 
5 3252 8000 8500 66 29 05 63 34 03 10.2 11 10 34 9 16 Nil Nil NAD Nil Nil NAD 
6 3264 7800 7600 65 29 6 67 32 1 10.1 10.9 13 26 4 8 Nil Nil NAD Nil Nil NAD 
7 3262 7200 7800 63 31 6 66 32 2 8.3 9.6 9 18 4 7 Nil Nil NAD Nil Nil NAD 
8 3373 8100 7900 70 27 3 66 33 1 10.1 10.8 8 16 3 7 Nil Nil NAD Nil Nil NAD 
9 77 7200 7600 60 34 6 64 35 1 10.5 11 10.5 21 4 8 Nil Nil NAD Nil Nil NAD 
10 35 7000 6900 56 42 2 69 30 1 10.8 11 11 22 3 6 Nil Nil NAD Nil Nil NAD 
11 90 6700 7400 65 30 5 67 32 1 8.5 9 16 32 9 18 Nil Nil NAD Nil Nil NAD 
12 166 8800 8600 62 28 10 63 34 3 11.1 11.6 15 30 4 9 Nil Nil NAD Nil Nil NAD 
13 199 10500 9600 60 30 10 64 33 3 10 10.6 7 15 3 7 Nil Nil NAD Nil Nil NAD 
14 
 
371 8200 7800 65 30 5 60 39 1 11 11.4 24 48 11 22 Nil Nil 1-3 pus 
cells Nil Nil NAD 
15 379 8400 8500 68 30 02 67 31 02 12.1 13 12 24 8 16 Nil Nil NAD Nil Nil NAD 
16 745 8000 7600 60 24 6 64 25 1 12.3 12.6 12 35 9 18 Nil Nil NAD Nil Nil NAD 
17 892 7800 8000 64 34 2 62 34 0 10.5 10.8 12 24 6 12 Nil Nil NAD Nil Nil NAD 
18 984 8500 8700 67 27 3 68 31 1 10.8 11 10 21 3 7 Nil Nil NAD Nil Nil NAD 
19 925 9500 9000 70 23 7 64 34 2 8.2 8.9 20 40 9 18 Nil Nil NAD Nil Nil NAD 
20 488 9900 9000 64 24 8 67 31 2 10.2 10.7 19 38 10 20 Nil Nil NAD Nil Nil NAD 
BT – Before Treatment AT- After Treatment ESR – Erythrocyte Sedimentation Rate HB – Haemoglobin BS – Blood sugar BU - Blood urea                                           
P-Polymorph  L-Lymphocytes   E – Eosinophils 
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BLOOD AND URINE INVESTIGATIONS OF OP PATIENTS 
s.no Op.no 
Haemotological investigation Uri ne analysis 
WBC Total WBC differential count(%) Hb mg/dl ESR mm BT AT 
BT AT BT AT BT AT 
BT AT 
sug alb dep sug Alb Dep 
½ hr 1 hr 
½ 
hr 1hr P L E P L E 
1 63678 9000 9800 64 30 6 65 32 3 9.9 11 10 22 8 16 Nil Nil 1-3 pus 
cells Nil Nil NAD 
2 65162 7800 8100 65 30 5 67 32 1 11.3 11.5 12 27 7 14 Nil Nil NAD Nil Nil NAD 
3 66875 7500 8000 67 27 6 68 30 2 9.1 9.8 7 15 4 9 Nil Nil NAD Nil Nil NAD 
4 68061 8800 8400 63 32 5 65 34 1 10.9 11.2 14 28 6 12 Nil Nil 
Few 
epithelial 
cells 
Nil Nil NAD 
5 70076 8800 9000 70 24 6 68 31 1 9.9 12 8 18 4 12 Nil Nil NAD Nil Nil NAD 
6 70477 10200 10620 62 20 8 64 32 4 11 11 20 45 15 23 Nil Nil NAD Nil Nil NAD 
7 71054 6800 7100 55 42 3 64 35 1 11 11.5 27 50 8 15 Nil Nil NAD Nil Nil NAD 
8 71915 8400 8600 67 31 2 65 31 4 9.6 11.5 18 36 6 13 Nil Nil NAD Nil Nil NAD 
9 2244 7800 8000 60 38 4 63 36 1 9.5 10 10 20 4 8 Nil Nil NAD Nil Nil NAD 
10 892 8900 9200 62 34 4 63 34 3 12.5 13 20 41 16 30 Nil Nil NAD Nil Nil NAD 
11 1001 8000 8500 61 35 4 66 32 2 13 13 6 12 6 12 Nil Nil NAD Nil Nil NAD 
12 1497 7800 7900 59 37 4 62 36 2 13 15 7 14 2 4 Nil Nil NAD Nil Nil NAD 
13 763 11200 11300 79 19 2 65 32 3 11.9 12 15 35 16 30 Nil Nil NAD Nil Nil NAD 
14 
 
10172 7800 7600 50 46 4 61 38 1 12.5 12.6 8 15 3 7 Nil Nil 1-3 pus 
cells Nil Nil NAD 
15 14510 7800 8000 60 37 3 64 34 2 10.5 11.2 30 66 20 40 Nil Nil NAD Nil Nil NAD 
16 14722 11000 9100 67 27 4 60 28 1 14. 14 20 40 6 12 Nil Nil NAD Nil Nil NAD 
17 17150 8100 8300 62 34 4 66 33 1 10.4 11 17 37 12 28 Nil Nil NAD Nil Nil NAD 
18 30518 7400 7600 69 29 2 63 35 2 11.2 11.5 23 40 20 30 Nil Nil NAD Nil Nil NAD 
19 30873 7500 7800 56 40 4 61 38 1 9.2 9.8 18 35 6 12 Nil Nil NAD Nil Nil NAD 
20 30872 10100 9900 64 32 4 65 34 1 11.7 11.6 25 50 12 24 Nil Nil NAD Nil Nil NAD 
BT – Before Treatment AT- After Treatment ESR – Erythrocyte Sedimentation Rate HB – Haemoglobin BS – Blood sugar BU - Blood urea                                           
P-Polymorph  L-Lymphocytes   E – Eosinophils 
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BLOOD INVESTIGATION OF OP PATIENTS 
S.no Op.no Age/sex 
Blood 
sugar(mgs%) 
Blood urea 
(mgs%) Serum cholesterol RA factor ASOtitre 
c-reactive 
protein 
BT AT BT AT BT AT BT AT 
1 63678 42/F 88 94 21 20 140 138 -VE -VE 9.5 2.7 
2 65162 57/F 73 81 40 34 214 198 -VE -VE 11.4 7.5 
3 66875 40/F 121 102 24 22 205 191 -VE -VE 15.7 4.1 
4 68061 55/F 115 98 26 20 187 180 -VE -VE 12.2 5.2 
5 70076 60/M 120 114 17 17 200 189 -VE -VE 14.1 5.3 
6 70477 42/F 98 99 21 17 200 178 -VE -VE 7.2 4.3 
7 71054 50/F 89 92 22 20 186 190 -VE -VE 12.2 5.2 
8 71915 53/F 83 90 27 26 164 162 -VE -VE 11.8 3.3 
9 2244 56/F 101 115 28 24 184 179 -VE -VE 13.3 6.6 
10 892 45/F 89 85 28 27 182 180 -VE -VE 12.6 7.3 
11 1001 45/M 134 112 18 19 200 198 -VE -VE 9.4 5.2 
12 1497 55/F 132 96 34 31 185 185 -VE -VE 17.2 8.3 
13 763 60/F 88 98 23 22 207 198 -VE -VE 12.4 4.3 
14 10172 55/M 124 119 35 29 168 172 -VE -VE 16.3 6.2 
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15 14510 42/F 70 93 25 25 200 195 -VE -VE 9.5 5.5 
16 14722 35/M 87 93 28 26 129 142 -VE -VE 9.6 3.8 
17 17150 60/M 85 89 34 32 164 162 -VE -VE 11.8 5.1 
18 30518 44/M 70 94 30 31 160 158 -VE -VE 15.7 6.3 
19 30873 38/F 110 105 34 29 158 164 -VE -VE 12.7 4.2 
20 30872 50/F 72 84 37 33 176 185 -VE -VE 19.4 7.5 
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DEGENERATIVE CHANGES IN THE LEFT KNEE JOINT 
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DISCUSSION 
 The main aim of the treatment was to study the Therapeutic effect of the drug 
SANTHUVATH CHOORANAM to reduce pain, swelling and restricted joint 
movements in the disease Santhuvatham.The clinical features of Santhuvatham can be 
correlated to PolyArthritis in modern science. PolyArthritis is a chronic inflammatory 
disease associated with symmetrical or asymmetrical involvement of joints. 
 According to the Gender among the 40 patients selected, the disease was 
found to be higher in outpatients females 70% and in males 30%.Among In patients 
70% females and 30% males. 
 According to Age group  In 31-40 years out patients was 15% and in patients 
was 5%. In 41-50 years out patients was 40% and in patients was 10% , In 51-60 
years outpatients was 45% and in patients 85%. 
 In Kaalam out of 40 cases 100%cases were in Pithakaalam . 
 In Paruvakaalam(Season) out of 40 cases 35% cases were included in 
Munpanikaalam, 22.5% cases were Pinpanikaalam and 17.5%were kaarkalam,15% 
cases were koothirkaalam,10% cases were muthuvenirkaalam. 
 Based on Gunam out of 40 cases 87.5% were Rasogunam and 7.5% were 
Thamogunam, 5% were sathuva gunam. 
 In Thinai out of 40 cases 82.5% cases were from MaruthaNilam,2.5% were 
from KurinjiNilam and the remaining 15% cases were NeithalNilam. 
 In Socio economic status out of 40 cases, 62.5% cases belonged to Middle 
Class, 32.5% cases belonged to Poor, 5% cases belonged to Rich. 
 Based on Etiological Factors out of 40 cases 67.5% were due to senility, 22.5 
%were due to Occupational and 10% were Exposure to cold. 
 In Occupational Distribution out of 40 cases, 17.5% were Farmers, 55% were 
Housewife, 5% were clerk and retired officer, 7.5% were watchman and beedi rolling, 
2.5% were saloon.. 
 In Vatham out of 40 cases, 100% cases were affected in Samaanan and 
Viyaanan, 25% cases were affected in Abanan, 85% cases were affected in 
Devathathan and 15% cases were affected in Kirukaran. 
 In Pitham out of 40 cases, Saathagam was affected in 100% cases. Anarpitham 
was affected in 45% cases and Ranjagam was affected in 20% cases. 
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 In Kabam out of 40 cases, Santhigam was affected in 100% . 
 In Udalthathukkal out of 40 cases, 85% Saaram, 100%Enbu,45% Moolai.     
50%  kozhuppu ,20% senner was affectedand 17.5% oon was affected. 
 In Envagaithervugal among the 40 cases,  100% was thontha naadi, 
          30% seen in sparisam and 25% seen in malam. 
While seeing the Naadi among the 50 cases PithaVaathanaadi was found 
,VaathaPithanaadi was found 27.5% cases and VaathaKabam was found in 22.5 cases. 
 In Neikkuri, among the 40 cases, 50% of the case showed combination of ring 
and pearl pattern, 25% of the case showed snake pattern 15% of the case showed pearl 
pattern and 10% shows ring pattern. 
 In Duration of illness out of 40 cases, 47.5% were occur 6 months, 25%  occur 
in  7-12 months and2. 5% occur in 13-18 months and 15% occur in 19-24 
months,10% occur  in above 30 months. 
 According to the clinical features all 100% of cases had joint pain, 75% cases 
showsmorning stiffness, 17.5% has restriction to walk, 57.5% cases shows 
sleeplessness, 12.5% cases shows loss of weight, 50% shows swelling of joints, 50% 
shows loss of appetite, 82.5% shows difficulty to walk, 25% shows constipation, 20% 
shows neck pain and 85% cases shows easy fatiguability. 
 In Locomotor system the Lower extremity was affected in 90% cases, Upper 
extremity was affected in 75% cases and both was affected in 77.5% cases. 
In Individual joint involvement in27.5% of cases in Hip joint .   90% of cases Knee 
joint were involved, in 20% cases inWrist joint and 30%cases Ankle joint were 
involved,5 7.5% cases Shoulder joint was involved and 30% cases Elbow joint was 
involved.    32.5% cases in minor and major joints in upper and lower limb.65% cases 
in lumbosacral joint,35% cases in cervical spine 
 Overall Result in my study - 70% cases showed Good improvement, 20% 
cases showed Moderate improvement, 10% cases showed Mild improvement. 
 Laboratory investigation of blood and urine were done for all 40 cases.There 
were significant changes in blood before and after treatment. Rheumatoid arthritis 
factor was negative in all cases. Blood sugar, blood urea and serum cholesterol were 
done. The values were found to be normal in all the cases. 
 Patients treated with varmam and pottanum  treatment showed very good 
results since there was good reduction in the pain of Santhuvatham patients in this 
clinical trial. 
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SUMMARY 
 A collective and comparative study of the disease Santhuvatham is made 
covering the all aspects of the disease enclosing siddha and modern science aspects  
.Study drug standardised are botanical, phyto chemical, pharmacological, and 
toxicological, these are supportive of trial drug for our santhuvatham.40 cases with 
santhuvatham were diagnosed clinically, out of 40, 20 admitted as in patients have 
received varmam and pottnam and 20 as out patients who were observed for clinical 
diagnosis, Lab Investigations and treatment of trial medicines.The peak age incidence 
of Santhuvatham was found 51-60 years age group.Clinical diagnosis of the above 
disease was done on the basis of clinical features described in  Yugi Vaidhya 
Chinthamani and Siddha Maruthuvam.Before admission for study their careful 
detailed history of the sufferings, duration, their occupation, native etc. are elicited 
from the 40 selected patients.The trial medicines for the clinical treatment and 
management of Santhuvatham were SANTHUVATHA CHOORANAM, twice a day 
with base of hot water and for external use VATHA ENNAI. External therpy 
pottanum and varmam had effective.Biochemical analysis of SANTHUVATHA 
CHOORANAM showed that the presence of calcium,chloride,starch,ferrous 
iron,tannic acid,unsaturated compound,reducing sugarand amino acid.In 
phytochemicalanalysis,santhuvathachooranamhadcarbohydrate,alkaloid,saponin,terpe
noid,phenol.The pharmacological study, the toxicological studies were done.During 
treatment, all the patients keep under strict pathiyam, a specific dietary regimen, it has 
been clearly mentioned in review of siddha literature.No any adverse effect of study 
drugs. All the patients were advised to exercise regularly.The observation made 
during the clinical study shows that the main drugs SANTHUVATHA  
CHOORANAM is  conducive. 
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CONCLUSION 
 Now a days Santhuvatham is more common causing social burden to 
families.The physiochemical and phytochemical analysis reveals that the trial drug 
contains important constiuents which have beneficiary effects in arthritis. 
The Toxicological studies reveal that the trial drug did not produce any toxicity in rat 
models.The Preclinical studies reveals that the trial drug has anti inflammatory anti 
analgesic action .The clinical study shows significant decrease in the symptoms of the 
disease.The trial drug gives a good confidence in the management of Santhuvatham 
and economicaly very low cost.No contra indications was noted during the course of 
treatment.Finally the author conclude that the trial drug SANTHUVATHA  
CHOORANAM and VATHA ENNAI  is effective in SANTHUVATHAM. 
Combined therapy(pottanum.varmam) with trial drug has given more effective than 
trial drug alone.  For more results further studies should be continued in this. 
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ANNEXURE – I 
PREPARATION AND PROPERTIES OF THE TRIAL DRUG 
INTERNAL DRUG: SANTHUVATHA  CHOORNAM 
 
Reference:  AATHMARAKSHAMIRTHAM  
Ingredients:  
chithiramoolam Ver   -  Plumbago indica        - 35 gm      
Mavilingu pattai        -  Grataevamagna          - 35 gm    
Konrai ver                   - cassia fistula               - 35 gm     
Murungai ver              -   moringa oleifera        - 35 gm     
Erukku ver                    - calotropis gigante       - 35 gm 
Veapam ver                  - Azadirachta indica      - 35 gm 
Thippili                          - Piper longum              -35 gm 
Velarugu  ver               - Enicostemma axillare  - 35 gm 
Milagu                            - piper nigrum              -  35 gm 
Sangu                            -  conch shell               -35 gm 
 Panchalavanam-kariuppu(table salt),indhuuppu(rock salt),kaluuppu(himalayan 
crystal salt),valiyaluuppu(glassgall),vediuppu(salt petre)-35 gm 
  DOSE         :  800mg – 1000mg 
 ADJUVANT   :  Hot water 
 DURATION    :  48 days 
 
STANDARD OPERATING PROCEDURE 
Source of raw drugs 
 The required drugs for preparation of SANTHUVATHA 
CHOORANAM(internal)  and VATHAENNAI (external)  would be purchased from a 
well reputed country shop  and standardized before preparing medicines. This raw 
drug would be authenticates and then they were  purified and the medicines were 
prepared in Gunapadam laboratory of Government Siddha Medical College, 
Palayamkottai. 
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PURIFICATION OF RAW DRUGS:  
Root of konrai,murungai,veapam,eruku: 
Wash with water and allow it to dry. (PothusuthiMurai)   
Chithiriramoolam ver 
 The root will be baked in steam of milk. 
Mavilingu pattai 
           Scrab the outerlayer of the bark. 
Milagu 
 Soak in butter milk in 3 days then fry it. 
 thippili 
 Remove the adulterant and allow it to dry. 
Velarugu  
 Wash with water and allow it to dry 
Sangu 
 Soaked in limestone ,heat it and wash and allow it to dry. 
Indhu uppu 
 Soaked in kaadi neer in 3 days,keep under sunlight ,then dry it. 
Kari uppu 
 Dissolve in 1:7 ratio of water,filter it,then heat it till semisolid form,then add 
lime juice in low flame and keep it under sunlight.repeat it for 10 times. 
 
Vallaiyal uppu 
 Dissolve  in kaadi neer, keep under sunlight until it dry. 
 
Vediuppu 
 Add 1:4 ratio of water,heat with low flame,then add 4white egg yolk & heat 
till bubbles come.filter it and keep it under sunlight,repeat this  for 7 times. 
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Kallu uppu 
 Soak in kaadi neer.keep under sunlight,allow it to dry. 
 
PREPARATION: 
 The above mentioned drugs are purified properly as said above and they are 
dried in shade and made into powder it separately and mix well. 
 
DRUG STORAGE:  
 The trial drug santhuvatha Chooranam is stored in a clean and dry air tight 
container and it is dispensed to the patients in packets. 
 
EXTERNAL MEDICINE 
VATHA ENNAI 
Ref : Agasthiyar vaithiya soothiram-650 (pg no-280,281) 
Ingredients : 
Veapam ennai  - Neem oil - 750 ml 
Punga ennai     - punga oil - 750 ml 
Amanakkuennai - castor oil - 750 ml 
Punnai ennai      - Fennel oil - 750 ml 
Nalla ennai        - Gingely oil - 750 ml 
Poondu               - Allium sativum- 17.5g 
Vasambu             - Acorus calamus- 17.5g 
 perugayam         - Ferula foetida  - 17.5g 
Thirikadugu   - 
Sukku                      - zingiber officinale   
Milagu                     - piper nigrum                 - 17.5 g 
Thippili                    - piper longum                                                     
Omam                - Trachyspermum ammi  -17.5 g 
Kirambu              - Syzigium aromaticum    -17.5g 
Sathakuppai        - Anethum graveolens    -17.5g 
Kadugurokini       - Picrorhiza scrophulariiflora -17.5g 
 Chithiramoolam ver  - Plumbago indica              -17.5g 
Kaadi neer            -  vinegar                         -2880 ml  
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PREPARATION : 
 Except oil, all drugs are grind with kaadi neer,then add 5 types of oils,kaadi 
neer into the grinding mixture& mix well,heat it,heat it,till melugu patham,then oil is  
filtered and transfer into another container . It can be used as an external application 
which cures all vatha diseases. 
 
DRUG STORAGE:  
 The trial drug is stored in clean dry air tight container and it is given to the 
patients in disposable pet bottles. 
 
EXTERNAL THERAPY 
SNEGHA POTTANAM 
Ingredients: 
Nochi kolunthu               - vitex negumdo 
Aamanaku illai                     - ricinus communis 
Sirramanaku vidai               - ricinus communis 
Paruthikottai                        - gossypium herbaceum 
theankai thiruval                  - cocos nucifera 
veapamkottai                         - azadirachta indica 
thazhuthalai kolzhunthu         - clerodendrum phlomoidis 
punnai vethai                         - calophyllum inophyllum 
,magilam vethai                    - mimusops elengi 
samuthira palam                    - barringtonia acutangula 
koliyavarai vethai                 -  canavalia lineata 
 
PREPARATION 
 All the ingredients are keep in pottanam,dip in the heated neem oil,apply to 
the affected area for 15-30 minutes. 
    It cures  the santhuvatham and some vatha diseases. 
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GUNAPADAM ASPECT 
 
INTERNAL MEDICINE  : SANTHUVATHA CHOORANAM 
1.Tamil name-chithiramoolam  
OuXohbi<< <<!
! n{qR<sqz<?! nkqgfiiq?! npz<?! wiq?! wPfi?! yzq?! gezq?! sqk<kqv&zq?kpz<?!
ue<eq?!ogicue<eq!
English name  - ceylon lead wort 
Botanical name - plumbago zeylanica 
 Family    - plumbaginaceae   
Part used  -  root 
Sju! ! ;!! gii<h<H!
ke<jl!! ;! ouh<hl<!
hqiqU!!!! ! ;gii<h<H!
 
Constituents: 
 Plumbagin I, Isohinanolone II, Plmbagic acid III, Beta sitosterol,  
transcinngemic acid, Vanillic acid. 
 
Action : 
     Anti periodic 
     Diaphoretic 
Root: 
 Digestive power & promote the appetite. 
ohiKG{l<!;<<< !
“gm<cuqv{r<gqvf<kqgiz<gt<!njvbih<Hg<!
!!!!!gm<cs<$jzuQg<gr<!gip<&zl<!.!Lm<cvk<kg<!
!!!!!gm<MfQOvx<xr<!gek<kohVubqXl<!
!!!!!nm<Mr<!ogicOuzqbil<”!
 
2.Tamil name-mavilingam 
 OuXohbi<! ;! liuqzr<G!!Glivgl<!!uv{q 
 English name : three leaud capu 
Botanical name:   crataeva magna 
           Family   :     capparaceae 
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Part used : bark  
Sju! ! ;! -eqh<H!! !
ke<jl!! ;! km<hl<!! <!
hqiqU!!!! ;! -eqh<H!
 
Constituents: 
 cerylalcohol, friedelin,betulinic acid,diosgenin,sitosterol 
glucoside,cadabacine,lupeol,tannin,saponin,glucocapparin. 
 
Action: 
• Rubefacient 
• Laxative 
• Lithontriptic         
!
ohiKG{l<!;<<< !
Svr<gcbqe<!Oximf<!okijzbik!uikl<!
! dvl<ohX!uqmr<g!otipqBl<!.nvLr<!
! gVli!uMubqZr<!g{<mR<Sr<!g{<{ib<!
yVliuq!zqr<Gg<!Gjv/!
 
 
 
 
3. Tamil name-sarakonrai 
! OuXohbi<;!ogie<jx!kill<!lkjz!-kpq!
 
Botanical name : cassia fistula 
Family    : caesalpinaceae 
Part used  : root 
Sju!!! ! ; jgh<H!!Kui<h<H! !
ke<jl!! ! ;!! ouh<hl<!
hqiqU! ! ! ;!! gii<h<H!
 
Constituents: 
 Tannin, phlobaphenes,oxyanthraquinone substance. 
Action  
       Purgative 
       Tonic 
       Febrifuge 
! !
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ohiKG{l<!;<<< !
!!!hi{<mvr<gi<!H,{ib<h<!hxg<gck<K!Olgk<jk!
!!!bi{<mir<gg<!jgg<Gt<us!lig<GOl.!gi{<mx<!
!!!Gkuqsqz!osb<Kmjz!Obil<HlqK!fQhii<!
!!!-kpqobEr<!ogie<jxHuq!bqz<!
!
 4. Tamil name-murungai 
OuXohbi<< <<!
! sqg<GVgqvR<sl<!!!
! gqpuqOsihiR<sel<!
English name  - Drum stick 
Botanical name - moringa oleifera 
 Family    -  moringaceae 
Part used  -  root 
! Sju!!! ;! jgh<H!Kuv<h<H!-eqh<H!
ke<jl!!! ;! km<hl<!
hqiqU!!!!! ;!! -eq<h<H!
 
Constituents-.spirochin alkaloid,moringine ,moringinine. 
Action  
• Antispasmodic 
• Stimulant 
• Expectorant 
• Diuretic 
• Antilithic 
 
ohiKG{l<!;<<< !
!!!!hqR<siz<!kqiqOkiml<!ohVl<H,!uiz<Ohigl<!
!!!!dR<Suqpqg<!Gg<Gtqi<s<sq!BR<OsVl<!.!uqR<sqjzouh<!
!!!!hix<Xf<Okiz<!fR<sXg<Gl<!nu<Oui<ui!ks<sqek<jk!
!!!!bix<X!LVr<jgbq!eK/!
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5. Tamil name- Erukku  
OuXohbi<< <<!
nVg<ge<!
English name  -  Madar 
Botanical name -  Calatropis gigantea 
Family    -  asclepiadaceae 
Part used  -  root 
Sju!!!! ;! jgh<H!givl<!-eqh<H!
ke<jl!!!!! ;! ouh<hl<!
hqiqU!!!!!! : gii<h<H!
 
Constituents: 
 Beta amyrin, alpha isomeric crystalline alcohols, giganteol, and iso iganteol. 
Action  
 Alterative 
 Tonic 
 Antispasmodi 
 
ohiKG{l<!;<<<  
! le<ejeBr<!jgobMg<g!juk<okbqx<xq!Oebgx<xq!
! Be<E!hq{qh<h{qjb!Obim<Mkzix<!.osie<Oee<!
! wVg<ogeOu!H,lq!bqeqOz!uqtr<Gl<!
! nVg<g!lVg<goee!zil<!!!!!)Ok/ou{<hi*!
!
6.Tamil name-vembu 
OuXohbi<!
! niqm<ml<!!fql<hl<!!Kk<jk!
English name  - Neem  
Botanical name - azadirachta indica 
Family    -  meliaceae 
Part used  - root 
! Sju!!;!! jgh<H!sqXKui<h<H! !
ke<jl!!;! ouh<hl<!
hqiqU!!!!;! gii<h<H!
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Constituents: 
 Nimbidiol, margolinin,margolilin, nimbilin, nimolinin, nimbolide . 
Action  
 Emetic 
 Anthelmintic 
 
!ohiKG{l<<<<!;!
!!!!Hf<kqbqjkk<!kQm<Muqg<Gl<!He<hq{qjb!Obim<Muqg<G!
!!!!lqf<kqbk<jk!fe<xi!bqjsuqg<Gl<!.sf<kkll<!!
!!!!uQX{<mir<!gx<h!lqgU{<mi!olR<Rie<Xl<!
!!!!lixe<xi!jvblqz<zi!lz<!!!!!!!)Ok/ou{<hi*!!!!
 
7. Tamil name- thippli 
OuXohbi<!<<< !
! Ni<gkq?!d{<svl<?!dzjufisq?! gile<?!GOmiiq?! OgijpbXg<gq?! hqh<hqzq?!
NkqlVf<K!
 
English name  -  long pepper 
Botanical name -  piper longum 
Family    -  piperaceae 
Part used  -  fruit  
Sju!!! ;! -eqh<H!
ke<jl!! ;! km<hl<!
hqiqU!!!! ;! -eqh<H!
Constituents 
  Piperine,  rutin  beto - carpophylleneliperline,  piperamine, lialool 
Action  
 Stimulant 
 carminative 
ohiKG{l<!;!<<<  
‘gm<cobkqi<fqe<XgMOfiobz<zil<!h{qBl<!
kqm<cuqjebgZl<!Okgolk<k!.!Hm<cbil<!
! lilEg<Glilolelx<xui<g<Glx<xueir<!
gilolEf<!kqh<hqzqg<Gl<!jg”!!!!!!!!!!.Okve<ou{<hi!
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8. Tamil name-vellaruku 
!!!!!OuXohbi<! ;!!!!!uz<zivq!
English name  -  indian white head 
Botanical name -  enicostemma axillare 
Family    -  gentianaceae 
Part used  -  root 
Sju!!! ;! jgh<H!
ke<jl! ;! ouh<hl<!
hqiqU! ! ;!!! gii<h<H!
 
Constituents 
  Alkaloids, carbohydrate, flavonoids ,tannins, terpenoids. 
Action 
• Stomachic 
• Tonic 
• Alterative 
• Laxative 
• Febrifuge 
 
ohiKG{l<!;<<< !
! Ge<loliM!uib<U!Gmz<uikl<!$jzbqju!
! ose<ll<uqm<!Omics<!sqjkBr<gi{<!.ue<Ljzbib<!
! dt<TXgq!vf<kqosixq!obim<cb!sqvr<GlXl<!
! out<tXG!ke<je!uqVl<H/!
 9.  Tamil name-milagu 
OuXohbi<!<<< !
! gzqj{?Ogitgl<?kqvr<gz<?sVlhf<kl<?ut<tqsl<?lisl<!
English name  -  black pepper 
Botanical name - pepper  nigrum 
Family    -  piperaceae 
Part used  -  unriped fruit 
! Sju!!! ;! jgh<H?gii<h<H!!
ke<jl!!! ;! ouh<hl<!
hqiqU!!!!! ;!! gii<h<H!
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Constituents 
 Pipenine, Superoxide anions, nitrioxdie,dipiperamicles D& E, Piptginne, 
wisanine. 
Action  
• Acrid 
• Carminative 
• Antiperiodic 
• Rubefacient 
• Stimulant 
• Resolvent 
• Antivatha 
• antidote 
!
ohiKG{l<!;!!
! -keiz<!uikOfib<kQVl<!
10. Tamil name: indhuppu 
OuXohbi<< <<!
!!!!jsf<kul</!sqf<Kivl</!lkqBh<H!!
 
Chemical name  :  sodium chloride impure 
English name   :  rock salt 
Action  :  
• highly carminative 
• Stomachic 
• Digestive  
• Cathartic 
• Emetic 
! !
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!ohiKG{l<<<<!
!!!!!nm<mGe<l!lf<kl<!nsqi<g<gvR<$i<!sQkhqk<kf<!
!!!!!Km<mjubl<!fich<H{<!Omimr<gt<!.!ogm<mlzg<!
!!!!!gm<Muqm!uqf<jkbg<!gilqbOfib<!ue<gvh<hie<!
!!!!!uqm<Muqm!uqf<Kh<jh!uqt</!!
11. Tamil name  :Kariuppu      
OuXohbi<< <<!
!!!Osix<Xh<H!gmZh<H/!sLk<kqvzu{l<!
!
Chemical name : sodium chloride 
English name    :tablesalt, common salt 
 
Action : 
• Antiseptic 
• Antiperiodic 
• Anthelmintic 
• Deobstruent  
ohiKG{l<<<<!
!!!lf<kl<!ohiVlzXl<!uiBUl<Ohil<kQhelil<!
!!!okif<kqk<k!\bf<!okimVOli.!sf<kkLl<!
!!!ng<gqeqbqe<!H]<c!nmVr<!gxqBh<hiz<!
!!!sqg<Ggqe<x!fQiqxr<GR<!osh<H/!
12. Tamilname  : valiyaluppu 
      English name:  selvitri 
!ohiKG{l<!<<<  
!!Kjtbii<!!Gmz<uikk<!okif<kui!kk<Oki!
!!cjtbis<!!SuislX!lqe<El<.ujtbZh<hix<!
!!Ge<luzq!$jzouh<hr<!%xih<hq!zQglqju!
!!ose<ll<uqm<!OmiMolek<!Oki</!
13. Tamil name – Vediuppu 
OuXohbi<< <<!
!!!ohim<cZh<H!/!hjmgive</!fus<sivlqk<V!
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Chemical name  :   potassium nitrate 
English name       :  salt petre 
Action       
• Refrigerant 
• Efficient diuretic 
• Disphoretic 
ohiK!G{l<<<<!
!!!!lz<ziV!lm<mGe<l!likVk!vg<gm<c!
!!!!gz<zi!ljkh<HfQi<g<!gm<mVg!–ozz<ziOl!
!!!!gl<hqgl<hq!obe<Xr<!gVU{<mi!lr<gqfqe<x!
!!!!gl<hqgl<hq!obe<Xjvg<Gr<!giz<!
14. Tamil name : sangu 
OuXohbi<!!!!!!<<< !
!!!!!!!!ff<K/!Sk<kq/!uiv{l</-ml<Hiq/!
Zoological  name  : Turbinella rapa 
English name   : conch shell 
Action  
• Anodye 
• Carminative 
• Digestive 
• Astringent 
!
ohiK!G{l<<<<!
gsqui!lqvk<k!hqk<kr<!g{<O{ib<g!OtGl<!
hsqbiXl<!uikl<!hxg<G!–lqsqUmOe!
kr<G!Ljtuqv{f<!kiegZ!Olout<jts<!
sr<glK!U{<mibqx<xie</!
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Fig : 1 Ingredients of SANTHUVATHA CHOORANAM 
INTERNAL MEDICINE 
Chithiramoola Ver Erukku 
Murungai Ver Konrai ver 
Thippili Maavilingapattai 
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Vellarugu Ver Veppam  ver 
Valaiyaluppu Milagu 
Kalluppu Indhuppu 
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Vediuppu Kariuppu 
Sangu Santhuvatha chooranam 
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EXTERNAL MEDICINE 
 
1.Tamil name :poondu 
Botanical name : Allium sativum 
Family    : liliaceae 
Part used  : bulb 
suvai    :  karppu  
thanmai  :  veppam 
pirivu   :   karppu 
Constituents: 
 allyl propyl chisulphide, diallyl disulphide,a allicin, allisatin I &II ,allin 
&amino acids 
Action  
• Carminative 
• antirheumatic 
• Stimulant 
• Tonic 
• Expectorant 
ohiK!G{l<<<<!
! se<eqobiM!uikf<!kjzOfiU!kie<uzq!
! le<equV!fQi<g<Ogiju!ue<sQkl<.!ne<eOl!"!
! dt<Tt<tq!g{<hib<!djt&z!OvigLl<!Ohil<!
! out<Tt<tq!ke<eiz<!ouV{<M!!)n/G/*!
 Uses: 
 Juice used as rubefacient liniment act very beneficially in infantile 
convulsions, other nervous and spasmodic affections. 
 
2.Tamil name : vasambu 
Botanical name :  acorus calamus 
Family       :  acoraceae 
Part used  :  rhizome 
Suvai   : karppu 
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Thanmai  : veppam 
Pirivu   : karppu 
Constituents  
 volatile oil, asarone, phenylindane derivative, phenyl propane derivative. 
Action  
• Stimulant 
• Emetic 
• Antispasmodic 
• Carminative 
• Nervine sedative 
ohiKG{l<<<<!
hil<hikq!fR<sx<!Hkh<H{<!uzquqmhigr<!Ge<ll<!
$l<hi!iqvk<khqk<!kl<Lg!fix<xl<ue<!$jzse<eq!
uQl<hil<jh!gisl<!hqzQgR<!sqzqhkl<!uQxqVlz<!
kil<hir<!gqVlq!bqjuObV!lisqu!sl<hqjeOb/!)Ok/G/*!
Uses: 
 Used in dyspepsia ,fever,skin disease,expectorant,stomachic 
 
3.Tamil name: Perungayam 
Botanical name :  ferula asafoetida 
Family   :  apiaceae 
Part used  :  dried latex 
Suvai    : kaippu ,karakarappu 
Thanmai  : vepam 
Pirivu   : karppu 
Constituents:  
 organic sulphur compound, allyl persulphide 2 turpenes, ferulic acid,malic 
acid ,acetic acid, valerainic acid. 
Action 
• Stimulant 
• Carminative 
• Antispasmodic 
• Expectorant 
! !
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ohiKG{l<<<<!;!
kf<kOu!kf<k!&zk<okPl<hq{q!
sVugitl<!uqVs<sqgr<gQml<li!
lf<kl<uikl<!dkiui<k<kl<!nz<Gz<Ofib<!
lii<h{r<gm<m!Ge<ll<lOgikvl<!
df<Kogi<h<hk<kqe<!uqk<kqvR<$jzs<$i<!
dkqvh<H,s<sq!sqOzk<Klk<KXl<uuzq!
uf<kolb<g<gMh<!OhicjuLx<XOl!
liBfiXfx<!gibr<gqjmg<gqOe/!!)Ok/G/*!
!
Uses 
 Used in vatha disease,acid peptic disease 
 
4.Tamil name; chukka 
Botanical name  : zingiber officinale 
Family   : zingiberaceae 
Part used  : rhizome 
Suvai   : karppu 
Thanmai  : veppam 
Pirivu   : karppu 
Constituents: 
  diarylheptanoids,essential oil,gingerdiol. 
Action 
• Local stimulant 
• Rubefacient 
ohiKG{l<<<<!;!
‘uikhq{qubqX~kx<!osuquib<!
uzqkjz!uzqjgz!uzqbqVuqpqfQi<!
sQkk<!okiMuiqOhkqh<!hzOvi!
sqglzqLglgLglqcghlii<!
sQks<!Svl<uqiqOhks<!SvOfib<!
okxqhMoleolipqGui<HuqkeqOz!
=kg<!GkUlqkQKg<!Gkui!
okEl<uqkqbqjzfuSXG{LeOu”/ 
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Uses 
 Used in indigestion, hyperacidity,cough ,asthma,oedema,cardiac disease. 
5.Tamil name : milagu 
Botanical name : pipernigrum 
Family   : piperaceae 
Part used  : unriped fruit 
Suvai   : kaippu,karppu 
Thanmai  : veppam 
Pirivu   : karppu 
Constituents: 
 amide- pipercide, oleoresin,volatile oil, alkaloid piperine. 
Action 
• Rubefacient 
• Stimulant to skin 
• Resolvent 
Uses 
 Used in hemiplegia,piles,peptic ulcer,vatha disease. 
6.Tamil name :  thippili 
Botanical name : piper longum 
Family   : piperaceae 
Partused  : fruit 
Suvai   :  inippu 
Thanmai  : thatpam 
Pirivu   :  inippu 
Constituents: 
 Essential oilwhich consist of monocyclic sesquiterpenes. 
Action 
• Rubefacient. 
ohiKG{l<!;<<< !
‘gm<cobkqi<fqe<XgMOfiobz<zil<!h{qBl<!
kqm<cuqjebgZl<!Okgolk<k!.!Hm<cbil<!
lilEg<Glilolelx<xui<g<Glx<xueir<!
gilolEf<!kqh<hqzqg<Gl<!jg”!
.Okve<ou{<hi!
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Uses 
  Used in pepticulcer,giddiness. 
 
7. Tamil name; omam 
Botanical name : trachyspermum ammi 
Family   : apiaceae 
Part used  : fruit 
Suvai   : karppu 
Thanmai  : veppam 
Pirivu   : karppu 
Constituents: 
 ajowan oil ,fatty oil, bergapten. 
Action 
• Antispasmodic 
• Tonic 
• Carminative 
• Stimulant 
• Antiseptic 
 
 Uses 
 Used in  Cough ,pepetic ulcer 
 
8.Tamilname; kirambu 
Botanical name : syzygium aromaticum 
Family   : myrtaceae 
Part used  : flowerbud 
Suvai   : karppu 
Thanmai  : veppam 
Pirivu   : karppu 
Constituents:  
 ellagitanin,eugenin,caryophyllene,eugenol,naphthalane,volatile oil. 
Action 
• Carminative 
• Stomachic 
!
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ohiKG{l<<<<!
“hqk<k!lbg<gl<!OhkqobiM!uif<kqBl<Ohil<!
Sk<kuqvk<!kg<gMh<Hf<!Okie<XOli!–!olk<k!
-zur<gr<!ogi{<muVg<!Ogx<!SgliGl<!
lzlr<Og!gm<Mole!uip<k<K!
!
9.Tamilname: sathakuppai 
 Botanical name  : anethum graveolens 
 Family   : umbelliferae 
 Part used  : seed 
Suvai   : inippu,karppu 
 Thanmai  : veppam 
 Pirivu   : karppu 
Constituents:  
 Seed given an essential oil known as dill oil containing flavonoids, beta 
sitosterol glucoside containing carvone. 
 
Action 
• Carminative 
• Stomachic 
• Aromatic 
• Stimulant 
• Diuretic 
!
ohiKG{l<!;<<< !
uikoliM!$kqgi!uikl<!sqvSOfib<!
!!!!!!OliKosuq!Ofib<ghOfib<!&MSvl<.!YKgqe<x!
!!!!!!&zg<!gMh<H!Lkqi<hqesl<!OhiGl<!
!!!!!!Rizs<!skGh<jh!fiM/!!)n/G/*!
  Uses: 
Anti vatha, head ache,earache. 
 
10. Tamilname : Kadugurokini 
 Botanical name  :  picrorhiza kurroa 
Family   : scrophulariaceae 
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           Part used  : rhizome 
Suvai   : kaippu 
Thanmai  : veppam 
            Pirivu   : karppu 
Constituents  : picrorrhizin 
Action 
• Antiperiodic  
• Stomachic 
• Anthelmintic          
ohiKG{l<!;<<< !
lif<kR<!Svjlbl<!uiBgvh<!hieilR<!
Osi<f<klzg<!gm<M!kqiqOkiml<.!Ohif<kohim<Mh<!
H{<ubqX!OfibqjuOhil<!ohix<ogicOb!–!OhkqB{<mil<!
kq{<gMG!Ovig{qg<Gk<!Oki<!!!)n/G/*!
Uses 
            Puerperal eclampsia, respiratory disease. 
 
11. Tamil name; chithiramoolam 
 Botanical name  :  plumbago zeylanica 
 Family   : plumbaginaceae 
 Part used  :  root 
Suvai   : karppu 
 Thanmai   : veppam 
Pirivu    : karppu 
 
ChemicalConstituents:  
  Plumbagin I, Isohinanolone II, Plmbagic acid III, Beta sitosterol,  
transcinngemic acid, Vanillic acid. 
Action 
• Stomachic 
• Tonic    
ohiKG{l<!;<<< !
“gm<cuqv{r<gqvf<kqgiz<gt<!njvbih<Hg<!
gm<cs<$jzuQg<gr<!gip<&zl<!.!Lm<cvk<kg<!
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gm<MfQOvx<xr<!gek<kohVubqXl<!
nm<Mr<!ogicOuzqbil<”!
 
12. Tamilname: Aamanukku ennai 
 English name   :  castor oil 
 Botanical name  :  jatropha curcas 
 Family   : euphorbiaceae 
 Part used  :  seed 
 Suvai    : karppu 
 Thanmai  : veppam 
 Pirivu   : karppu 
 
 Constituents: 
 Glycosides, arabinose, lipase, fats, fixed oils. 
Action 
• Laxative 
• Emollient 
Uses 
    It relieves constipation, act as antivatha . 
 
13. Tamilname: nalla ennai  
Botanical Name   : Sesamum indicum 
English Name     :  gingelly oil 
Family     : Pedaliaceae 
Part used    : Seeds 
Suvai   : inippu 
 Thanmai   : veppam 
 Pirivu    :  inippu 
Constituents 
 Vitamin A, Sesamin, sesamolin, phytosterol 
Action 
• Demulcent 
• Laxative 
• Nutritive 
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• Emollient 
 
Uses:  
 It gives immunity , cure ear and eye disorder,scabies,wound 
 
 
14. Tamilname: pungu ennai 
Botanical Name  : Pongamia pinnata 
Family     : Fabaceae 
Part used  :  seed 
Suvai    : kaippu,thuvaruppu 
Thanmai  : veppam 
Pirivu   : karppu 
 
Chemical Constituents: 
 Karangin,  Pongamol, Galbone, dimethylpuranol 
 Action  
• Antiseptic 
• Stimulant 
ohiKG{l<!;<<< !
“uikg<!gMh<Hlgi&i<s<jskihSvl<!
uikGe<ll<!vk<kkiz<!uf<kqMOfib<!.!yKgqe<x!
h{<HjvBl<!uz<uqmLl<!OhiGl<!kqv{<mV{<Om!
h{<HXr<!gl<Oui<g<Gh<!hii<”!
!!!!!!!!!!!!!!!!!!!.ngk<kqbi<!G{uigml</!
 
15. Tamilname- punnai ennai 
 Botanical name : calophyllum inophyllum 
 Family       : calophyllaceae 
Part used  : seed 
 Suvai   : kaippu 
 Thanmai  : veppam 
Pirivu   : karppu 
Chemical constituents 
  leucocyanidin,calophyllolide 
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Action 
• Anthelmintic 
• Caustic 
Uses 
 Seed oil is highly used in rheumatism,antipsoric,gonorrhea, scabies. 
16.Tamil name: vembu ennai 
 Botanical name  :  azadirachta indica 
 Family   : Meliaceae 
Partused  : seed 
 Suvai   : kaippu 
 Thanmai  : veppam 
 Pirivu   : karppu 
Chemical constituents: 
 Nimbidiol,margocinin, margocilin, nimbilin,nimolinin,nimbolide. 
 Action 
• Stimulant 
• Antiseptic 
• insecticide 
 Uses 
    Anti vatha disease, scabies, eczema,fever cured. 
17. Tamilname; kaadineer 
 Common name :  rice vinegar 
Uses : 
 As a antiseptic. 
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EXTERNAL MEDICINE  - VATHA ENNAI 
Vasambu Poondu 
Perungayam Milagu 
Thippili Chukku 
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Kirambu Omam 
Kadugurogini Sathakuppai 
Aamanakku Ennai Chithiramoolam 
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Pungu ennai Nallannai 
Vembu ennai Punnai ennai 
Vatha Ennai Kaadineer 
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EXTERNAL THERAPY 
 SNEGHA POTTANAM 
1. Tamil name –nochi 
Botanical name - Vitex negundo 
Family   - Lamiaceae 
Part used   - Leaf 
Action  
o Analgesic 
o Anti-inflammatory  
o Antimicrobial  
o Carminative 
o Muscle relaxant 
Uses: Relieves in pain and inflammation of muscles and joints. Used as fomentation 
in sprains ,rheumatism ,swelled testicles, contusions. 
2. Tamil name –aamanakku  
Botanical name  – Ricinus communis 
Family   – Euphorbiaceae 
Part used  - Leaf 
Action:   
Anti vatha 
Uses:  
   Cure inflammation,relieves pain , to pacify vata dosha. 
3. Tamil name –sirramanakku  
Botanical name - Ricinus communis 
Family     -  Euphorbiaceae 
Part used   - Seeds 
Action 
    Anti  vatha 
Uses 
    Cure vata dosha related disorders like arthritis,facial paralysis and abdominal 
disorders. 
4.Tamil name –paruthi 
Botanical name - Gossypium herbaceum 
Family   - Malvaceae 
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Part used   - Seeds 
Action  
    Anti viral 
    Anti bacterial  
Uses: 
   Externally ,it is used to treat herpes,scabies,wounds and orchitis 
5.Tamil name- thenkai 
Botanical name  – Cocos nucifera 
Family   –  Arecaceae 
Part used   – Grated coconut 
Action  
   Vermicide 
Uses 
Helps relieve symptoms associated with chronic fatigue syndrome. 
 
6.Tamil name- veambu 
Botanical name  - Azadirachta indica 
Family   – Meliaceae 
Part used  - Seed 
Action 
     Anthelmintic 
     Antiperiodic 
    Antiseptic 
Uses  
 Used to treat boils .rheumatism,ringworm,ulcers. 
7.Tamil name – thazhuthalai 
Botanical name- clerodendrum phlomoidis 
Family – lamiaceae 
Part used- leaf 
Action  
   Alterative 
Astringent 
Uses: 
    Leaves is applied externally on swelling. 
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 8.Tamil name- Punnai 
Botanical name -  Calophyllum inophyllum 
Family   – Calophyllaceae 
Part used  - Seed 
Action  
   Anthelmintic 
   Caustic 
Molluscicidal activity 
Uses: 
   Externally as an analgesic against rheumatism and sciatica and as a medication 
against swellings,ulcers,scabies. 
9.Tamil name: magilam 
Botanical name  – Mimusops elengi 
Family   – Sapotaceae 
Part used  - Seed 
Action  
  Tonic 
   Astringent 
10.Tamil name – samuthira pazham 
Botanical name  –  Barringtonia acutangula 
Family    –  Lecythidaceae 
 Part used   –  Dried fruit  
Action  
    Antibiotic 
Uses  
It is used as topical. And pacifies vatha. 
11. Tamil name – koliyavarai  
Botanical name  – Canavalia lineata 
Family     - Fabaceae 
Part used   – Seeds 
Uses: 
    All kinds of inflammatory disease and atopic dermatitis. 
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SNEGHA POTTANAM 
Amanakku Nochi 
Paruthi Sitramanakku 
Vembu Thengai 
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Magilam Thaluthalai 
Koliavarai 
  
 
 
 
Samuthira Pazham 
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ANNEXURE II 
BIO – CHEMICAL ANALYSIS 
BIO – CHEMICAL ANALYSIS OF SANTHUVATHA CHOORANAM 
PREPARATION OF THE EXTRACT: 
5gms of  the drug was weighed accurately and placed in a 250ml clean beaker then 
50ml distilled water is  added and dissolved well. Then it is boiled well for about 10 
minutes. It is cooled and filtered in a 100ml volumetric flask and then it is  made  to 
100ml with distilled water. This fluid is taken for analysis. 
QUALITATIVE ANALYSIS: 
S.NO       EXPERIMENT     
OBSERVATION 
                  
INFERENCE 
1. 
 
Test for calcium: 
2ml of the above prepared extract 
is taken ina clean test tube. To this 
add 2 ml of 4%ammonium oxalate 
solution. 
A white precipitate 
is formed. 
 
Indicates the 
presence of 
calcium. 
 
2. 
 
Test for sulphate: 
2ml of the extract is added to 
5%bariumchloride solution. 
No  white 
precipitate is 
formed 
 
Absence  of 
sulphate. 
 
3. 
 
Test for chloride: 
The extract is treated with 
silvernitrate solution 
A  white Precipitate 
is 
formed. 
 
Indicates the 
presence of 
Chloride 
 
4. 
 
Test for carbonate: 
The substance is treated with 
concentrated Hcl. 
No brisk 
effervescence is 
formed 
Absence of 
carbonate. 
 
5. 
 
Test for Starch: 
The extract is added with weak 
iodinesolution. 
Blue colour is 
formed 
 
Indicates the 
Presence of 
starch. 
 
6. 
 
Test for Ferric Iron: 
The extract is treated with 
concentrated glacial acetic acid and 
potassium ferro cyanide. 
No blue colour is 
formed. 
 
Absence of 
ferric iron. 
7. 
 
Test of FerrousIron: 
The extract is treated with 
concentrated Nitric acid and 
ammonium thiocyanide solution. 
Blood red Colour is 
formed. 
 
Indicates the 
presence of 
ferrous iron. 
8. 
 
Test for phosphate: 
The extract is treated with 
ammonium 
molybdate and concentrated nitric 
acid. 
No yellow 
Precipitate is 
formed. 
 
Absence of 
phosphate 
9. Test for albumin: No yellow Absence of 
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The extract is treated with Esbach’s 
reagent. 
precipitate 
formed. 
 
albumin. 
 
10. 
 
Test for Tannic acid: 
The extract is treated with ferric 
chloride. 
Blue black 
precipitate is 
formed. 
 
Indicates the 
presence of 
Tannic acid. 
 
11. 
 
Test for unsaturation: 
Potassium permanganate solution 
is added to the extract. 
It gets decolorised. 
 
Indicates the 
Presence of 
unsaturated 
compound. 
 
12. 
 
Test for the reducing sugar: 
5ml of Benedict’s qualitative 
solution is taken in a test tube and 
allowed to boil for 2 minutes and 
added 8-10 drops ofthe extract and 
again boil it for 2 minutes. 
 
colour change 
occurs. 
 
Indicates the 
presence  of 
reducing 
sugar. 
 
13. 
Test for amino acid: 
One or two drops of the extract is 
placed on a filter paper and dried 
well. After drying,1% ninhydrin is 
sprayed over the same and dried it 
well. 
Violet Colour 
develops. 
 
Indicates the 
presence of 
amino acid. 
 
14. 
Test for zinc: 
The extract is treated with 
Potassium 
ferrocyanide. 
No white 
Precipitate is 
formed 
 
Absence of zinc. 
 
 
 Inference: 
  The given sample of “SANTHUVATHA  CHOORANAM” contains calcium, 
chloride, Starch, Ferrous iron, tannic acid,  unsaturated compound ,reducing sugar and 
amino acid. 
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PHYTOCHEMICAL ANALYSIS 
QUALITATIVE METHOD OF SANTHUVATHA CHOORANAM 
 
S.NO. TEST NAME RESULT 
1 Carbohydrate Present 
2 Protein Absent 
3 Alkaloid Present 
4 Flavanoid Absent 
5 Glycoside Absent 
6 Steroid Absent 
7 Saponin Present 
8 Phenol Present 
9 Tannin Absent 
10 Terpenoid Present 
 
Procedure 
Test for Carbohydrates - Benedict’s test (Brain & Turner, 1975) 
  To 0.5 ml of test drug about 0.5 ml of Benedict’s reagent is added. The 
mixture is heated on a boiling water bath for 2 minutes. A characteristic coloured 
precipitate indicates the presence of sugar. 
  Brain KR, Turner TD. The Practical Evaluation of Phytopharmaceuticals. 
Bristol:Wright-  
 
Glycosides (Ansari, 2006) 
 Keller-Killiani Test: To 2 ml of the extract, glacial acetic acid, one drop 5% FeCl3 
and conc. H2SO4 was added. Reddish brown colour appeared at junction of two 
liquid layers and upper layer turned bluish green indicating the presence of 
glycosides.  
 
Ansari, S. H. 2006. Essentials of pharnacognosy, 1st edition, Birla publications, New 
Delhi. pp. 357-359, 588-590. 
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 Steroids (IP, 1996) 
  Salkowski Test: To 2 ml of extract, 2 ml of chloroform and 2 ml of conc. 
H2SO4 was added. The solution was shaken well. As a result chloroform layer turned 
red and acid layer showed greenish yellow fluorescence. 
  Indian Pharmacopoeia (IP). 1996. Govt. of India, Ministry of Health and 
Family Welfare Published by the Controller of Publications, New Delhi, A-47, A-53, 
A-54. 
 
Alkaloids (Ansari, 2006)  
  The extract was evaporated in a test tube. To the residue dilute HCL was 
added, shaken well and filtered.  
 
Mayer’s Test: To the 2-3 ml of filtrate Mayer’s reagent was added. Formation of 
yellow precipitate showed the presence of alkaloids. 
 
Ansari, S. H. 2006. Essentials of pharnacognosy, 1st edition, Birla publications, New 
Delhi. pp. 357-359, 588-590. 
 
Flavanoids (Kokate, 1994) 
Shinoda Test: 
 
  To the extract, 5 ml of 95% ethanol and few drops of concentrated 
hydrochloric acid was added. To this solution 0.5 gm of magnesium turnings were 
added. Pink colouration indicated the presence of flavanoids. 
Kokate, C. K. 1994. Practical Pharmacognosy, 4th edition, Vallabh Prakashan, New 
Delhi.  4 - 29. 
Tannins (Mukherjee, 2002) 
 Lead Acetate Test: On addition of lead acetate solution to the extract white 
precipitate appeared. 
Mukherjee, P. K. 2002. Quality control of herbal drugs, business horizons 
pharmaceutical publishers, New Delhi.  356 - 358. 
 Saponin (Ansari, 2006) 
Foam Test: Drug extract was shaken vigorously with water. No persistent foam was 
formed. 
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 Protein (Ansari, 2006) 
Biuret test  
With 3 ml of test solution, few drops of 4% NaOH and 1% CuSO4 solution were 
added. The tubes were observed for violet or pink colour formation. 
Ansari, S. H. 2006. Essentials of pharnacognosy, 1st edition, Birla publications, New 
Delhi. pp. 357-359, 588-590. 
Phenol (Mukherjee, 2002) 
Ferric chloride test  
The extract was diluted to 5 ml with distilled water. To that a few drop of neutral 5% 
ferric chloride solution was added. A dark green color indicates the presences of 
phenolic compounds.  
Mukherjee, P. K. 2002. Quality control of herbal drugs, business horizons 
pharmaceutical publishers, New Delhi.  356 - 358. 
Test for Glycosides (Horbone, 1984) 
0.5 mg of extract was dissolved in 1 ml of water and then aqueous NaOH solution 
was added. Formation of yellow color indicates the presence of glycosides. 
Horbone, J.B., In: Phytochemical methods, 2nd edition. Chapman and Hall, New 
York,1984. 
Test for Triterepnoids (Horbone, 1984) 
To the test solution 2ml chloroform was added with few drops of conc. Sulphuric acid 
(3ml) at the side of the test tube. An interface with a reddish brown coloration is 
formed if terpenoids constituent is present. 
Horbone, J.B., In: Phytochemical methods, 2nd edition. Chapman and Hall, New 
York,1984. 
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QUANTITATIVE  RESULT: 
 
S.NO QUANTITATIVE OF TEST RESULT mg/g 
1 CARBOHYDRATE 96 ± 0.43 
2  ALKALOID 59 ± 0.61 
3 SAPONIN 21 ± 0.64 
4 TERPENOID 35 ± 0.41 
5 PHENOL 49 ± 0.26 
 
PROCEDURE 
Quantitative Estimation of Alkaloids: (Evans, 1996) 
To 1ml of Methanolic extract 5 ml pH 4.7 phosphate Buffer was added and 5 ml BCG 
solution and shake a mixture with 4 ml of chloroform. The extracts were collected in a 
10-ml volumetric flask and then diluted to adjust volume with chloroform. The 
absorbance of the complex in chloroform was measured at 470 nm against blank 
prepared as above but without extract. Atropine is used as a standard material and 
compared the assay with Atropine equivalents. 
 
Evans, W.C., 1966. Trease Evans Pharmacognosy., 14 th Ed, London: WB Saunders 
Ltd, 119- 159 
Quantitative Estimation of carbohydrate 
The total sugar content was estimated by Anthrone method (Roe, 1955). A known 
amount of the sample was taken, ground well with 80% ethanol and was centrifuged 
at 4000 rpm. From the supernatant, 0.5 ml was taken and 5 ml of anthrone reagent 
was added. The tubes were kept in a boiling water bath for 15 min. After that, they 
were kept in a dark room for another 15 minutes. The colour intensity developed was 
read in a spectrophotometer at 650 nm. 
 
Ref: ROE, J. H. (1955), “The determination of sugar in blood and spinal fluid with 
anthrone reagent” Ibid., ill: 335-343. 
Quantitative Estimation of Saponins: (Evans, 1996) 
     Methanolic and water extract was dissolved in 80% methanol, 2ml of Vanilin in 
ethanol was added, mixed well and the 2ml of 72% sulphuric acid solution was added, 
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mixed well and heated on a water bath at 600c for 10min, absorbance was measured 
at 544nm against reagent blank. Diosgeninis used as a standard material and 
compared the assay with Diosgenin equivalents. 
 
Evans, W. C., Trease and Evans. 1996. Pharmacognosy 14th edition. W. B. Saunders 
company, London, 1996. Experts on Systemic Short-term and (Delayed) 
Neurotoxicity. 
 
Quantitative Estimation of Phenolic Compounds: (Evans, 1996) 
  The total phenolics content in different solvent extracts was determined with 
the Folin- Ciocalteu’s reagent (FCR). In the procedure, different concentrations of the 
extracts were mixed with 0.4 ml FCR (diluted 1:10 v/v). After 5 min 4 ml of sodium 
carbonate solution was added. The final volume of the tubes were made upto 10 ml 
with distilled water and allowed to stand for 90 min at room temperature. Absorbance 
of sample was measured against the blank at 750 nm using a spectrophotometer. A 
calibration curve was constructed using Gallic acid solutions as standard (0 to 
250µg/µl). 
 
Evans, W. C., Trease and Evans. 1996. Pharmacognosy 14th edition. W. B. Saunders 
company, London, 1996. Experts on Systemic Short-term and (Delayed) 
Neurotoxicity. 
 
Total terpenoid determination  
  Total terpenoid content was determined by the method of Ghorai et al (2012). 
To 1 mL of the plant extract, 3 mL of chloroform was added. The sample mixture was 
thoroughly vortexed and left for 3 min and then 200 µl of concentrated sulfuric acid 
(H2SO4) was added. Then it was incubated at room temperature for 1.5h-2h in dark 
condition and during incubation a reddish brown precipitate was formed. Then 
carefully and gently, all supernatant of reaction mixture was decanted without 
disturbing the precipitation. 3 mL of 95% (v/v) methanol was added and 
www.ijppr.humanjournals.com Citation: Natesan Geetha et al. Ijppr.Human, 2015; 
Vol. 2 (2): 98-106. 102 vortexed thoroughly until all the precipitation dissolve in 
methanol completely. The absorbance was read at 538 nm using UV/visible 
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spectrophotometer. The total terpenoid content was calculated by calibration curve of 
Linalool and the results were expressed as Linalool equivalent (mg/g). 
 
Ghorai N, Chakraborty S, Gucchait S, Saha, SK, Biswas S, Estimation of total 
Terpenoids concentration in plant tissues using a monoterpene, Linalool as standard 
reagent. Nature protocol Exchange, 2012. 
 
PHYTO CHEMICAL ANALYSIS 
 
 
 
 
135 
 
 
ACUTE TOXICITY STUDY IN FEMALE WISTER RATS TO EVALUATE 
TOXICITY PROFILE OF SANTHUVATHA CHOORANAM WITH                      
HOT WATER 
Table1. Test substance details 
NAME OF THE TEST SUBSTANCE SANTHUVATHA CHOORANAM WITH 
HOT WATER 
 
Colour of the test substance BROWN 
Nature of the test substance Powder 
 
Table 2. Experimental protocol 
Name of the study Acute toxicity 
Guideline followed OECD 423 method-acute toxic class method 
Animals 
Healthy young adult female wister rats, 
nulliparous, non-pregnant 
Body weight 150-200 g 
Sex                       female 
Administration of dose and volume 
2000 mg/kg in 200g body weight, single 
dose in 1 ml 
Number of groups and animals 
5 groups and 3 animals in each group 
100mg,250mg,500mg,1000mgand 
2000mg/kg 
Route of administration Oral Cavage (po) 
Vehicle Hot Water 
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Table3. Housing and feeding conditions 
Room temperature 22°C  ±  3°C 
Humidity 40-60% 
Light 12 h : 12h (light : dark cycle) 
Feed 
Standard laboratory animal food pellets 
with water ad libitum 
 
Table 4. Study period and observation parameters 
Initial once observation First 30 minutes and periodically 24 h 
Special attention First 1-4 h after drug administration 
Long term observation Upto 14 days 
Direct observation parameters 
Tremors, convulsions, salivation, diarrhea, 
lethargy, sleep and coma. 
Additional observation parameters 
Skin and fur, eyes and mucous membrane, 
respiratory, circulatory, autonomic and 
central nervous systems, somato motor 
activity and behavior pattern etc. 
 
The time of death, if any, is recorded. (Complete observations: annexure I). After 
administration of the drug, food is withheld for a further 1-2 hours. 
 
Study procedure 
  Acute oral toxicity was performed as per organization for economic co-
operation for development (OECD) guideline 423 method. The SANTHUVATHA 
CHOORANAM WITH HOT WATER was administered in a single dose by 
tuberculin syringe. Animals are fasted 3 h prior to dosing (food was withheld for 3 h 
but not water). Following the period of fasting animals was weighed and test 
substance was administered orally at a dose of 100mg,250mg,500mg,1000mgand 
2000mg/kg. After the SANTHUVATHA CHOORANAM WITH HOT WATER 
administration, food was withheld 2 h in mice. Animals are observed individually 
after at least once during the first 30 minutes, periodically during the first 24 hrs, with 
special attention given during the first 4 hrs, and daily thereafter, for a total of 14 
days.  
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REPORT 
Toxicological evaluation of SANTHUVATHA CHOORANAM WITH HOT 
WATER 
Table:5 Effect of SANTHUVATHA CHOORANAM WITH HOT WATER on acute 
toxicity test in female rats. 
 
 
S.NO 
 
 
RESPONSE 
 
    HEAD 
 
     BODY 
 
        TAIL 
 
 
BEFOR
E 
 
AFTER 
 
BEFO
RE 
 
AFTE
R 
 
BEFO
RE 
 
AFTER 
 
  1 
Alertness Normal Normal Normal Normal Normal Normal 
 
 2 
Grooming Absent Absent Absent Absent Absent Absent 
  3 Touch response Absent Absent Absent Absent Absent Absent 
  4 Torch response Normal Normal Normal Normal Normal Normal 
  5 Pain response Normal Normal Normal Normal Normal Normal 
  6 Tremors Absent Absent Absent Absent Absent Absent 
  7 Convulsion Absent Absent Absent Absent Absent Absent 
  8 Righting reflux Normal Normal Normal Normal Normal Normal 
   9 Gripping strength Normal Normal Normal Normal Normal Normal 
   10 Pinna reflux Present Present Present Present Present Present 
   11 Corneal reflux Present Present Present Present Present Present 
    12 Writhing Absent Absent Absent Absent Absent Absent 
    13 Pupils Normal Normal Normal Normal Normal Normal 
   14 Urination Normal Normal Normal Normal Normal Normal 
   15 Salivation Normal Normal Normal Normal Normal Normal 
   16 Skin colour Normal Normal Normal Normal Normal Normal 
    17 Lacrimation Normal Normal Normal Normal Normal Normal 
 
RESULT: 
 From acute toxicity study it was observed that the administration of 
SANTHUVATHA CHOORANAM WITH HOT WATER to Female Wister rats did 
not induce drug-related toxicity and mortality in the animals up to 2000mg/kg in 200g 
female Wister rats. So No-Observed-Adverse-Effect- Level (NOAEL) of 
SANTHUVATHA CHOORANAM WITH HOT WATER is 2000 mg/kg equal to 
human dose 
DISCUSSION 
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SANTHUVATHA CHOORANAM WITH HOT WATER was administered single 
time at the doses of 100mg, 250mg, 500mg, 1000mg and 2000mg/kg to female Wister 
rats and observed for consecutive 14 days after administration. Doses were selected 
based on the pilot study and literature review. All animals were observed daily once 
for any abnormal clinical signs. Weekly body weight and food consumption were 
recorded. No mortality was observed during the entire period of the study. Data 
obtained in this study indicated no significance physical and behavioral signs of any 
toxicity due to administration of SANTHUVATHA CHOORANAM WITH HOT 
WATER at the doses of 100 mg, 250mg ,500mg, 1000mg and 2000mg/kg to female 
Wister rats  
At the 14th day, all animals were observed for functional and behavioral examination. 
In functional and behavioral examination, home cage activity, hand held activity were 
observed. Home cage activities like Body position, Respiration, Clonic involuntary 
movement, Tonic involuntary movement, Palpebral closure, Approach response, 
Touch response, Pinna reflex, Sound responses, Tail pinch response were observed. 
Handheld activities like Reactivity, Handling, Palpebral closure, Lacrimation, 
Salivation, Piloercetion, Papillary reflex, abdominal tone, Limb tone were observed. 
Functional and behavioral examination was normal in all treated groups. Food 
consumption of all treated animals was found normal as compared to normal group. 
 
SUMMARY & CONCLUSION 
Summary: 
  The present study was conducted to know single dose toxicity of 
SANTHUVATHA CHOORANAM WITH HOT WATER on female Wister rats. The 
study was conducted using 15 female Wister rats. The female animals were selected 
for study of 8- 12 weeks old with weight range of within ± 20 % of mean body weight 
at the time of randomization. The groups were numbered as group I, II, III, IV and V 
and dose with 100mg, 250mg, 500mg, 1000mg and 2000mg/kg of SANTHUVATHA 
CHOORANAM WITH HOT WATER. The drug was administered by oral route 
single time and observed for 14 days. Daily the animals were observed for clinical 
signs and mortality.  
  14 There were no physical and behavioral changes observed in Female Wister 
rats during days. Mortality was not observed in any treatment groups. 
 
139 
 
Conclusion: 
  The study shows that SANTHUVATHA CHOORANAM WITH HOT 
WATER did not produce any toxic effect at dose of 100mg, 250mg, 500mg, 1000mg 
and 2000mg/kg to rats. So No-Observed-Adverse-Effect-Level (NOAEL) of 
SANTHUVATHA CHOORANAM WITH HOT WATER is 2000 mg/kg. 
 
7.0 ABBREVIATIONS 
No    Number 
Mg    Milligram 
Kg     Kilogram 
LD50  LethalDose 50 
p.o      peros 
ML    Milliliter 
%       percentage 
R&D Research and Development 
g%     Gram percentage 
g         Gram 
NOAEL   No-Observed-Adverse-Effect-Level 
MLD     Minimum Lethal Dose 
MTD     Maximum Tolerated Dose 
OECD    Organisation of Economic Co-operation and Development 
CPCSEA  Committee for the Purpose of Control and Supervision of 
Experiments on Animals 
 
8.0 REFERENCES: 
OECD. Guideline for Testing of Chemicals 423, Acute oral toxicity (acute toxic class 
method). December 2001. 
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SUB-ACUTE TOXICITY STUDY IN WISTER RATS TO EVALUATE 
TOXICITY PROFILE OF SANTHUVATHA CHOORANAM WITH                      
HOT WATER 
Objective 
The objective of this study is to evaluate the toxic effects, if any, as a result of the 
repeated once daily oral administration of SANTHUVATHA CHOORANAM WITH 
HOT WATER to Wister Albino rats for a minimum period of 28 consecutive days. 
This study will provide information on any major toxic effects, target organs and a 
rationale for concluding the No-Observed-Adverse-Effect-Level (NOAEL) and/or No 
Observed Effect Level (NOEL) / LOEL (Low Observed Effect Level) and risk 
assessment in humans.  
This study plan is prepared as per the following guidelines: 
1. Test Guidelines  
 
Schedule – Y, Amendment version 2005, Drugs and Cosmetics Rules, 1945. 
OECD – 407 – Repeated dose 28-day Oral Toxicity Study in Rodents, Adopted 3 
October, 2008. 
1.1. Test System Details 
Species : Rat 
Strain : Wister Albino  
Source    : Sree Venkateshwara Enterprises Pvt Ltd, Bangalore  
Age : 6-8 weeks  
Sex : Male / Female (nulliparous and non-pregnant) 
Body weight  : 160.0 to 180.0 g 
1.2.  Acclimatization 
Animals will be allowed to acclimatize to the experimental room conditions for five 
days prior to the commencement of dosing. During the acclimatization period, the 
animals will be observed daily for any apparent adverse clinical signs. Prior to 
assignment to the study and commencement of treatment, a detailed physical health 
examination will be performed on all animals by a veterinarian and animals with any 
evidence of ill health or poor physical condition will not selected for the study. 
1.3. Randomization and Grouping 
On the starting day of dosing, the animals will be weighed and health examination 
will be performed by veterinarian. Animals will be randomly allocated to different 
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groups according to their body weight by using MS-Excel sheet as described in the 
randomization SOP. Animals will be divided into four groups (vehicle control, low, 
intermediate, and high dose). At the initiation of the treatment, the body weight 
variation between the groups did not exceed ±20% of the mean weight of each sex. 
1.4. Animal Identification 
In each cage, animals will be identified with numbers by marking at the base of the 
ear. The cages will be identified with an attached colored cage label showing study 
number, study code, group number, sex, dose, strain, species, cage number, route of 
administration and animal number. 
2. Animal Husbandry 
2.1. Animal Welfare and approval 
The study was approved by the IAEC (SLS) and Committee for the Purpose of 
Control and Supervision of Experiments on Animals (CPCSEA registration number: 
Abc14).Their recommendations regarding animal care and handling will be followed. 
2.2. Environmental Conditions 
The temperature of the experimental room will be maintained at 22±30Cand the 
relative humidity between 30-70 %. The photoperiod will be 12 hours light and 12 
hours dark cycles  
2.3. Housing Conditions 
Two animals will be housed in autoclaved polypropylene rat cages (Size in mm=L x 
W x H: 430 x 290 x 160) using paddy husk as the bedding material. Each cage will be 
fitted with a top grill having provision for keeping rodent pellet feed and an 
autoclaved polypropylene water bottle with stainless steel drinking nozzle. Cages will 
be placed on 3-tier racks and cage rotation will be performed every week. Cages will 
be changed at least twice a week. The cages and water bottles will be cleaned and 
autoclave sterilized. 
2.4. Sanitation 
Each day, the floor of the animal room will be swept and mopped. Cages and bedding 
material will be changed once in three days and water bottles will be changed daily. 
All the experimental procedures will be done in a clean environment. 
2.5. Feed 
The experimental animals will be provided with irradiated rodent pellet feed ad 
libitum supplied from Sai feeds Pvt ltd, Chennai . Feed will be withheld for four hours 
prior to blood collection and necropsy. 
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2.6. Drinking Water 
Animals will be provided with filtered drinking water ad libitum  passed through 
water filter system (Aquaguard™) in autoclaved polypropylene bottles. Water bottles 
will be changed daily. Microbial analysis of water will be carried out once monthly 
and the report is maintained in the study file. 
3. Personnel Safety 
All personnel handling animals undergo regular medical examination. Protective 
clothing like apron, face mask, head cap, and gloves will be used to maintain hygienic 
conditions. 
4. Materials and Methods  
4.1. Preparation of Dose formulation 
The dose formulation will be prepared under aseptic conditions as per SLS, SOP.  
4.2. Route of Administration and Justification 
Administration will be by oral gavage, as it is one of the possible routes of exposure. 
4.3. Frequency and Duration of Administration  
Once daily for 28 consecutive days 
4.4. Dosing Procedure 
The test item will be administered in once daily by oral gavage using a suitable 
intubation cannula fitted with a graduated syringe. The scheme of dosing and sacrifice 
time points are presented in the below below Table. 
4.5. Experimental Procedures 
All experimental procedures will be performed in accordance with the Study plan and 
Standard Operating Procedures (SOPs) of SLS. 
 
CONVERSION FORMULA: 
Human dose is 1000 mg /kg day 
Total clinical dose (a) x conversion factor (b) 0.018 = (c) per 150 gm of Rat 
1000 mg x 2(a) x 0.018 (b) = 18 (c) /150 gm of Rat 
18/1000x150 = 2.7 mg  
Experimental Doses Calculated as per the standard procedures are 
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S.No 
 
Groups 
 
Dose /kg, weight 
 
Volume of administration 
 
1 Vehicle Control -- 1 ml 
 
2 Therapeutic Dose 2.7 mg /kg 
 
1 ml 
3 Middle  Dose 13.5mg/kg 1 ml 
 
4 High Dose 67.5mg/kg 1 ml 
 
Experimental Design 
Group 
No. Group 
Dose                          
(mg/kg  
b.wt /day) 
No. of Animals 
Male Female 
G1 Vehicle control HOT WATER 5 5 
G2 
Low dose of  SANTHUVATHA 
CHOORANAM WITH HOT 
WATER 
2.7mg/kg 5 5 
G3 
Intermediate dose 
SANTHUVATHA 
CHOORANAM WITH HOT 
WATER 
      13.5mg/kg 5 5 
G4 
High dose  SANTHUVATHA 
CHOORANAM WITH HOT 
WATER 
     67.5mg/kg 5 5 
 
5. Observations 
Animals will be observed daily throughout the treatment period at regular intervals. 
During the treatment period, animals will be observed twice daily for any clinical 
signs of toxicity, morbidity and mortality. All the surviving animals will be sacrificed 
at the end of scheduled period and subjected to gross necropsy and histopathological 
evaluations. 
5.1. Clinical Signs 
All the animals will be subjected to cage-side (home-cage) observations twice a day 
for any clinical signs of toxicity, preferably at the same time each day and considering 
the peak period of anticipated effect. In addition to home cage observations, a detailed 
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clinical examination will be performed once prior to dosing and weekly thereafter 
during treatment period.  
5.2. Morbidity/ Mortality 
All animals will be examined twice a day for mortality and signs of morbidity.  
5.3. Body Weights 
Body weights will be recorded at the beginning of acclimatization, before 
randomization, there after at weekly intervals and at the time of necropsy. 
5.4. Feed Consumption 
Feed consumption will be calculated on a weekly basis throughout the study period. 
5.5. Haematology and Clinical Biochemistry  
Hematology and clinical biochemistry tests will be performed with terminally 
collected blood samples on day-29 from all animals. Animals will be deprived of feed 
overnight and blood samples will be collected by tapping the ear for visibility of the 
vein site and inserted the needle into the marginal ear vein and collected the blood 
into micro centrifuge tube. Approximately 0.5 ml of blood will be collected in vials 
containing 1% EDTA (20µl) as an anticoagulant for hematological analysis. 
Approximately 2 ml blood will be collected from each animal in micro centrifuge 
tubes containing 15µl of heparin (19 units) and the plasma will be separated by 
centrifugation at 4000 rpm for ten minutes at 4oC. The plasma will be stored at -20 oC 
± 2 and used for all clinical chemistry analysis. 
5.6. Hematology 
Erythrocyte count (RBC), Total Leucocyte count (WBC), Hemoglobin (Hb), 
Hematocrit (HCT), Mean Corpuscular Volume (MCV), Mean Corpuscular 
Hemoglobin (MCH), Mean Corpuscular Hemoglobin Concentration (MCHC) and 
Platelet (PLTC). 
5.7. Clinical Biochemistry  
Glucose, Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST), 
Alkaline phosphatase (ALP), Total protein, Albumin, Creatinine, Urea, Cholesterol, 
Triglycerides, Sodium, Potassium, Calcium, and  Chloride. 
5.8 Pathology 
All animals will be euthanized by CO2 asphyxiation and subjected to necropsy under 
the supervision of the veterinary pathologist. Different tissues/organs of thoracic, 
abdominal and cranial cavities will be examined for any gross pathological changes. 
Tissues from vehicle control and high dose groups will be subjected to detailed 
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histopathological analysis (Ovaries/ testes,  kidneys, liver, lungs). The organs will be 
fixed using Bouin’s (reproductive organs) and 10% neutral buffered formalin 
(kidneys, liver, spleen, lungs).Processing of tissue will be done by spin tissue 
processer, embedding of the tissue by tissue embedder. The tissues will be initially 
trimmed to 10-20µ thickness and later 3-6µ to obtain thinner tissue sections by using 
rotary microtome. Haematoxylin and Eosin staining will be performed for all tissues. 
5.8. Organ Weights 
Absolute weights of adrenal glands, brain, ovaries/testes, epididymis/uterus, heart, 
kidneys, liver, spleen and lungs will be recorded for all the animals after trimming 
adherent tissue immediately after dissection from the animal. Paired organs will be 
weighed together. Relative weights of these organs against fasting animal body 
weights will be calculated and reported. 
6. Data Compilation  
Data will be summarised in a tabular form showing the number of animals, 
experimental design, dose groups, dose volume and concentrations, test item and 
vehicle control details. All findings like clinical signs, mortality and morbidity data, 
time of death, body weights, feed consumption, clinical signs, and necropsy and 
pathology observations will be recorded and given in the final report. One original 
copy of the final report is issued to the sponsor.  
7. Statistical Analysis 
All the parameters of treated groups of both sex, viz. body weight, feed consumption, 
organ weights (absolute and relative), biochemical parameters, and hematology 
parameters will be analyzed using SPSS software, version 16.0 by using one-way 
ANOVA test with multiple comparison (vehicle controls treated groups) in the study 
report, and p value < 0.05 is considered as statistically significant.  
8. References 
1. Committee for the Purpose of Control and Supervision 
of Experiments on Animals (CPCSEA) guidelines for Laboratory Animal Facility, 
The Gazette of India, 1998. 
2. Hayes AW, 2000. Principles and Methods of 
Toxicology, 4th ed., Taylor and Francis, London. 
3. Karl-Heinz Diehl, R. H. (2001). A Good Practice 
Guide to the Administration of Substances and Removal of Blood, Including Routes 
and Volumes. journal of applied toxicology , 15-23. 
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4. OECD – 407 - Repeated dose 28-day oral Toxicity 
Study in Rodents, Adopted    October 3, 2008. 
5. Schedule – Y, Amendment version 2005, Drugs and 
Cosmetics Rules, 1945. 
 
MATERIALS AND METHODS 
         ESTIMATION OF HEMATOLOGICAL PARAMETERS: 1 
Collection of blood for hematological studies 
After the treatment period the animals were anaesthetized by ketamine hydrochloride 
and the blood was collected from Retro-orbital sinus by using capillary into a 
centrifugation tube which contains EDTA for haematological parameters The 
haematological parameters like RBC, WBC and Hb percentage, Differential cell 
count, MCV, MCHC, Hematocrit, MCH, platelet count were estimated by the 
following procedures. 
1. ENUMERATION OF RED BLOOD CELLS: 1Ramnic 2007) 
Reagents : RBC diluting fluid 
       Procedure: 
Using a red blood cell pipette of haemocytometer, well mixed blood was drawn up to 
0.5 mark and RBC diluting fluid was taken up to mark II. The fluid blood mixture was 
shaken and transferred onto the counting chamber. The cells were allowed to settle to 
the bottom of the chamber for 2 min. See the fluid does not get dried. Using 45X or 
high power objective the RBC’s were counted uniformly in the larger corner squares.   
The cells were expressed as number of cells x1012/l 
2. ENUMERATION OF WBC: 2    John 1972) 
      Reagents: 
 Turk’s fluid: Turk’s fluid was prepared by mixing 2ml 
of acetic acid with 100 ml of distilled water. To this 10 drop of aqueous methylene 
blue 3 %    w/v) was added. This solution haemolysis the red cells due to acidity so 
that counting of white cells becomes easy. 
Procedure:     
Using a white blood cell pipette of haemocytometer, well mixed blood was drawn up 
to 0.5 mark and WBC diluting fluid was taken up to mark II. The fluid blood mixture 
was shaken and transferred onto the counting chamber. The cells were allowed to 
settle to the bottom of the chamber for 2 min. See the fluid does not get dried. 
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 Using 10X or low power objective the WBC’s were 
counted uniformly in the larger corner squares.  
 The cells were expressed as number of cells/10mm. 
3. DIFFERENTIAL LEUCOCYTE COUNT: 3 John 1972) 
Reagent: 
              Leishmann’s stain: 150mg of powdered leishmann’s stain was dissolved in 
133ml of acetone free methanol. 
Procedure: 
 A blood film stained with leishmann’s stain was 
examined under oil immersion and the different types of WBCs were identified. The 
percentage distribution of these cells was then determined. Smears were made from 
anticoagulant blood specimens and stained with leishmann’s stain. The slides were 
preserved for counting the number of lymphocytes and neutrophils, per 100 cells were 
noted.  
 From the different Leukocyte count and WBC count, 
absolute lymphocyte and neutrophil count were calculated. 
           Number of neutrophils  
 Absolute neutrophil count =   _______________________________   x  TWBC 
                        100  
                                                                  Number of lymphocytes  
 Absolute lymphocyte count =   _______________________________ x TWBC 
                        100 
 
DETERMINATION OF BIOCHEMICAL PARAMETERS: 
 
  For assessment of biochemical parameters, blood samples were collected from 
the animals by puncturing the retro-orbital plexus and centrifuged. The serum 
collected after centrifugation was analyzed for various biochemical parameters like 
SGOT, SGPT, ALP,TC.TG,HDL All of the above biochemical parameters were 
estimated using semi autoanalyzer (Photometer 5010 V5+, Germany) with enzymatic 
kits procured from Piramal Healthcare limited, Lab Diagnostic Division, Mumbai, 
India. 
 
 
1. Total Cholesterol (TC)
Principle 
Determination of cholesterol is done after enzymatic hydrolysis and oxidation. The 
colorimetric indicator is quinoneimine, which is generated from 4
and phenol by hydrogen peroxide under the catalytic action of peroxidase (trinder’s 
reaction). 
Cholesterol ester + H2O       
Cholesterol + O2CHO      Cholesterol
2H2O2  + 4- Amino antipyrine + Phenol      
Method  
 CHOD-PAP: Enzymatic photometric test
Table 6: Reagents 
Goods buffer (pH 6.7) 
Phenol 
4-aminoantipyrine 
Cholesterol estrase 
Cholesterol oxidase 
Peroxidase 
Standard 
 
Assay procedure 
1. 1 ml (1000 µl) of reagent
2. Added 0.01 ml (10 µl) of serum.
3. Mixed well and incubated at 37
4. Read the test sample.
NORMAL RANGE: <200 mg/dl in serum. 
1. Deeg R, Ziegenhorn J, Kinetic enzymatic method for automated determination 
of total cholesterol in serum, Clin. Chem., 1983, 29:1798
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-aminoanti
CHE
       Cholesterol + Fatty acid 
-3-one +H2O2 
POD
          Quinonelimine + 4 H
 
50 mmol/ l 
5 mmol/l 
0.3 mmol/l 
>  200 U/l 
>  100 U/l 
3 KU/l 
(5.2 mmol/l) 
-1 is taken in a 5 ml test tube. 
 
◦C   for 5 min. 
 
 
-802. 
 
pyrine 
2O2 
2. Triglycerides 
Principle 
Determination of triglycerides (TG) alters enzymatic 
Indicator is quinoneimine which is generated from 4
chlorophenol by hydrogen peroxidase under the catalytic action of peroxidase.
Triglycerides              LPL           
Glycerol + ATP              GK            
Glycerol-3-phosphate +O
2H2O2  + 4- Amino antipyrine + 4
4H2O2 
Method 
   Colorimetric enzymatic test 
Reagents 
  Components and concentrations in the test Goods buffer pH 7.2, 50 mmol/ l
Table 7: Reagents 
4-chloroPhenol
ATP 
Mg2+ 
Glycerokinase
Peroxidase
Lipoprotein lipase
4-aminoantipyrine
Glcerol-3-
Standard 
 
Assay procedure 
a. 1 ml (1000 µl) of reagent
b. Added 0.01 ml (10 µl) of serum.
c. Mixed well and incubated at
d. Read the test sample.
 Normal Range: <200 mg/dl in serum.
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splitting with lipoprotein lipase. 
-aminoantipyrine and 4
Glycerol + fatty acid 
Glycerol-3-phosphate+ ADP 
2 
GPO
 Dihydroxyaceton phosphate + H2O2 
- chlorophenol         POD  Quinonelimine + HCL + 
using glycerol-3-phosphate-oxidase (GPO).
 4 mmol/l 
2 mmol/l 
15 mmol/l 
 > 0.4 Kµ/l 
 > 2 Kµ/l 
 > 4 Kµ/l 
 0.5 mmol/l 
phosphate- oxidase > 1.5Kµ/l 
(2.3 mmol/l) 
-1 is taken in a 5 ml test tube. 
 
 37◦C for 15 min. 
 
 
- 
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Cole T.G, Klotzsch S.G, Mcnarmara J, Measurement of triglyceride concentration, In 
Rifai N, Warnick G.R, Dominiczak M.H, Handbook of lipoprotein testing, 
Washington:AACC, Press, 1997, 115-26. 
3. HDL Cholestrol 
 Principle  
Chylomicrons, VLDL and LDL are precipitated by adding phosphotungstic acid and 
magnesium ions to the sample. Centrifugation leaves only the HDL in the supernatant. 
The cholesterol content in it is determined enzymatically. 
Method 
Phosphotungstic acid precipitation method. 
Table 8: Reagents 
Phosphotungstic acid 0.55 mmol/l 
Magnesium chloride 25 mmol/l 
Assay procedure 
A.  Preparation of supernatant for the HDL-CHL estimation 
    Added 200 µl of serum to the 500 µl of HDL-Cholesterol precipitating reagent 
(from HDL kit) in 1.5 ml centrifuge tube and mixed well. Centrifuged the above 
solution at 4000 rpm for 10 min. 
B. Preparation of test sample for the estimation of HDL-Cholesterol 
a. Taken 1000 µl of reagent-1 (from cholesterol kit) in a 5 ml test tube. 
b. Added, 100 µl of supernatant from above centrifuged solution 
c. Mixed well and incubated at 37◦C for 15 min. 
d. Read the test sample.  
Normal Range: >60 mg/dl in serum. 
1. Friedewald W.T, Levy R.T, Frederickson D.S, Estimation of VLDL and LDL 
cholesterol, Clin. Chem., 1972, 18:499-502. 
 
4. ESTIMATION OF SERUM GLUTAMATE PYRUVATE TRANSAMINASES 
(SGPT/ ALT) 
1. Determination of aspartate aminotransferase (AST) 
  Aspartate aminotransferase, also known as Glutamate Oxaloacetate 
Transaminase (GOT)catalyses the transamination of L-aspartate and α keto glutarate 
to form oxaloacetate and L- glutamate. Oxaloacetate formed is coupled with 2,4- 
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Dinitrophenyl hydrazine to form hydrazone, a brown coloured complex in alkaline 
medium which can be measured colorimetrically. 
Reagents  
Buffered aspartate  (pH 7.4); 2,4- DNPH reagent;  4N sodium hydroxide;  working 
pyruvate standard; solution I (prepared by diluting 1 ml of reagent 3 to 10 ml with 
purified water). 
Procedure  
  Rietman and Frankle method was adopted for the estimation of SGOT. 
(Reitmann S, Frankel S, 1957. A colorimetric method for the determination of serum 
oxaloacetic and glutamic pyruvate transminases. American Journal of Clinical 
Pathology.28: 56-63.The reaction systems used for this study included blank, 
standard, test (for each serum sample) and control (for each serum sample). 0.25 ml of 
buffered aspartate was added into all the test tubes. Then 0.05 ml of serum was added 
to the test group tubes and 0.05 ml of working pyruvate standard into the standard 
tubes. After proper mixing, all the tubes were kept for incubation at 37oC for 60 min, 
after which 0.25 ml each of 2,4- DNPH reagent was added into all the tubes. Then, 
0.05 ml of distilled water and 0.05 ml of each serum sample was added to the blank 
and the serum control tubes respectively. The mixture was allowed to stand at room 
temperature for 20 min. After incubation, 2.5 ml of solution I was added to all test 
tubes. Mixed properly and optical density was measured in a spectrophotometer at 
505 nm within 15 min. 
The enzyme activity was calculated as:-  
AST (GOT) activity in IU/L) = [(Absorbance of test - Absorbance of control)/ 
(Absorbance of standard - Absorbance of blank)] x concentration of the standard         
2.  Determination of alanine aminotransferase(ALT) 
 Alanine aminotransferase, also known as Glutathione Peroxidase (GPT) 
catalyses the transamination of L-alanine and α keto glutarate to form pyruvate and L- 
Glutamate. Pyruvate so formed is coupled with 2,4 – Dinitrophenyl hydrazine to form 
a corresponding hydrazone, a brown coloured complex in alkaline medium which can 
be measured colorimetrically. 
Reagents 
Buffered alanine (pH 7.4), 2,4–DNPH, 4N sodium hydroxide, working pyruvate 
standard, solution I (prepared by diluting 1 ml of reagent 3 to 10 ml with purified 
water). 
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Procedure  
Rietman and Frankle method was dopted for the estimation of SGPT. The reaction 
systems used for this study included blank, standard, test (for each serum sample) and 
control (for each serum sample). 0.25 ml of buffered alanine was added into all the 
test tubes. This was followed by the addition of 0.05 ml of serum into the test group 
tubes and 0.05 ml of working pyruvate standard into the standard tubes. After proper 
mixing, all the tubes were kept for incubation at 37oC for 60 minutes, after which 0.25 
ml each of 2,4- DNPH reagent was added into all the tubes. Then, 0.05 ml of distilled 
water and 0.05 ml of each serum sample was added to the blank and the serum control 
tubes respectively. The mixture was allowed to stand at room temperature for 20 min. 
After incubation, 2.5 ml of solution I was added to all test tubes. Mixed properly and 
optical density was read against purified water in a spectrophotometer at 505 nm 
within 15 min. 
The enzyme activity was calculated as:- ALT (GPT) activity in IU/L) = [(Absorbance 
of test - Absorbance of control)/ (Absorbance of standard - Absorbance of blank)] x 
concentration of the standard.        
3. Determination of alkaline phosphatase (ALP) 
Alkaline phoshatase from serum converts phenyl phosphate to inorganic phosphate 
and phenol at pH 10.0. Phenol so formed reacts in alkaline medium with 4-
aminoantipyrine in presence of the oxidising agent potassium ferricyanide and forms 
an orange-red coloured complex, which can be measured spectrometrically. The color 
intensity is proportional to the enzyme activity. 
Reagents: 
Buffered substrate 
Chromogen Reagent 
Phenol Standard, 10 mg% 
Procedure: 
ALP was determined using the method of Kind (Kind PRM, King EJ, 1972. In-vitro 
determination of serum alkaline phosphatase. Journal of Clinical Pathology 7: 321-
22\). The working solution was prepared by reconstituting one vial of buffered 
substrate with 2.2 ml of water. 0.5 ml of working buffered substrate and 1.5 ml of 
purified water was dispensed to blank, standard, control and test. Mixed well and 
incubated at 370C for 3 min. 0.05 ml each of serum and phenol standard were added 
to test and standard test tubes respectively. Mixed well and incubated for 15 min at 
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370C. Thereafter, 1 ml of chromogen reagent was added to all the test tubes. Then, 
added 0.05 ml of serum to control. Mixed well after addition of each reagent and the 
O.D of blank, standard, control and test were read against purified water at 510 nm. 
Serum alkaline phosphatase activity in KA units was calculated as follows  
[(O.D. Test-O.D. Control) / (O.D. Standard- O.D. Blank)] x 10 
4. Determination of bilirubin  
In toxic liver, bilirubin levels are elevated. Hyperbilirubinemia can result from 
impaired hepatic uptake of unconjugated bilirubin, such a situation can occur in 
generalized liver cell injury, certain drugs (e.g Rifampin and probenecid) interfere 
with the rat uptake of bilirubin by the liver cell and may produce a mild unconjugated 
hyperbilirubinemia. Bilirubin level rises in diseases of hepatocytes, obstruction to 
bilirubin excretion into duodenum, in haemolysis and defects of hepatic uptake and 
conjugation of Bilirubin pigment such as Gilbert’s disease.  
Elevation of total serum bilirubin may occur due to:  
1.Excessive haemolysis or destruction of the red blood cells.Eg:Haemolytic disease of 
the new born. 
2.Liver diseases.Eg.Hepatitis and cirrhosis. 
3.Obstruction of the biliary tract.Eg.Gall stones. 
The method is based on the reaction of Sulfonilic acid with sodium nitrite to form 
azobilirubin which has maximum absorbance at 546nm in the aqueous solution. The 
intensity of the color Produced is directly proportional to the amount of direct or total 
bilurubin concentration present in the sample. 
Reagents 
1. Diazo A-(Reagent-R1) :Ready to use 
2. Diazo B-(Reagent-R2):Ready to use 
3. Bilirubin Activater :Ready to use 
Procedure 
Kind & King’s method was followed for the estimation of Bilirubin. Five hundred µl 
of working reagent was added to 50 µl of rat serum & incubated for 5 min at 37°C. 
Absorbance was measured AT 546 NM in semi auto analyzer against the standard. 
The Bilirubin content was calculated using the following equation: 
Total bilirubin (mg/dt) = Abs of the sample blank x 15. 
Direct Bilirubin(mg/dt) = Abs of sample blank x 10. 
 
5. ESTIMATION OF UREA
Urea is the nitrogen-containing end product of protein catabolism. States associated 
with elevated levels of urea in blood are referred to as hyper uremia or azotemia. 
Method 
Estimation of urea was done by Urease
Principle 
Urea + 2H2O     Urease       
2- Oxoglutarate +NH4+ +NADH      
Table 14. Reagents 
R 1 
TRIS pH 7.8
2-Oxoglutarate
ADP 
Urease 
GLDH 
R 2 NADH 
R 3 Standard 
 
Procedure 
a. Take 1000 µl of reagent
b. To this, add 10 µl of serum.
c. Mix well and immediately read the test sample
nm optical path 1 cm against reagent blank (2
d. And note down the value.
Normal range: 10 – 50 mg/dl.
6. ESTIMATION OF URIC ACID
Uric acid and its salts are end products of the purine  metabolism. In gout the most 
common complication of  hyperuricemia, ie. Increased serum levels of uric acid lead 
to formation of  monosodium urate crystal around the joints.
Method  
Enzymatic photometric test using  TOOS (N ethyl
toluidin) 
Principle  
Uric acid + H2O + O2       uricase         Allantoin +CO
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-GLDH: enzymatic UV test.  
2NH4 + 2HCO3 
GLDH
      L- Glutamate +NAD+ + H2O
 120  mmol/l 
 7 mmol/l 
0.6 mmol/l 
≥ 6 KU/l 
≥ 1 KU/l 
0.25 mmol 
40 mg/dl 
-1 and 250 µl of reagent-2 in 5 ml test tube.
 
 at 340 nm Hg 334 nm Hg 365 
-point kinetic). 
 
 
 
 
- N (hydroxyl -3- sulfopropyl)
2 +H2O2 
 
 
 
-m- 
TOOS + 4 aminoantipyrine + 2H
Table 15.reagents 
R1 Phosphate buffer pH 7.0
TOOS
Ascorbate oxidase
R2 Phosphate buffer pH 7.0
4-
K
Peroxidase
Uricase
Procedure 
a. Take 800µl of  reagents 
b. To this add 20µl of serum.
c. Mix well and incubate at 30°c for 5 minutes.
d. Then add 200µl of
e. Mix well incubate for 5min at 37°c
f. Measure the not down the values.
Normal range: 1.9-8.2mg/dl
7. ESTIMATION OF CREATININE
Principle: 
Creatinine forms a coloured complex with picrate in alkaline medium. 
The rate of formation of the complex is measured. 
Reagents: 
Reagent 1    Standard Creatinine
Reagent 2    Picric acid solution.
Reagent 3     sodium hydroxide solution 
Procedure: 
 Take 500 µl of reagent 
add 100 µl of serum. Mix well and immediately read the test sample at Hg 492 nm 
1cm light path and note down the values. 
Normal range is 0.6 -1.1 mg/dl.
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2O2POD       Indamine + 3H2O 
 100mmol/l 
 1mmol/l 
 ≥1 KU/l 
 100mmol/l 
 amino antipyrine 0.3mmol/l 
4 (Fe( CN)6) 10µmol/l 
 ≥1KU/l 
 ≥50U/l 
-1 in a2ml centrifuge tube. 
 
 
 reagent2 
 
 
 
:  
 
 
 (2mg/100ml) 
 
 
-2 and 500 µl of reagent -3 in a 5ml test tube. To this 
 
 
TABLE: 1  EFFECT OF SUB
SANTHUVATHA CHOORANAM WITH HOT WAT
IN Gram (PHYSICAL PARAMETER
 
GPs Control Low Dose
 
Male Female Male
1stwk 139.7± 
2.728 
 
134.7± 
3.712 
 
136.7±
2.404
 
2ndw
k 
144.3± 
2.028 
 
141±3 
 
142.3±
2.667
 
 
3rdwk 
152.7± 
2.028 
 
150± 
2.646 
 
153.3±
3.283
 
 
4thwk 
169.3± 
1.333 
 
163.7± 
2.906 
 
164.3±
2.728
 
 
Values are expressed as the mean ± S.D
 
 
156 
-ACUTE DOSES (28 DAYS) OF 
ER ON BODY WEIGHT 
) 
 Middle Dose High Dose
 Female Male Female Male
 
 
136± 
1.732 
 
138.7± 
1.764 
 
134.7± 
3.528 
 
134±
2.646
 
 
 
143.7± 
1.202 
 
144± 
1.732 
 
141± 
4.359 
 
143.3±
3.283
 
 
 
155.3± 
2.028 
 
157.3± 
1.202 
 
153± 
2.646 
 
153±
2.517
 
 
 
167.3±2.
028 
 
167.3±0.
8819 
 
164.3± 
2.728 
 
164.3±
2.728
 
 
 
 
 Female 
 
 
138± 
1.155 
 
 
 
145.7± 
1.453 
 
 
 
158.7± 
2.028 
 
 
 
169± 
3.786 
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TABLE: 2EFFECT OF SUB-ACUTE DOSES (28 DAYS) OF SANTHUVATHA 
CHOORANAM WITH HOT WATER ON FOOD INTAKE IN Gram 
(PHYSICAL PARAMETER) 
Groups Control Low Dose Middle Dose High Dose 
 
DAY Male Female Male Female Male Female Male Female 
Day 1 
68 54 42 34 78 46 64 30 
DAY2 
64 40 80 55 44 88 80 34 
DAY3 
56 64 42 56 64 52 46 58 
Day 4 
58 68 45 32 38 56 80 56 
DAY5 
61 88 36 58 34 24 74 62 
Day 6 
62 48 54 60 38 62 56 64 
DAY7 
54 78 72 56 38 44 57 74 
DAY8 
72 56 38 19 54 50 16 74 
Day 9 
56 28 48 36 64 71 82 56 
DAY10 
56 77 56 78 54 42 56 80 
Day 11 
56 74 56 78 64 58 44 56 
DAY12 
62 54 45 52 34 56 72 64 
DAY13 
64 58 50 48 62 56 88 64 
Day 14 
72 34 16 35 20 75 35 56 
DAY15 
58 62 32 44 18 40 26 64 
Day 16 
56 64 80 56 22 60 48 56 
DAY17 
24 58 74 62 45 56 64 74 
DAY18 
70 56 44 54 68 58 30 62 
Day 19 
39 24 34 28 30 39 25 60 
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DAY20 
56 58 38 62 56 31 28 80 
DAY21 
34 14 38 30 44 52 66 32 
Day 22 
42 22 56 18 34 24 18 22 
DAY23 
38 26 34 10 18 6 44 58 
DAY24 
58 64 60 12 58 68 32 38 
Day 25 
62 74 50 14 61 88 58 34 
DAY26 
58 62 32 44 18 40 26 64 
DAY27 
56 64 80 56 22 60 48 56 
DAY28 
24 58 74 62 45 56 64 74 
 
Values are expressed as the mean ± S.D 
Values are expressed as the mean ± S.D 
  
 EFFECT OF SUB
CHOORANAM WITH HOT WATER ON ORGAN WEIGHT
 
GROUP CONTROL
LIVER  WEIGHT 7.168±0.54
KIDNEY 
WEIGHT 
L 1.082±0.1 
R 1.329±0.341
HEART WEIGHT 0.859±0.007
LUNGS  WEIGHT 2.04±0.318
TESTIS WEIGH 2.998±0.34
UTERUS 0.3955±0.0265
 
Values arae expressed as mean ± SEM Statistical significance (p) calculated by one 
way ANOVA followed by dunnett’s (n=6); 
***p<0.001, calculated by comparing treated groupswith control group. 
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-ACUTE DOSES (28 DAYS) OF SANTHUVATHA 
 
 
Low Dose 
 
Middle Dose 
 4.896±0.598 6.343±0.088 
0.7925±0.0725 0.7405±0.0575 
 0.733±0.055 0.7445±0.0545 
 0.929±0.069 0.7685±0.0395 
 0.753±0.073 1.025±0.199 
 2.615±0.909 2.006±0.562 
 0.4755±0.0505 0.385±0.035 
nsp>0.05, *p<0.05, **p<0.01, 
 
 
 in gm 
 
High Dose 
6.039±0.227 
0.872±0.106 
0.909±0.023 
0.9955±0.0335 
1.828±0.2005 
2.627±0.3995 
0.753±0.027 
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EFFECT OF SUB ACUTE DOSES (28 DAY) 0FSANTHUVATHA 
CHOORANAM WITH HOT WATER ON HAEMATOLOGICAL 
Groups Control
Rbc (X106/µl)  
 
3.41±1.495
 
Wbc(X103/µl)  
 
10.55±1.75
 
 
Hb (g/dl) 
15.9±1.5
 
 
Values are expressed as the mean ± S.D; Statistical significance (p)calculated by one 
way ANOVA  followed by dunnett’s ns
0.05 calculate by comparing
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PARAMETERS 
 Low Dose Middle Dose High Dose
 5.795±0.3666 
 
5.28±0.0866 
 
5.765±0.1992
 
 13.05±2.55 
 
14.7±0.1 
 
11.75±0.05
 
 14.4±1.9 
 
12.85±0.45 
 
14.25±1.05
 
- no significant  *P< 0.001,  **P < 0.01, 
 treated group with CONTROL group.     
 
 
 
 
 
***P < 
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EFFECT OF SUB ACUTE DOSES (28 DAY) 0FSANTHUVATHA 
CHOORANAM WITH HOT WATER ON BIOCHEMICAL PARAMETER 
Groups Control
Total 
Bilirubin(mg/dl) 
 
0.61±0.14
 
 
Values are expressed as the mean ± S.D; Statistical significance (p)calculated by one 
way ANOVA  followed by dunnett’s ns
0.05 calculate by comparing
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(LIVER PROFILE) 
 Low Dose Middle Dose 
 0.695±0.025 
 
0.905±0.055 
 
- no significant  *P< 0.001,  **P < 0.01, 
 treated group with CONTROL group.         
 
 
High Dose 
0.865±0.095 
 
***P < 
EFFECT OF SUB ACUTE DOSES (28 DAY) 0FSANTHUVATHA 
CHOORANAM WITH HOT WATER ON BIOCHEMICAL PARAMETER 
(LIVER PROFILE) 
 
Groups Control 
 
SGOT (U/L) 
 
78.25±16.95
 
SGPT (U/L) 35.19±11.12
 
ALP (U/L) 252.7±20 
 
 
Values are expressed as the mean ± S.D; Statistical significance (p) calculated by one 
way ANOVA  followed by dunnett’s ns
0.05 calculate by comparing
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Low Dose Middle Dose High Dose
 126.8±44.35 
 
69.4±6.4 
 
82.55±1.85
 
 51.55±2.35 
 
32±5.7 
 
27.85±6.35
 
299.9±37.65 
 
225.9±11.35 
 
198.8±41.6
 
- no significant  *P< 0.001,  **P < 0.01, 
 treated group with CONTROL group.         
 
 
 
 
 
***P < 
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EFFECT OF SUB ACUTE DOSES (28 DAY) 0FSANTHUVATHA 
CHOORANAM WITH HOT WATER ON BIOCHEMICAL PARAMETER 
Groups Control 
Urea (mg/dl) 37.04±10 
 
Uric acid 
(mg/dl) 
1.35±0.13
 
Creatinine 
(mg/dl) 
0.36±0.02
 
 
Values are expressed as the mean ± S.D; Statistical significance (p)calculated by one 
way ANOVA  followed by dunnett’s ns
0.05 calculate by comparing
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(KIDNEY PROFILE) 
Low Dose Middle Dose High Dose
38.5±5.3 
 
33.85±4.59 
 
30.56±4.945
 
 0.81±0.35 
 
1.52±0.28 
 
1.46±0.08
 
 0.2±0.07 
 
0.18±0.03 
 
0.32±0.06
 
- no significant  *P< 0.001,  **P < 0.01, 
 treated group with CONTROL group.         
 
 
 
 
 
***P < 
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EFFECT OF SUB ACUTE DOSES (28 DAY) 0FSANTHUVATHA 
CHOORANAM WITH HOT WATER ON BIOCHEMICAL PARAMETER 
Groups Control 
Total 
cholesterol 
(mg/dl) 38.6±7.9 
Triglycerides 
(mg/dl) 107.1±0.75
HDL-
Cholesterol 
(mg/dl) 
7.59±2.34
 
 
Values are expressed as the mean ± S.D; Statistical significance (p)calculated by one 
way ANOVA  followed by dunnett’s ns
0.05 calculate by comparing
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(LIPID PROFILE) 
Low Dose Middle Dose High Dose
50.5±6.4 49.75±12.85 46.35±6.25
 72.65±5.95 102.7±36.9 99.6±15.4
 8.39±3.71 
 
4.4±0.2 
 
3.65±0.45
 
- no significant  *P< 0.001,  **P < 0.01, 
 treated group with CONTROL group.         
 
 
 
 
 
***P < 
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RESULTS: 
    CLINICAL SIGNS: 
All animals in this study were free of toxic clinical signs throughout the dosing   
period of 28 days. 
 Mortality: 
All animals in control and in all the treated dose groups survived throughout the 
dosing period of 28 days. 
 Body weight: 
Results of body weight determination of animals Table-1 from control and different 
dose groups exhibited comparable body weight gain throughout the dosing period of 
28 days. 
Food consumption: 
During dosing and the post-dosing recovery period, the quantity of food consumed by 
animals from different dose groups was found to be comparable with that by control 
animals. 
Organ Weight: 
Group Mean Relative Organ Weights (% of body weight) are recorded in Table No.4 
Comparison of organ weights of treated animals with respective control animals on 
day 29 was found to be comparable similarly. 
Hematological investigations: 
The results of hematological investigations (Table 4) conducted on day 29 revealed 
following significant changes in the values of different parameters investigated when 
compared with those of respective controls; however, the increase or decrease in the 
values obtained was within normal biological and laboratory limits or the effect was 
not dose dependent. 
Biochemical Investigations: 
Results of Biochemical investigations conducted on days 29 and recorded in Table 2 
revealed the following significant changes in the values of hepatic serum enzymes 
studied. When compared with those of respective control. However, the increase or 
decrease in the values obtained was within normal biological and laboratory limits. 
Histopathology: 
In histopathological examination, revealed normal architecture in comparison with 
control and treated animal. 
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 DISCUSSION: 
1)  All the animals from control and all the treated dose groups up to 500 mg/kg 
survived throughout the dosing period of 28 days. 
2)  No signs of toxicity were observed in animals from different dose groups during 
the dosing period of 28 days. 
3)  Animals from all the treated dose groups exhibited comparable body weight gain 
with that of controls throughout the dosing period of 28 days. 
4) Food consumption of control and treated animals was found to be comparable 
throughout the dosing period of 28 days 
5)   Haematological analysis conducted at the end of the dosing period on day 29, 
revealed no abnormalities attributable to the treatment. 
6) Biochemical analysis conducted at the end of the dosing period on day 29 no 
abnormalities attributable to the treatment. 
7) Organ weight data of animals sacrificed at the end of the dosing period was found 
to be comparable with that of respective controls. 
8) Histopathological examination revealed normal architecture in comparison with 
control and treated animal. 
 SUMMARY AND CONCLUSION:  
In conclusionSANTHUVATHA CHOORANAM WITH HOT WATER can be 
considered safe, as it did not cause either any lethality or adverse changes with 
general behavior of rats and also there were no observable detrimental effects (100 to 
300 mg/kg body weight) over a period of 28 days. Our results have demonstrated that 
the SANTHUVATHA CHOORANAM WITH HOT WATER is relatively safe 
when administered orally in rats. 
9.0 ABBRVIATION 
No.   Number 
Mg  Milligram 
Kg   Kilogram 
LD50  Lethal Dose 50 
p.o.  peros 
mL  Milliliter 
%   percentage 
R&D   Research and Development 
EDTA  Ethylene Diamine Tetra Acetic Acid 
174 
 
M   Male 
g%   Gram percentage 
g  Gram 
NOAEL  No-Observed-Adverse-Effect-Level 
MLD   Minimum Lethal Dose 
MTD   Maximum Tolerated Dose 
OECD  Organisation of Economic Co-operation and Development 
CPCSEA  Committee for the Purpose of Control and Supervision of Experiments 
on Animals 
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EFFECT OF SANTHUVATHA CHOORANAM WITH HOT WATER ON 
CARRAGEENAN-INDUCED LOCALISED INFLAMMATORY                    
PAIN IN RATS 
SUMMARY 
The study plan was developed based on the guidelines of Vogel1 and also it has 
reference to Chao Ma and Jun-Ming Zhang2 and Walker et al. 3,Winter CA, Risley 
EA, Nuss GW. Carrageenin induced edema in hind paw of the rat as an assay for anti-
inflammatory drugs. Proc Soc Exp Biol Med. 1962;111:544–7. 
OBJECTIVE 
To study the anti-inflammatory effect of SANTHUVATHA CHOORANAM were 
prepared with HOT WATER in the rat model of Carrageenan-induced localized 
inflammation.  
Methods: 
Test System 
Species : Rat   
Strain : Albino Wister 
Age : 6-8 weeks at the time of dosing 
Total no. of Rats : 24 
Sex : Male 
Weight                   :    150 gm 
 The animals were housed in polypropylene cages with stainless steel top grills 
having facilities for holding pellet food and drinking water in bottle with stainless 
steel sipper tube. Each cage contained 6 rats. All rats had free access to potable water 
and standard pelleted laboratory animal diet ad libitum. Paddy husk was used as 
bedding material. The animals were divided into 5 groups (6 rats/group). Localized 
inflammatory pain was induced in all groups of animals by intraplantar injection of 
carrageenan (50 µl of 3% suspension).  
 One day before the experiment, three basal readings of hind paw in each rat 
were recorded. Group 1 received vehicle orally, Group 2 received a standard drug 
Diclofenac sodium (10 mg/kg i.p), whereas groups 3,4and 5 received 
SANTHUVATHA CHOORANAM. The doses of SANTHUVATHA 
CHOORANAM were prepared with HOT WATER, whereas Diclofenac 
sodiumwas dissolved in normal saline.After 30 min, the rats were challenged with 
subcutaneous injection of 0.1 ml of 1% w/v solution of carrageenan into the sub 
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plantar region of left paw. The paw was marked with ink at the level of lateral 
malleolus and immersed in mercury up to the mark. The paw volume was measured at 
0, 1, 2, 3, 4, 5 and 6th hr after carrageenin injection using Digital Plethysmometer. The 
difference between initial and subsequent reading gave the actual edema volume.  
 
CONVERSION FORMULA: 
  Human dose is 1000 mg /kg day 
Total clinical dose (a) x conversion factor (b) 0.018 = (c) per 150 gm of Rat 
1000 mg x 2(a) x 0.018 (b) = 18 (c) /150 gm of Rat 
18/1000x150 = 2.7 mg  
Experimental Doses Calculated as per the standard procedures are 
 
 
S.No 
 
Groups 
 
Dose /kg, weight 
 
Volume of administration 
 
1 Vehicle Control -- 1 ml 
 
2 Therapeutic Dose 2.7 mg /kg 
 
1 ml 
3 Middle  Dose 13.5mg/kg 1 ml 
 
4 High Dose 67.5mg/kg 1 ml 
 
EXPERIMENTAL DESIGN: 
Group-I:   Served as a negative control (0.1ml of 1% carrageenin) 
Group-II: Served as standard received Diclofenac sodium (10mg/kg, i.p) + 
                  (0.1ml of 1% carrageenin) 
Group-III: Received SANTHUVATHA CHOORANAM were prepared with HOT 
WATER 
        (2.7 mg /kg) + (0.1ml of 1% carrageenin) 
Group IV: Received SANTHUVATHA CHOORANAM were prepared with HOT 
WATER 
                   (13.5 mg/kg ) + (0.1ml of 1% carrageenin) 
Group V: Received SANTHUVATHA CHOORANAM were prepared with HOT 
WATER 
                   (67.5 mg/kg ) + (0.1ml of 1% carrageenin) 
 
TABLE: EFFECT OF SANTHUVATHA CHOORANAM WITH HOT WATER 
ON Carrageenin -INDUCED PAW EDEMA IN RATS (BODY WEIGHT in gms)
 
 
 
Group 
 
 
Only 
Carrageenan 
 
 
INITIA
L 
BODY 
WEIG
HT 
 
134±1.155 
 
 
 
Values are expressed as the mean ± S.D. Statistical significance (p) calculated by one 
way ANOVA followed by dunnett’s. ns
comparing treated group with control group
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Carrageena
n+ 
Diclofenac 
10mg/kg 
 
Carrageenan
+ 
SC L.D 
 
 
 
Carrageen
an 
+SC M.D 
Carrageenan+SC 
136±4 
 
 
138.7±0.881
9 
 
 
137±2.88
7 
 
 
- not significant **P< 0.05 calculated by 
 
 
 
H.D 
132±2.309 
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EFFECT OF SANTHUVATHA CHOORANAM WITH HOT WATER ON 
Carrageenin -INDUCED PAW EDEMA IN RATS 
 
 
Group 
Mean 
paw 
volume 
before 
carrag
eenan 
injecti
on 
Paw Volume after 
induction with 
carrageenin Increase 
in paw volume (ml) 
after carrageenan 
injection (mean ± 
SEM) 
 
 
Paw Volume after induction with 
carrageenin 
Increase in paw volume (ml) after 
carrageenan injection (mean ± 
SEM) 
 
0 min 30 
min 1hr 2hr 3h 4h 5h 6h 
Only 
Carrag
eenan 
 
3.37±0.
054 
 
 
7.02±
0.20 
 
7.63±0
.301 
 
8.27±
0.30 
 
8.49±
0.23 
 
8.52±0.
20 
 
8.59±0.
04 
 
8.37±0.
084 
 
Carrag
eenan 
+ 
Standa
rd 
 
 
3.33±0.
068 
 
7.06±
0.102 
 
7.587±
0.168 
7.2±0
.061 
 
 
7.15±
0.40* 
 
 
6.78±0.
083** 
 
 
 
6.37±0.
10*** 
 
5.13±0.
16*** 
 
Carrag
eenan 
+ SC 
L.D 
 
 
3.67±0.
13 
 
7.16±
0.284 
 
7.85±0
.219 
 
8.67±
0.37 
 
8.1±0.
36 
 
7.907±
0.54 
 
7.17±0.
40** 
 
6.57±0.
29** 
 
Carrag
eenan 
+ SC 
M.D 
 
4.06±0.
35 
 
7.42±
0.274 
 
7.62±0
.0731 
7.47±
0.27 
 
 
7.41±
0.12 
6.99±0.
24* 
 
 
6.61±0.
05*** 
 
6.45±0.
33** 
 
Carrag
eenan 
+ SC 
H.D 
 
3.97±0.
37 
 
6.21±
0.206 
 
 
6.79±0
.330 
7.21±
0.22 
 
 
7.49±
0.27 
7.06±0.
23* 
 
 
6.07±0.
17*** 
 
 
5.87±0.
30*** 
    
 
Values are expressed as the mean ± S.D. Statistical significance (p) calculated by one 
way ANOVA followed by dunnett’s. ns- not significant **P< 0.05 calculated by 
comparing treated group with control group 
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EFFECT OF SANTHUVATHA CHOORANAM WITH HOT WATER ON 
Carrageenin -INDUCED PAW EDEMA IN RATS  
 
 
 
                  Only Carrageenin                                        Carrageenin+ STD 
 
 
          Carrageenin   + SC L.D                                  Carrageenin+ SC M.D 
 
 
 
Carrageenin+ SC H.D 
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EFFECT OF SANTHUVATHA CHOORANAM WITH HOT WATER ON 
ACETIC ACID INDUCED WRITHING IN MICE1 
1. Kaneria MS, Naik SR, Kohli RK. Anti-inflammatory,antiarthritic and 
analgesic activity of a herbal formulation. Indian J.Experimental Biol. 2007; 45: 279. 
 
       Acetic acid induced writhing method was adopted for evaluation of analgesic 
activity. Writhing is defined as a stretch, tension to one side, extension of hind legs, 
contraction of the abdomen so that the abdomen of mice touches the floor, turning of 
trunk (twist). Any writhing is considered as a positive response. 
 
MATERIAL AND METHODS 
ANIMALS: 
          Healthy Swiss albino rats of either sex weighing 20-25g were used in this study. 
All the animals were obtained from Animal house of the KMCH College of 
Pharmacy, Coimbatore. The animals were housed comfortably in a group of six in a 
single clean plastic cage with a metal frame lid on its top. They were housed under 
standard environmental conditions of temperature (24±1°C) and relative humidity of 
30-70 %. A 12:12 h light dark cycle was followed. All animals had free access to 
water and standard pelletized laboratory animal diet ad libitum. All the experimental 
procedures and protocols used in this study were reviewed and approved via the 
Approval No. ----------------------------- by the Institutional Animal Ethical Committee 
(IAEC) of KMCH College of Pharmacy, Coimbatore (685/PO/Re/S/2002/CPSCEA 
Dated 21st August 2002 constituted in accordance with the guidelines of the CPCSEA, 
Government of India. 
DRUGS: 
         Acetic acid (Sigma Chemical Co. Bangalore, India) and Indomethacin  were 
purchased from (Ranbaxy, India). All drugs were dissolved in saline. The different 
doses of SANTHUVATHA CHOORANAM were prepared WITH HOT WATER. 
The control group received vehicle as control. All drugs were prepared just before 
use. 
 
PREPARATION OF ACETIC ACID: 
   A solution of acetic acid (1% v/v) in distilled water was prepared. 
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CONVERSION FORMULA: 
Human dose is 1000 mg /kg day 
Total clinical dose (a) x conversion factor (b) 0.018 = (c) per 30 gm of Mice 
1000 mg x 2(a) x 0.018 (b) = 18 (c) /30 gm of Mice 
18/1000x30 = 0.54 mg  
Experimental Doses Calculated as per the standard procedures are 
 
 
S.No 
 
Groups 
 
Dose /kg, weight 
 
Volume of administration 
 
1 Vehicle Control -- 1 ml 
 
2 Therapeutic Dose 0.54 mg /kg 
 
1 ml 
3 Middle  Dose 2.7mg/kg 1 ml 
 
4 High Dose 13.5mg/kg 1 ml 
 
EXPERIMENTAL PROCEUDRE: 
 
        GROUP 1 – CONTROL (IP injection of 0.1 ml 1% acetic acid) 
       GROUP 2 -- IP injection of 0.1 ml 1% acetic acid +Indomethacin (5mg/kg, i.p) 
       GROUP 3 -- 0.1 ml 1% acetic acid (ip) + SANTHUVATHA CHOORANAM 
WITH HOT WATER   0.54MG /KG(PO)                        
       GROUP 4 -- 0.1 ml 1% acetic acid (ip) + SANTHUVATHA CHOORANAM 
WITH HOT WATER  2.7mg/Kg(Po) 
      GROUP 5 -- 0.1 ml 1% acetic acid (ip) + SANTHUVATHA CHOORANAM 
WITH HOT WATER 
13.5mg/kg(po) 
 PROCEDURE: 
Wister albino mice of either sex were divided into five different groups each 
containing  
Six animals, the animals were marked individually. Food was withdrawn 12 hours 
prior to drug 
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administration till completion of experiment. The animals were weighed and 
numbered appropriately. The test and standard drugs were given orally. After 60 
minutes writhing was induced by intra-peritoneal injection of 1% acetic acid in 
volume of 0.1 ml/10g body weight. The writhing episodes were recorded for 30 
minutes; stretching movements consisting of arching of the back, elongation of body 
and extension of hind limbs were counted. 
  Anti-nociceptive  activity was expressed as the percentage inhibition of 
abdominal constrictions using the ratio:  
             (Control mean – Treated mean) × 100/Control mean 
 
EFFECT OF SANTHUVATHA CHOORANAM WITH HOT WATER ON 
ACETIC ACID WRITHING IN MICE1 
 
 
GROUP 
 
No of Writhing (30min) 
 
Inhibition (%) 
 
 
CONTROL 
 
 
45.25±3.4 
 
---- 
 
Indomethacin (5mg/kg, i.p) 
 
 
22.75±1.25 
 
 
SC 0.028mg/kg(po) 
 
 
51.25±1.25 
 
SC 0.014mg/kg(po) 
 
 
41.75±1.031 
 
 
SC 0.28mg/kg(po) 
 
 
36.75±2.496 
 
     
Values are expressed as the mean ± S.D; Statistical significance (p)calculated by one 
way ANOVA  followed by dunnett’s ns- no significant  *P< 0.001,  **P < 0.01, ***P < 
0.05 calculate by comparing treated group with CONTROL group.         
 EFFECT OF SANTHUVATHA CHOORANAM WITH HOT WATER ON HOT 
PLATE METHOD IN MICE
 
1. Turner RA. Screening methods in pharmacology. In: Turner, R., Hebborn, P. 
(eds.). Academic press, New York. 1965; 100. 
 
            The paws of mice and rats are very sensitive to heat at temperatures which are 
not                 damaging the skin. The responses are jumping, withdrawal of the paws 
and licking of the paws. 
MATERIAL AND METHODS
ANIMALS: 
          Healthy Swiss albino rats of either sex weighing 20
All the animals were obtained from Animal house of the KMCH College of 
Pharmacy, Coimbatore. The animals were housed comfortably in a group of six in a 
single clean plastic cage with a m
standard environmental conditions of temperature (24±1°C) and relative humidity of 
30-70 %. A 12:12 h light dark cycle was followed. All animals had free access to 
water and standard pelletized laboratory a
procedures and protocols used in this study were reviewed and approved via the 
Approval No. -----------------------------
(IAEC) of KMCH College of Pharmacy, Coimbato
Dated 21st August 2002 constituted in accordance with the guidelines of the CPCSEA, 
Government of India. 
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1 
 
 
-25g were used in this study. 
etal frame lid on its top. They were housed under 
nimal diet ad libitum. All the experimental 
 by the Institutional Animal Ethical Committee 
re (685/PO/Re/S/2002/CPSCEA 
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      The hot plate, which is commercially available, consists of a electrically heated 
surface. The temperature is controlled for 55° to 56 °C. This can be a copper plate or a 
heated glass surface. The animals are placed on the hot plate and the time until either 
licking or jumping occurs is recorded by a stop-watch. 
EXPERIMENTAL PROCEUDRE: 
 
        GROUP 1 – CONTROL  
       GROUP 2 –Pentazocine (10mg/kg, I.P) 
       GROUP 3 -- SANTHUVATHA CHOORANAM WITH HOT WATER 
                                   0.54 mg /kg(po)           
 
       GROUP 4 – SANTHUVATHA CHOORANAM WITH HOT WATER 
                                      2.7mg/kg(po) 
 
      GROUP 5 -- SANTHUVATHA CHOORANAM WITH HOT WATER 
                                      13.5mg/kg(po) 
 
PROCEUDRE: 
Mice were screened by placing them on a hot plate maintained at 55±1ºC and 
recording the reaction time in seconds for forepaw licking or jumping. Only mice 
which reacted within 15sec and which did not show large variation when tested on 
four separate occasions, each 15min apart, were taken for the test. The time for 
forepaw licking or jumping on the heated plate of the analgesiometer maintains at 
55ºC was taken as the reaction time. Prior to treatment, the reaction time of each 
mouse (licking of the forepaws or jumping response) was done at 0- and 10-min 
interval. The average of the two readings was obtained as the initial reaction time 
(Tb). The reaction time (Ta) following the administration of the ---------------, 
Pentazocine and distilled water was measured at 0.5, 1, 2, and 3h after latency period 
of 30min. 
The following calculation was:  
          Percentage analgesic activity = Ta-Tb/Tb × 100 
 
 
 
 EFFECT OF SANTHUVATHA CHOORANAM WITH HOT WATER ON HOT 
PLATE METHOD IN MICE
 
GROUP 
 
Reaction time in seconds at time (minutes) (mean ± sem) (mean ± 
sem) 
 
O mints 
 
CONTROL 
 
3.413±0.1009
 
 
STANDAR
D 
 
3.367±0.2035
 
 
S C + LOW 
DOSE 
 
3.6±0.3602
 
 
SC  + 
MIDDLE 
DOSE 
 
3.657±0.0648
9 
 
 
SC+ HIGH 
DOSE 
 
3.37±0.1358
 
 
Values are expressed as the mean ± S.D; Statistical significance (p)calculated by one 
way ANOVA  followed by dunnett’s 
comparing treated group 
 
186 
1 
60 mints 90 mints 120 mints 
 4.37±0.093 
 
4.4±0.305 
 
4.62±0.25
6 
 
 
5.483±0.29
6 
 
6.69±0.191 
 
7.47±0.30
3 
 
 
7.563±0.29
2 
 
8.573±0.32
6 
 
8.26±0.41
7 
 
7.553±0.11
6 
 
7.607±0.14
3 
 
7.57±0.32
8 
 
 
6.423±0.27
6 
 
6.793±0.33
6 
 
7.05±0.3 
 
***P< 0.001, **P < 0.01,*P < 0.05 calculated by 
with CONTROL group. 
180 mints 
4.333±0.2
2 
 
6.707±0.1
8 
 
8.263±0.1
8 
 
7.197±0.1
4 
 
6.67±0.42 
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Name   : 
Ref. No. : [H0 335A/18] 
 
 
Rec.On :  25/03/2018 
Rep.On :  18/04/2018 
 
 
HISTOPATHOLOGY 
TOXICITY STUDY 
 
SPECIMEN                   : A) Liver. 
 
Group –                   : Kunthai – S.C. 
 
GROSS APPEARANCE: 
 
                     Received a specimen of liver measuring 3.4x2.4x1.5cms.                     
 
(PE): Two bits – One block. 
 
MICROSCOPIC APPEARANCE:  
 
                     Section from liver shows altered lobular architecture with interface 
hepatitis. Individual Hepatocytes shows reactive atypia. Portal triad shows no 
significant pathology. Central vein shows congestion. Sinusoids show dilatation. 
 
                                                                                                                                             
Dr.C.R.Ajeethkumar.M.D. (Path). 
 
Consultant pathologists: 
Dr.S.Kalyani.M.D. (Path),   Dr. C.R.Ajeeth kumar.M.D. (Path), 
 
Checked 
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Name   : 
Ref. No. : [H0 335B/17] 
 
Rec.On :  25/03/2018 
Rep.On :  18/04/2018 
 
 
HISTOPATHOLOGY 
         Toxicity study                
 
SPECIMEN                   :  B) spleen. 
 
Group –                   : Kunthai – S.C. 
 
GROSS APPEARANCE:  
 
                     Received a specimen of spleen measuring 2.4x0.8x0.4cms. 
 
 (PE): Two bits – One block. 
 
MICROSCOPIC APPEARANCE:  
 
                     Section studied from spleen shows normal white pulp and red pulp. Red 
pulp shows pigment laden macrophages and congested vessels. White pulp shows 
lymphocytic infiltrates forming germinal centre. The pencillar artery shows normal 
morphology. Megakaryocytes are seen. 
 
 
Dr.C.R.Ajeeth kumar. M.D. (Path), 
 
Consultant pathologists: 
Dr.S.Kalyani.M.D. (Path), Dr. C.R.Ajeeth kumar.M.D. (Path), 
 
 
 
Checked 
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Name   :   
Ref. No. : [Ho 335C/18]                      
 
Rec.On :  25/03/2018 
Rep.On :  18/04/2018 
 
 
HISTOPATHOLOGY 
                                 Toxicity study 
SPECIMEN                          : C) Kidney. 
 
Group –                   : Kunthai – S.C. 
 
GROSS APPEARANCE    : 
 
Received specimen of kidneys each measuring 1.4x0.7x0.5cms and 1.3x0.6x0.4cms. 
 
PE : Two bits – One block.  
 
MICROSCOPIC APPEARANCE:  
 
                     Section from kidney shows both cortex and medulla. Glomeruli shows 
mesangeal matrix expansion and focal hypercellularity (Less than 50%). Tubules 
show no significant pathology. Interstitium shows no significant pathology. Blood 
vessels show congestion.  
 
                                                                       Dr. C.R.Ajeeth kumar.M.D. (Path). 
 
 
 
Consultant pathologists: 
Dr.S.Kalyani.M.D. (Path),   Dr. C.R.Ajeeth kumar.M.D. (Path), 
 
 
 
Checked 
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Name   :   
Ref. No. : [Ho 333D/18]                      
 
Rec.On :  25/03/2018 
Rep.On :  18/04/2018 
 
 
HISTOPATHOLOGY 
                                 Toxicity study 
SPECIMEN                          : D) Testis. 
 
Group –                   : Kunthai – S.C. 
 
GROSS APPEARANCE    : 
 
Received specimen of both testis measuring each 1.2x0.7x0.5cms and 
1.0x0.5x0.4cms. 
 
PE : Two bits – One block.  
 
MICROSCOPIC APPEARANCE:  
 
                     Section from testes with seminiferous tubules showing maturation arrest 
with lacking of spermatogenesis.  
 
                                                                       Dr. C.R.Ajeeth kumar.M.D. (Path). 
 
 
Consultant pathologists: 
Dr.S.Kalyani.M.D. (Path),   Dr. C.R.Ajeeth kumar.M.D. (Path), 
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HISTOPATHOLOGY SLIDES 
 
LIVER 
 
               
 10X shows altered architecture                    40X shows central vein dilatation and congestion 
                
       40X interface hepatitis                                      40X shows reactive atypia 
                 
40 X shows sinusoidal dilatation                          40X shows sinusoidal dilatation 
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SPLEEN 
                  
        10X shows normal spleen                             40 X shows megakaryocytes 
 
                 
40X shows lymphocytic infiltrates      40X shows lymphocytic infiltrates red pulp congestion 
               
40X shows red pulp congestion                      40X  shows lymphocytic infiltrates 
 
     10 X shows global hyperplasia                            10X shows interstitium
     40 X shows hypercellularity
    
   40X shows normal interstitium
193 
KIDNEY 
                
                 
                                   40 X shows mesangeal matrix 
   expansion with hypercellularity
                
                             40X shows tubules 
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TESTIS 
             
      10 X shows maturation arrest                      10 X shows maturation arrest 
 
               
     40X shows maturation arrest                        40X shows maturation arrest 
            
 40X shows maturation arrest with no spermatogenesis    40X shows maturation arrest 
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ANNEXURE –V 
ASSESSMENT FORMS 
 
FORM I  : Screening and Selection Proforma 
FORM I A  : History Proforma on Enrollment 
FORM II  : Clinical assessment on enrollment 
FORM II A  : Clinical assessment during and after trial 
FORM III  : Laboratory Investigation on enrollment and conclusion  of 
trial 
FORM IV  : Consent Form 
FORM IV B  : Withdrawal form 
FORM IV C  : Patient information sheet 
FORM IV D  : Dietary Advice form 
FORM IV E  : Adverse Reaction form 
FORM IV F  : Discharge proforma 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
POST GRADUATE DEPARTMENT 
PALAYAMKOTTAI, TIRUNELVELI – 627002 
BRANCH – III SIRAPPU MARUTHUVAM 
 
A PILOT STUDY TO EVALUATE THE THERAPEUTIC EFFICACY OF SIDDHA 
FORMULATION “SANTHUVATHA CHOORANAM ” INTERNAL & “VATHA 
ENNAI” EXTERNAL IN “SANTHU VATHAM” (POLYARTHRITIS). 
 
FORM I – SCREENING & SELECTION PROFORMA 
 
1. OP / IP NO    : ___________ 
2. NAME   : ___________ 
3. RELIGION    : H / C / M / O 
4. AGE / GENDER  : ___________ 
5. OCCUPATION  : ___________ 
6. INCOME   : ___________ 
7. CONTACT NO  : ___________ 
8. INCLUSION CRITERIA :  
 
INCLUSION CRITERIA: 
● Age   :  between 20- 60 years  
● Sex  : Both  
● Joints pain : more than 5 joint 
● Swelling   
● Stiffness  
● Restricted movements in affected joint.  
Willing for admission and study in IPD for 40 days or willing to attend OPD 
EXCLUSION CRITERIA: 
● Rheumatic Fever  
● Rheumatoid  
● Gout  
● Fracture  
● Dislocation of joints 
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● Malignancy  
● Use of narcotic drugs  
● Pregnancy and Lactating women 
● Tuberculosis 
● Other systemic illness 
 
ADMITTED TO TRIAL: 
    YES  NO 
If Yes Serial Number : 
Date  :  
Station: 
Signature of the Investigator : 
Signature of the Lecturer :    Signature of the HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
POST GRADUATE DEPARTMENT 
PALAYAMKOTTAI, TIRUNELVELI – 627002 
BRANCH – III SIRAPPU MARUTHUVAM 
A PILOT STUDY TO EVALUATE THE THERAPEUTIC EFFICACY OF SIDDHA 
FORMULATION “SANTHUVATHA CHOORANAM ” INTERNAL & “VATHA 
ENNAI” EXTERNAL IN “SANTHU VATHAM” (POLYARTHRITIS). 
 
FORM I A – HISTORY PROFORMA 
1. SL.NO     : ___________ 
2. OP / IP NO     : ___________ 
3. NAME    : ___________ 
4. RELIGION     : H / C / M / O 
5. AGE / GENDER   : ___________ 
6. OCCUPATION   : ___________ 
7. INCOME    : ___________ 
8. CONTACT NUMBER  : ___________ 
9. MARITAL STATUS   : Married / Unmarried 
10. COMPLAINTS & DURATION : 
 
11. PERSONAL HISTORY: 
PERSONAL HABITS YE
S 
N
O 
IF YES SPECIFY 
DURATION 
Smoking    
Tobacco Chewing    
Alcohol    
Narcotic Drug 
Addiction 
   
12. DRUG HISTORY: 
 Whether the Patient has underwent any allopathic Treatment  
1. Yes    2. No. 
 If yes specify the nature of the drug and treatment duration _____ 
 
13. FAMILY HISTORY:
 Whether this problem runs in family?
1. Yes  2. No
If yes, mention the relationship of affected person(s)
1. ___________ 
2. ___________ 
14. DIETARY HABITS :
 
   1. Pure vegetarian
   2. Non
 
Date  :  
Station: 
Signature of the Investigator
Signature of the Lecturer 
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-Vegetarian 
 : 
:    Signature of the HOD
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
POST GRADUATE DEPARTMENT 
PALAYAMKOTTAI, TIRUNELVELI – 627002 
BRANCH – III SIRAPPU MARUTHUVAM 
A PILOT STUDY TO EVALUATE THE THERAPEUTIC EFFICACY OF SIDDHA 
FORMULATION “SANTHUVATHA CHOORANAM ” INTERNAL & “VATHA 
ENNAI” EXTERNAL IN “SANTHU VATHAM” (POLYARTHRITIS). 
 
FORM II AND II-A  CLINICAL ASSESSMENT ON ENROLLMENT AND ON 
VISITS 
 
1. OP / IP No     :  
2. BED No    :  
3. SL. NO    : 
4. NAME    : 
5. AGE     : 
6. GENDER    : 
7. OCCUPATION   : 
8. SOCIAL STATUS   : 
9. DATE OF ADMISSION  : 
10. DATE OF DISCHARGE  : 
11. POSTAL ADDRESS   : 
12. COMPLAINTS & DURATION : 
13. HISTORY OF PRESENT ILLNESS : 
14. PAST HISTORY   : 
15. FAMILY HISTORY   : 
16. MENSTRUAL HISTORY (If Applicable): 
17. HABITS: 
1. Smoker    : 
2. Alcoholic    : 
3. Tobbaco chewer   :  
4. Betel nut chewer   : 
5. Non-Vegetarian   : 
6. Drug addiction   : 
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18. GENERAL EXAMINATION: 
1. Body weight (Kg)   : 
2. Height (Cm)   :  
3. Body Temperature (F) :  
4. Blood Pressure (mmHg)  : 
5. Pulse Rate (/min)   : 
6. Heart Rate (/min)   : 
7. Respiratory Rate (/min)  :  
8. Pallor    :  
9. Jaundice    : 
10. Clubbing    : 
11. Cyanosis    : 
12. Pedal Oedema   :  
13. Lymphadenopathy   :  
14. Jugular venous pulsation  : 
 
19. CLINICAL EXAMINATION: 
I. INSPECTION: 
1. Attitude    : 
2. Muscular spasm   : 
3. Muscle wasting – Proximal :  
4. Muscle wasting – Distal  : 
5. Minor Joint Swelling  : 
6. Major Joint Swelling  : 
7. Nodules    : 
8. Deformity    : 
II. PALPATION: 
1. Swelling    : 
2. Tenderness   :  
3. Joint Stiffness   : 
4. Muscle wasting   : 
5. Local heat    : 
6. Local Lymphadenopathy  : 
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7. Pitting Oedema   : 
8. Nodules    : 
III. MOVEMENTS: 
Restriction of joint movements 
1. Neck              :            Full            Partial    
2. Shoulder  : 
3. Elbow joint  : 
4. Knee joint  : 
5. Ankle joint  : 
6. Hip joint  : 
7. Minor joints  : 
IV. PAIN: 
1. Onset :    Sudden : Gradual : 
2. Early morning stiffness :   Present : absent  : 
3. Nature of pain:  Mild  : Moderate :     Severe: 
4. Aggravating factor –Movements  : 
5. Relieving factor – rest   : 
6. Stiffness     : 
7. Tenderness    :  
 
V. CLINICAL ASSESSMENT :  
1. Arthritis of three or more Joints  : 
2. Arthritis of hand joints   : 
3. Morning Stiffness    : 
4. Fever     : 
5. Anorexia     : 
6. Anaemia     : 
7. Spindle appearance of fingers : 
8. Restricted movements  : 
9. Rheumatoid Nodules   : 
10. Numbness     : 
20. EXAMINATION OF OTHER SYSTEMS:  
1. CVS    : 
2. RS     : 
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3. CNS    : 
4. ABDOMEN   : 
5. GENITO – URINARY  : 
 
EXAMINATION – SIDDHA ASPECTS 
1. NILAM: 
 1. Kurinji 2. Mullai 3. Marutham 4. Neithal 5. Paalai 
2. KAALAM: 
 1. Kaar Kaalam 2. Koothir Kaalam 3. Munpani Kaalam 
 4. Pinpani Kaalam 5. Elavenir Kaalam 6. Mudhuvenir Kaalam 
3. YAAKKAI:  
 1. Vatham   2. Pitham   3. Kabam 
 4. Vathapitham  5. Pithavatham  6. Kabavatham 
 7. Vathakabam  8. Pithakabam   9. Kabapitham 
4. GUNAM:  
 1. Sathuvam   2. Rasatham   3. Thamasam 
5. KANMENDHIRIUM / KANMAVIDAYAM 
 1. Kai   : 
 2. Kaal   : 
 3. Vaai   : 
 4. Eruvaai  : 
5. Karuvaai  : 
6. UYIR THATHUKKAL: 
I. VATHAM: 
1. Piraanan  : 
2. Abaanan  : 
3. Viyaanan  : 
4. Uthaanan  : 
5. Samaanan  : 
6. Naagan  : 
7. Koorman  : 
8. Kirukaran  : 
9. Devathathan : 
10. Dhananjeyan : 
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II. PITHAM : 
1. Analagam  : 
2. Ranjagam  : 
3. Saathagam  : 
4. Aalosagam  : 
5. Praasagam  : 
III. KABAM: 
1. Avalambagam : 
2. Kilethagam : 
3. Pothagam  : 
4. Tharpagam : 
5. Santhigam  : 
7. UDAL THAATHUKKAL: 
1. Saaram : 
2. Senneer  : 
3. Oon  : 
4. Kozhuppu  : 
5. Enbu  : 
6. Moolai  : 
7. Sukkilam / Suronitham: 
8. ENVAGAI THERVUGAL: 
1. Naadi  : 
2. Sparisam  : 
3. Naa  :  
4. Niram  : 
5. Mozhi  : 
6. Vizhi  : 
7. Malam :  
i. Niram:  ii. Thanmai: iii. Irugal: iv.Ilagal: 
8. Moothiram : 
I. NEERKURI: 
 a. Niram : 
 b. Manam : 
 c. Edai  : 
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 d. Nurai : 
 e. Enjal : 
II. NEIKURI: 
 Vatha Neer  :  Pittha Neer   :    Kaba Neer : 
Date  :  
Station: 
Signature of the Investigator : 
Signature of the Lecturer :    Signature of the HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
POST GRADUATE DEPARTMENT 
PALAYAMKOTTAI, TIRUNELVELI – 627002 
BRANCH – III SIRAPPU MARUTHUVAM 
A PILOT STUDY TO EVALUATE THE THERAPEUTIC EFFICACY OF SIDDHA 
FORMULATION “SANTHUVATHA CHOORANAM ” INTERNAL & “VATHA 
ENNAI” EXTERNAL IN “SANTHU VATHAM” (POLYARTHRITIS). 
 
FORM III – LABORATORY INVESTIGATION 
1. BLOOD: 
1. TC    : (Cells / Cumm) 
2. DC (%)  : N : L : M : E : 
3. ESR (mm)  : ½ hr : 1 hr : 
4. Hb   : 
5. Blood Sugar  : a) Fasting : b) Post Prandial : 
6. Renal function tests: 
Blood Urea:  Serum creatinine: 
7. Lipid profile  : 
HDL:   LDL:  VLDL: 
Total Cholesterol : TGL : 
8. Liver Function tests: 
Serum Bilirubin :  Total  Direct  Indirect 
 
SPECIFIC INVESTIGATIONS 
 RA factor   : 
 ASO titre   : 
 C-Reactive Protein  : 
 SGOT    : 
SGPT    : 
 Serum albumin & globulin : 
 Total protein   : 
II. URINE: 
1. Albumin   : 
2. Sugar   : 
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3. Epithelial cells : 
4. Pus cells   : 
5. Red blood cells  : 
6. Casts / Crystals  : 
III. MOTION: 
1. Ova   : 
2. Cyst   : 
3. Occult blood  : 
4. Pus cells   : 
IV. X-RAY FINDINGS 
 
 
 
Date  :  
Station: 
Signature of the Investigator : 
Signature of the Lecturer :    Signature of the HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
POST GRADUATE DEPARTMENT 
PALAYAMKOTTAI, TIRUNELVELI – 627002 
BRANCH – III SIRAPPU MARUTHUVAM 
A PILOT STUDY TO EVALUATE THE THERAPEUTIC EFFICACY OF SIDDHA 
FORMULATION “SANTHUVATHA CHOORANAM ” INTERNAL & “VATHA 
ENNAI” EXTERNAL IN “SANTHU VATHAM” (POLYARTHRITIS). 
 
FORM IV A – CONSENT FORM 
 
CERTIFICATE BY INVEST INVESTIGATOR 
 I certify that I have disclosed all the details about the study in the terms readily 
understood by the patient. 
Signature ______________ 
Date      ______________ 
Name    ______________ 
CONSENT BY PATIENT 
 I have been informed to my satisfaction, by the attending physician, the 
purpose of the clinical trial, and the nature of drug treatment and follow-up including 
the laboratory investigations to be performed to monitor and safeguard my body 
functions. 
 I am aware of my right to opt out of the trial at any time during the course of 
the trial without having to give the reasons for doing so. 
 I exercising my free power of choice, hereby give my consent to be included 
as a subject in the clinical trial of “SANTHUVATHA CHOORANAM ” (Internal 
drug) and “VATHA ENNAI” (External drug) for the treatment of “SANTHU 
VATHAM” (POLYARTHRITIS)”. 
 
Place :        Signature  :  
Date :         Name  : 
        Witness Signature: 
        Name  : 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
POST GRADUATE DEPARTMENT 
PALAYAMKOTTAI, TIRUNELVELI – 627002 
BRANCH – III SIRAPPU MARUTHUVAM 
A PILOT STUDY TO EVALUATE THE THERAPEUTIC EFFICACY OF SIDDHA 
FORMULATION “SANTHUVATHA CHOORANAM ” INTERNAL & “VATHA  
ENNAI” EXTERNAL IN “SANTHU VATHAM” (POLYARTHRITIS). 
FORM IV – B  - WITHDRAWAL FORM 
 
1. SL.NO    : ___________ 
2. OP / IP NO    : ___________ 
3. NAME   : ___________ 
4. RELIGION    : H / C / M / O 
5. AGE / GENDER  : ___________ 
6. OCCUPATION  : ___________ 
7. SOCIAL STATUS  : ___________ 
8. CONTACT NO  : ___________ 
9. DATE OF TRIAL COMMENCEMENT  : ___________ 
10. DATE OF WITHDRAWAL FROM TRIAL : ___________ 
11. REASONS FOR WITHDRAWAL   : ___________ 
➢
 Long absence at reporting   :  Yes / No 
➢
 Irregular treatment    :  Yes / No 
➢
 Shift of locality    :  Yes / No 
➢
 Increase in severity of symptoms  :  Yes / No 
➢
 Development of severe adverse drug reactions:  Yes / No 
 
Date  :  
Station: 
Signature of the Investigator : 
Signature of the Lecturer :    Signature of the HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
POST GRADUATE DEPARTMENT 
PALAYAMKOTTAI, TIRUNELVELI – 627002 
BRANCH – III (SIRAPPU MARUTHUVAM) 
 
A PILOT STUDY TO EVALUATE THE THERAPEUTIC EFFICACY OF SIDDHA 
FORMULATION “SANTHUVATHA CHOORANAM ” INTERNAL & “VATHA 
ENNAI” EXTERNAL IN “SANTHU VATHAM” (POLYARTHRITIS). 
 
FORM – IV C  DRUG COMPLIANCE FORM 
 
Name of the Drug : SANTHUVATHA  CHOORANAM 
Drugs issued  : (Mg / Gram) 
Drugs returned : (Mg / Gram) 
 
S. NO DATE DRUG TAKEN TIME 
MORNING / TIME EVENING / 
TIME 
Day 1    
Day 2    
Day 3    
Day 4     
Day 5    
Day 6    
Day 7    
Day 13    
Day 14    
Day 15    
Day 16    
Day 17    
Day 18    
Day 19    
Day 25    
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Day 26    
Day 27    
Day 28    
Day 29    
Day 30    
Day 31    
Day 37    
Day 38    
Day 39    
Day 40    
Day 41    
Day 42    
Day 43    
Day 44    
Day 45    
Day 46    
Day 47    
Day 48     
 
 
Date  :  
Station: 
Signature of the Investigator : 
Signature of the Lecturer :    Signature of the HOD  
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